<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1007/s00394-020-02324-y</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">394</journal-id><journal-id journal-id-type="doi">10.1007/394.1436-6215</journal-id><journal-title-group><journal-title>European Journal of Nutrition</journal-title><abbrev-journal-title abbrev-type="publisher">Eur J Nutr</abbrev-journal-title></journal-title-group><issn pub-type="ppub">1436-6207</issn><issn pub-type="epub">1436-6215</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s00394-020-02324-y</article-id><article-id pub-id-type="manuscript">2324</article-id><article-id pub-id-type="doi">10.1007/s00394-020-02324-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Akobeng</surname><given-names>Anthony K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Parul</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Manoj</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Al Khodor</surname><given-names>Souhaila</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs0039402002324y_cor4">d</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution content-type="org-division">Division of Gastroenterology, Hepatology, and Nutrition</institution><institution content-type="org-name">Sidra Medicine</institution></institution-wrap><addr-line content-type="city">Doha</addr-line><country country="QA">Qatar</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution content-type="org-division">Weill Cornell Medicine</institution><institution content-type="org-name">Cornell University</institution></institution-wrap><addr-line content-type="city">Doha</addr-line><country country="QA">Qatar</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution content-type="org-division">Research Department</institution><institution content-type="org-name">Sidra Medicine</institution></institution-wrap><addr-line content-type="city">Doha</addr-line><country country="QA">Qatar</country></aff></contrib-group><author-notes><corresp id="IDs0039402002324y_cor4"><label>d</label><email>salkhodor@sidra.org</email></corresp></author-notes><pub-date date-type="epub"><day>10</day><month>7</month><year>2020</year></pub-date><pub-date date-type="ppub"><month>12</month><year>2020</year></pub-date><volume>59</volume><issue seq="2">8</issue><fpage>3369</fpage><lpage>3390</lpage><history><date date-type="registration"><day>1</day><month>7</month><year>2020</year></date><date date-type="received"><day>16</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>7</month><year>2020</year></date><date date-type="online"><day>10</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>Â© The Author(s) 2020</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Purpose</title><p id="Par1">Although genetic predisposition and exposure to dietary gluten are considered necessary triggers for the development of coeliac disease, alterations in the gut microbial composition may also contribute towards the pathogenesis of coeliac disease. This review aims to provide an overview of the available data on the potential mechanisms through which the gut microbiota plays a role in the causation of coeliac disease and to discuss the potential therapeutic strategies that could diminish the consequences of microbial dysbiosis.</p></sec><sec id="ASec2"><title>Method</title><p id="Par2">A search of the literature was performed using the PubMed, Embase, and JSTOR databases; relevant articles were included.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">Recent studies in patients with coeliac disease have reported an increase in the relative amounts of gram negative bacterial genera such as <italic>Bacteroides</italic>, <italic>Prevotella</italic>, and <italic>Escherichia</italic>, and reduced amounts of protective anti-inflammatory bacteria such as <italic>Bifidobacteria</italic> and <italic>Lactobacilli</italic>. Dysbiotic microbiota may lead to a dysregulated immune response that may contribute to the pathogenesis of coeliac disease. In infancy, antibiotic use and certain infant feeding practices may lead to alterations in the developing gut microbiota to influence the immune maturation process and predispose to coeliac disease.</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">The induction of the intestinal immune system and gluten intolerance may be influenced by the relative abundance of certain microbiota. Factors such as infant feeding practices, diet, antibiotics, and infections, may be involved in the development of coeliac disease due to their influence on gut microbial composition. The efficacy of potential modulators of the gut microbiota such as probiotics, prebiotics, and fecal microbial transplant as adjunctive treatments to gluten-free diet in coeliac disease is unproven and requires further investigation.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Coeliac disease</kwd><kwd>Microbiota</kwd><kwd>Metagenomics</kwd><kwd>Dysbiosis</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Open access funding provided by Qatar National Library</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Springer</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>8</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>43</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>Springer-Verlag GmbH Germany, part of Springer Nature</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>7</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/394_2020_Article_2324.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-month</meta-name><meta-value>11</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-day</meta-name><meta-value>17</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-month</meta-name><meta-value>11</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-day</meta-name><meta-value>17</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Chemistry</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nutrition</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Chemistry and Materials Science</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="AuthorContribution"><p>Anthony K. Akobeng and Parul Singh equal first authors.</p></notes></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Coeliac disease is an autoimmune disorder triggered by the ingestion of gluten in genetically susceptible people [<xref ref-type="bibr" rid="CR1">1</xref>]. The disorder is characterized by a mucosal disease of the proximal small bowel as a result of a T-cell mediated destruction of mucosal epithelial cells. It is generally acknowledged that coeliac disease affects about 1% of the population with an increasing prevalence [<xref ref-type="bibr" rid="CR2">2</xref>] that varies between countries [<xref ref-type="bibr" rid="CR3">3</xref>]. Patients with coeliac disease develop a permanent loss of immune tolerance to gluten [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], a protein found in cereals such as wheat, rye, and barley. Upon ingestion, gluten can cause a pathological injury characterized by progressive degrees of inflammation and loss of villi in the proximal small bowel leading to the development of gastrointestinal malabsorption along with extra-gastrointestinal manifestations [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par6">Coeliac disease is a multifactorial disease, characterized by a complex interplay of genetic and environmental factors. While genetic factors (such as the presence of Human Leukocytic Antigenâmainly HLA-DQ2 or HLA DQ-8) and exposure to dietary gluten are considered to be necessary triggers, they are not sufficient for disease development [<xref ref-type="bibr" rid="CR6">6</xref>]. Additional factors such as infant feeding practices, the amount of gluten ingested, the age at which gluten is introduced, neonatal infections, rotavirus infections, and early life exposure to antibiotics can play a pathogenic role in the development of the disease possibly through modulation of the gut microbiota [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par7">The human gastrointestinal tract harbors approximately 100 trillion micro-organismsâmainly bacteria, but also viruses, fungi, and protozoa [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The gut microbiota provides the host with several significant benefits including maintaining the integrity of the mucosal barrier, providing nutrients such as vitamins, protecting against pathogens, and helping to regulate immune function [<xref ref-type="bibr" rid="CR12">12</xref>]. Various chronic disorders such as inflammatory bowel disease [<xref ref-type="bibr" rid="CR13">13</xref>], and type 1 diabetes [<xref ref-type="bibr" rid="CR14">14</xref>] have been shown to be associated with alterations in the gut microbial composition. Recent studies have also suggested that intestinal dysbiosis may play a role in the pathogenesis of coeliac disease [<xref ref-type="bibr" rid="CR15">15</xref>â<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par8">In this article, we aim to discuss the latest findings regarding the intestinal microbiota composition, and its potential mechanisms for causing coeliac disease. We also highlight the current knowledge on the enteric virome and the mobile microbiota such as oral and blood microbiota in relation toÂ coeliacÂ disease. Finally, we discuss the therapeutic strategies that could diminish the consequences of microbial dysbiosis in coeliac disease.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><p id="Par9">A medical literature search was conducted using PubMed, Embase, and JSTOR databases for articles published from the beginning of the database until Jan 5th, 2020. The initial search was done using the general search terms: (coeliac disease OR celiac disease OR gluten-sensitive enteropathy) AND (gut microbiota OR gut microbiome OR intestinal microbiome). Additional searches were performed to collect specific data on the use of diet, probiotics, prebiotics, antibiotics, and fecal microbial transplantation in coeliac disease. Only articles published in English were included. No restrictions were placed on the study design or the type of article. References of the included articles were also reviewed for additional relevant articles.</p></sec><sec id="Sec3" sec-type="results"><title>Results</title><p id="Par10">FigureÂ <xref rid="Fig1" ref-type="fig">1</xref> details the flow-chart of the literature review process. We have included 206 studies based on their relevance to the review topic.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Flowchart of the Study selection for literature review</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="394_2020_2324_Fig1_HTML.png" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Gluten and immune system in coeliac disease</title><p id="Par11">Several studies have highlighted the complex interplay between host polygenic disorder and the ingested gluten proteins in disturbing the host epithelial functions in patients with coeliac disease [<xref ref-type="bibr" rid="CR19">19</xref>â<xref ref-type="bibr" rid="CR21">21</xref>], but little is known about the multifactorial interplay and how gluten starts the entire process.</p><p id="Par12">The primary event of a gluten-induced inflammatory immune response requires that gluten peptides translocate via intracellular or paracellular mechanisms through the intestinal epithelial barrier [<xref ref-type="bibr" rid="CR22">22</xref>] and have access to the lamina propria. Glutens consists of the subunits of monomeric gliadins and polymeric glutenins. The high content of proline and glutamine-rich polypeptide residues in the gluten subunits makes them resistant to the proteolytic degradation by the gastrointestinal enzymes, thus, yielding rather large peptides, up to 33-mer in length [<xref ref-type="bibr" rid="CR23">23</xref>]. Intestinal epithelia under normal physiological conditions are impermeable to macromolecules, such as gliadin. In coeliac disease, the integrity of the tight junction (TJ) system in the epithelial cells layer is compromised partly due to the upregulation of zonulin, an intestinal peptide involved in TJ regulation [<xref ref-type="bibr" rid="CR24">24</xref>]. Nonetheless, the relatively poor digestion of these proteins or the resulting increased gut permeability is not sufficient to cause coeliac disease [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The multifactorial pathogenesis of coeliac disease appears to stem from genetic susceptibility which, in addition to other unknown contributing factors, triggers the innate and adaptive immune response. In a process called deamidation, tissue transglutaminase 2 (tTG2) modifies gluten peptides to negatively charged glutamic acid [<xref ref-type="bibr" rid="CR27">27</xref>]. The deamidated gluten peptides in the lamina propria are then taken up by the dendritic cells (DC) carrying human leukocyte antigen (HLA-DQ2 and HLA-DQ8) haplotypes [<xref ref-type="bibr" rid="CR21">21</xref>], which in turn modulate the gluten-specific immune response by activating the gluten-reactive CD4â+âT cells and intraepithelial-CTLs [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Different types of HLA complexes such as HLA-DQ2.5 (HLA-DQA1*05/HLA-DQB1*02), HLA-DQ8 (HLA-DQA1*03/HLA-DQB1*03:02), and HLADQ2.2 (HLA-DQA1*02:01/HLA-DQB1*02) are associated with coeliac disease pathogenesis [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] and have been reported in more than 90% of coeliac disease patients [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par13">Stimulated gluten-specific CD4â+âT cells can result in the overactivation of the various immune functionsâfor example activated CD4â+âT cells can further stimulate B cells to produce autoantibodies such as anti-gluten, transglutaminase 2 (TG2) and anti-tissue antibodies [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] that could induce changes in the cytoskeleton of enterocyte through actin redistribution and the consequent epithelial cell damage [<xref ref-type="bibr" rid="CR32">32</xref>]. The CD4â+âT cells can also produce a high level of pro-inflammatory cytokines and induce specific T<sub>H</sub>1 cells leading to the production of excessive amounts of IL-21 and IFN-Î³ [<xref ref-type="bibr" rid="CR33">33</xref>]. As a result, the undue amounts of IL-21 and IFN-Î³ in the lamina propria not only exacerbate intestinal inflammation, epithelial tissue damage and tissue junction disassembly, but also lead to fibroblast or lamina propria mononuclear cell secretion of matrix metalloproteinases. These are responsible for tissue remodeling resulting in villus atrophy and crypt hyperplasia, the known characteristics of coeliac disease (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>). Intriguingly, the increased production of IL-15 by intestinal epithelial cells was observed only in coeliac disease patients with HLA-DQ allotypes, not only disturbing the integrity of the epithelial barrier to induce coeliac disease pathogenesis, but also altering the intestinal immune regulation [<xref ref-type="bibr" rid="CR34">34</xref>]. For example, IL-15 has been found to inhibit the inducible differentiation of T<sub>Reg</sub> cells [<xref ref-type="bibr" rid="CR35">35</xref>], induce cytotoxic killing of epithelial cells [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], and trigger the production of IL-21 [<xref ref-type="bibr" rid="CR38">38</xref>] leading to increased epithelial transport of toxic and immunogenic gluten peptides in coeliac patients [<xref ref-type="bibr" rid="CR39">39</xref>]. Furthermore, it has been shown that IL-15 stimulates the activation of IFN-Î³ producing CD8â+âIELs (intraepithelial lymphocytes) such as (CD8â+âTCRÎ±Î²â+âand TCRÎ³Î´â+âT cells harboring the NK receptor) in the lamina propria, and contributes to the selective expansion of the IEL population independently of antigen presentation [<xref ref-type="bibr" rid="CR30">30</xref>], indicating the crucial role of IL-15 in causing inflammation and lesions in the intestines.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>The immune response in coeliac disease pathogenesis is mediated by both B cell and T cell response. The intestinal microbiota, both commensals microbes and pathobionts, might contribute to the development of coeliac disease by influencing the gluten peptide digestion, stimulation of DC and T<sub>Reg</sub> cells, epithelial cell stress, intestinal permeability modulation, and pro-inflammatory cytokines production. Microbial flagellin or LPS can stimulate AMPs from epithelial cells and release of mucins from goblet cells. The translocated gluten peptides in the lumen of the small intestine are first deamidated by the tissue TG2 in the lamina propria and are then taken up by the dendritic cells to trigger the proinflammatory gluten-specific CD4â+âT-cell response in the mesenteric lymph nodes. The activated CD4â+âT-cell prime the B-cells to produce different types of antibodies such as anti-gliadin, anti-TG2 IgA antibodies and also stimulate the gluten-specific TH1 cell to produce IL-21 and IFN-Î³ cytokines to cause intestinal inflammation in genetically predisposed hosts. Activation of the innate immune response is a key initial step in coeliac disease. Increased epithelial stress due to microbial dysbiosis or ingested gluten peptides can trigger stress molecules on epithelial cells (HLA-E, MICA/B) and induce IL-15 production from epithelial cells. In the presence of IL-15, CD8â+âIELs can induce epithelial lesions via production of different cytotoxic molecules (perforin or granzymes). <italic>DC</italic> dendritic cells, T<sub>Reg</sub> cells T Regulatory cells, <italic>IL</italic> interleukin, <italic>TG2</italic> transglutaminase 2, <italic>IgA</italic> immunoglobulin A, <italic>IFN</italic> interferon, <italic>LPS</italic> lipopolysaccharides, <italic>SCFAs</italic> short-chain fatty acids, <italic>TNF</italic> tumor necrosis factor, <italic>Th</italic> T helper, <italic>HLA</italic> human leukocyte antigen, <italic>TLR</italic> toll-like receptors, <italic>IEL</italic> intraepithelial lymphocytes, <italic>NKG2C</italic> natural killer group 2C receptor, <italic>NKG2D</italic> natural killer group 2D receptor</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="394_2020_2324_Fig2_HTML.png" id="MO2"/></fig></p><p id="Par14">It is currently unclear how gluten could have such a range of immunological effectsÂ (as shown above) and how it binds to unrelated receptors. Further studies are needed to identify the exact molecular mechanisms involved in the immunogenicity of gluten. Based on the current data, it is fair to conclude that in genetically susceptible individuals, gluten leads to the activation of cellular stress pathways and the release of proinflammatory mediators promoting the development of inflammatory T-cell responses.Â Clinical trials of drugs aimed at reducing the immune activation in response to gluten are currently underway with promising results [<xref ref-type="bibr" rid="CR40">40</xref>].</p></sec><sec id="Sec5"><title>Gut microbiota and coeliac disease</title><p id="Par15">Approximately 30% of the general population bears the main susceptibility genes for coeliac disease (HLA-DQ2 and HLA DQ-8), but only a small proportion of these individuals can develop the disease [<xref ref-type="bibr" rid="CR41">41</xref>]. Studies have shown, in contrast to the original hypothesis, that coeliac disease can occur at any age [<xref ref-type="bibr" rid="CR42">42</xref>] irrespective of delayed or early gluten introduction [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], and in some cases years after the introduction of gluten [<xref ref-type="bibr" rid="CR9">9</xref>]. The increasing number of patients experiencing the onset of coeliac disease in adult life despite their early exposure to gluten [<xref ref-type="bibr" rid="CR44">44</xref>], together with the lack of 100% concordance of coeliac disease in monozygotic twins, suggests that additional factors such as infections and changes in the gut microbial composition may contribute to pathogenesis and full manifestation of the disease [<xref ref-type="bibr" rid="CR45">45</xref>]. The intestinal microbiota establishesÂ mutual relationships with the humanÂ host and plays a central roleÂ in the host immune system regulation. Healthy gut microbiota supports many aspects of overall health while several complex inflammatory immune-mediated diseases including IBD [<xref ref-type="bibr" rid="CR46">46</xref>], obesity, and diabetes [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] have beenÂ linked to dysbiosis of the gut microbiota.</p><sec id="Sec6"><title>The human gut microbiota</title><p id="Par16">The human microbiota consists of a wide range of bacteria, viruses, fungi, and archaea that live inside and on our bodies. The largest population of microbes resides in our gut and consists of 70% of all microbes [<xref ref-type="bibr" rid="CR49">49</xref>]. It is estimated that we can bear up to 2Â kg of microbes in our gut, and out of those trillions of microorganisms there are at least 500â1000 species of bacteria with more than 3 million genes overwhelmingly exceeding the 20,000â25,000 human genes [<xref ref-type="bibr" rid="CR50">50</xref>â<xref ref-type="bibr" rid="CR52">52</xref>]. <italic>Firmicutes</italic> (60â80%) and <italic>Bacteroidetes</italic> (15â25%) are the dominant bacterial phyla, which along with other less abundant phyla such as <italic>Proteobacteria</italic>, <italic>Actinobacteria</italic> and <italic>Verrucomicrobia</italic> make up 98% of the gut microbiome in healthy adults. The microbial species diversity and density increase distally from the stomach to the colon, which contains the highest microbial density recorded in any habitat on Earth with over 10<sup>13</sup>Â microbial cells [<xref ref-type="bibr" rid="CR53">53</xref>]. The initial colonization of the gut by microbes is one of the most important processes in human life. It is generally believed that microbial colonization of the gastrointestinal tract (GIT) begins at birth with theÂ maternal inoculum transferred during delivery and breastfeeding imprinting the early infant microbiota [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Perinatal factors such as mode of delivery, diet, genetics, the environment, and geographical factors may also influence microbial composition [<xref ref-type="bibr" rid="CR56">56</xref>]. The microbial diversity increases and converges in the first 2â5Â years of life towards an adult-like microbiota, along with the development of the intestinal epithelium and the secreted intestinal mucosal barrier, which supports the mutual relationship with the commensal gut microbiota and provides a barrier against pathogenic organisms. Gut microbes benefit the host byÂ fermentingÂ dietary fiberÂ intoÂ short-chain fatty acidsÂ (SCFAs), such asÂ acetic, propionic and butyric acids, which are then absorbed by the host [<xref ref-type="bibr" rid="CR57">57</xref>], and in synthesizingÂ vitamin BÂ andÂ vitamin KÂ as well as metabolizingÂ bile acids,Â sterols, andÂ xenobiotics [<xref ref-type="bibr" rid="CR58">58</xref>]. Once established, the composition of the gut microbiota is relatively stable, however, lifetime events such as infections, antibiotics treatment, and long-term dietary changes can lead to microbial dysbiosis [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par17">Characterization of the human intestinal microorganisms was performed conventionally by traditional culture-based methods, limiting the output range to cultivable microbes only. The advances in next-generation sequencing (NGS) technologies have enabled the intestinal microbiota genomes to be fully evaluated [<xref ref-type="bibr" rid="CR59">59</xref>â<xref ref-type="bibr" rid="CR61">61</xref>]. The most widely used method of microbiome research relies on the amplicon sequencing of the 16S rRNA gene [<xref ref-type="bibr" rid="CR62">62</xref>].</p></sec><sec id="Sec7"><title>Characteristics of the gut microbiota in coeliac disease</title><p id="Par18">Maintaining a diverse and well-balanced (homeostatic) gut microbial population is essential for good health. Pathogenic and symbiotic microbiota coexist in a healthy body, however, disturbance in that balance can result in dysbiosis due to various reasons. Several studies have suggested that intestinal dysbiosis drives the pathogenesis and progression of chronic GIT diseases such as inflammatory bowel disease (IBD), colorectal cancer (CRC), irritable bowel syndrome (IBS) among others [<xref ref-type="bibr" rid="CR63">63</xref>]. Indeed, some recent studies have shown that compared to healthy subjects patients with coeliac disease have an altered composition of gut microbiota [<xref ref-type="bibr" rid="CR64">64</xref>]. Also, although the majority of patients diagnosed with coeliac disease showed clinical improvement following strict adherence to a gluten-free diet (GFD), there is a subgroup of patients with coeliac disease who do not respond to GFD [<xref ref-type="bibr" rid="CR65">65</xref>]. Patients with persistent symptoms of coeliac disease with long-term GFD have been shown to have an altered microbial gut composition [<xref ref-type="bibr" rid="CR66">66</xref>]Â with significant differences between patients with classical gastrointestinal symptoms (such as weight loss, diarrhea, distended abdomen) and patients with extraintestinal manifestations (such as anemia, malabsorption of iron, folate, Vitamin D, calcium, short stature) [<xref ref-type="bibr" rid="CR65">65</xref>]. Although coeliac disease in the vast majority of patients involves the proximal small intestine, it may extend distally into the ileum for a variable length [<xref ref-type="bibr" rid="CR67">67</xref>]. It was confirmed that 66.6% of coeliac disease patients had an extension of the changes in the mucosa beyond the proximal small intestine [<xref ref-type="bibr" rid="CR68">68</xref>]. Indeed, patients with extra-intestinal manifestations at diagnosis have a diffuse and severe grade of intestinal mucosal atrophy compared to patients with gastrointestinal symptoms only [<xref ref-type="bibr" rid="CR69">69</xref>]. Such situations will significantly alter the composition of the gut microbiota that resides in both the small bowel and the colon.</p><p id="Par19">The data characterizing the gut microbiota in coeliac disease patients was derived from both fecal samples and duodenal mucosa biopsies in studies done mostly in children with coeliac disease [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR70">70</xref>â<xref ref-type="bibr" rid="CR81">81</xref>] with fewer studies being done in adults [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR82">82</xref>â<xref ref-type="bibr" rid="CR85">85</xref>]. These studies showed differences in the microbial composition of fecal and duodenal samples in children and adults when comparing active coeliac disease with patients with treated coeliac disease, or healthy controls [<xref ref-type="bibr" rid="CR86">86</xref>]. The most abundant bacterial phylum in adults with coeliac disease was <italic>Firmicutes</italic>, whereas <italic>Proteobacteria</italic> are present mainly in children with coeliac disease [<xref ref-type="bibr" rid="CR86">86</xref>]. <italic>Bacteroidetes</italic> and <italic>Actinobacteria</italic> were among the other major phyla shared by both adults and children [<xref ref-type="bibr" rid="CR86">86</xref>]. Most studies were conducted using different methods such as culture-based methods in combination with or without other technologies, denaturing gradient gel electrophoresis [DGGE], fluorescence hybridization [FISH], temporal temperature gradient gel electrophoresis [TTGE] and real-time polymerase chain reaction [RT-PCR], and consequently failed to identify all microbial taxa. The variability in the sample size of the studies and the age of the participants also makes interpretation of the findings difficult. In this review, we have summarized some of the major studies including those using culture-based methods and PCR or 16S rRNA sequencing to generate microbial signatures in children (Table <xref rid="Tab1" ref-type="table">1</xref>) and adults (Table <xref rid="Tab2" ref-type="table">2</xref>) using either fecal samples or duodenal biopsies or both.<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Microbial signatures in children with active coeliac disease relative to healthy controls<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Study</p></th><th align="left"><p>Sample source</p></th><th align="left"><p>Subject details</p></th><th align="left"><p>Methodology</p></th><th align="left"><p>Conclusion (microbiota signatures in coeliac disease) compared to controls</p></th></tr></thead><tbody><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR75">75</xref>]</p></td><td align="left"><p>Stool</p></td><td align="left"><p>26 coeliac patients and 23 controls</p></td><td align="left"><p>Culture</p></td><td align="left"><p><sup>#</sup>Bacteroides</p><p><sup>#</sup>Staphylococcus</p><p><sup>#</sup>Clostridium</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR76">76</xref>]</p></td><td align="left"><p>Stool and duodenal biopsies</p></td><td align="left"><p>30 Coeliac patients, 30 controls</p></td><td align="left"><p>PCR</p></td><td align="left"><p>Stool sample:</p><p><sup>$</sup><italic>Bifidobacterium count</italic></p><p><sup>$</sup><italic>Bifidobacterium Longum</italic></p><p>Duodenal biopsies<bold>:</bold></p><p><sup>$</sup><italic>Bifidobacterium count</italic></p><p><sup>$</sup><italic>Bifidobacterium Longum</italic></p><p><sup>$</sup><italic>Bifidobacterium cantenulatum</italic></p><p><sup>#</sup><italic>B. lactis</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR77">77</xref>]</p></td><td align="left"><p>Stool and duodenal biopsies</p></td><td align="left"><p>25â30 Coeliac patients, 8â30 controls</p></td><td align="left"><p>PCR</p></td><td align="left"><p>Stool sample:</p><p><sup>#</sup><italic>E. coli</italic> prevalence and count</p><p><sup>$</sup><italic>Bifidobacterium</italic> count</p><p><sup>##</sup><italic>Clostridium leptum</italic> counts</p><p><sup>#</sup><italic>Staphylococcus</italic> prevalence and counts</p><p>Duodenal biopsies:</p><p><sup>$</sup>Bifidobacterium count</p><p><sup>#</sup>Bacteroides counts</p><p><sup>#</sup>Clostridium leptum</p><p><sup>#</sup>E. coli count</p><p><sup>#</sup>Staphylococcus counts</p><p><sup>$</sup><italic>C. coccoides</italic> prevalence</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR79">79</xref>]</p></td><td align="left"><p>Duodenal biopsies</p></td><td align="left"><p>20 Coeliac patients, 10 controls</p></td><td align="left"><p>PCR</p></td><td align="left"><p><sup>#</sup><italic>Bacteroides vulgatus</italic> prevalence</p><p><sup>#</sup><italic>E. coli</italic> prevalence</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR74">74</xref>]</p></td><td align="left"><p>Stool sample and duodenal biopsies</p></td><td align="left"><p>19 Coeliac patients, 15 controls</p></td><td align="left"><p>PCR/Culture</p></td><td align="left"><p>Stool sample and duodenal Biopsies:</p><p><sup>#</sup>Eubacteria diversity</p><p><sup>$</sup><italic>Lactobacillus</italic> counts</p><p><sup>$</sup><italic>Enterococcus</italic> counts</p><p><sup>$</sup>Bifidobacterium counts</p><p><sup>#</sup>Bacteroides</p><p><sup>#</sup>Porphyromonas</p><p><sup>#</sup>Prevotella</p><p><sup>#</sup><italic>Staphylococcus</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR193">193</xref>]</p></td><td align="left"><p>Stool sample</p></td><td align="left"><p>20 Coeliac patients, 20 controls</p></td><td align="left"><p>PCR/Culture</p></td><td align="left"><p><sup>#</sup><italic>Staphylococcus epidermidis</italic></p><p><sup>#</sup><italic>Staphylococcus haemolyticus</italic></p><p><sup>$</sup><italic>Enterococcus faecium</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR89">89</xref>]</p></td><td align="left"><p>Duodenal biopsies</p></td><td align="left"><p>32 Coeliac patients, 8 controls</p></td><td align="left"><p>Culture/ 16S rRNA sequencing</p></td><td align="left"><p><sup>$</sup><italic>Streptococcus mutans</italic></p><p><sup>$</sup><italic>Streptococcus anginosus</italic></p><p><sup>$</sup><italic>Firmicutes</italic></p><p><sup>#</sup><italic>Staphylococcacea</italic></p><p><sup>#</sup><italic>Staphylococcus epidermidis</italic></p><p><sup>#</sup><italic>Staphylococcus pasteuri</italic></p><p><sup>$</sup><italic>Streptococcaceae</italic></p><p><sup>#</sup><italic>Proteobacteria</italic></p><p><sup>#</sup><italic>Enterobacteriaceae</italic></p><p><sup>#</sup><italic>Klebsiella oxytoca</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR64">64</xref>]</p></td><td align="left"><p>Duodenal biopsies</p></td><td align="left"><p>10 Coeliac patients, 9 controls</p></td><td align="left"><p>16S rRNA sequencing</p></td><td align="left"><p><sup>#</sup><italic>Prevotella melaninogenica</italic></p><p><sup>#</sup><italic>Haemphilus</italic></p><p><sup>#</sup><italic>Serratia</italic></p><p><sup>$</sup><italic>Prevotella oralis</italic></p><p><sup>$</sup><italic>Proteus</italic></p><p><sup>$</sup><italic>Clostridium stercorarium</italic></p><p><sup>$</sup><italic>Ruminococcus bromii</italic></p><p><sup>$</sup><italic>Papllibacter cinnamivorans</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR78">78</xref>]</p></td><td align="left"><p>Duodenal biopsies</p></td><td align="left"><p>8 Coeliac Disease, 5 controls</p></td><td align="left"><p>16S rRNA gene sequencing</p></td><td align="left"><p><sup>$</sup>Streptococcus</p><p><sup>$</sup>Prevotella</p><p><sup>#</sup>Neisseria</p><p><sup>#</sup>Haemophilus</p></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>This table only includes the comparison of the patients with active or untreated Coeliac disease and healthy controls</p><p><sup>#</sup>Increase in relative abundance</p><p><sup>$</sup>Decrease in relative abundance</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Microbial signatures in adults with active coeliac disease relative to healthy controls<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Study</p></th><th align="left"><p>Sample source</p></th><th align="left"><p>Subject details</p></th><th align="left"><p>Methodology</p></th><th align="left"><p>Conclusion (microbiota signatures in coeliac disease) compared to controls</p></th></tr></thead><tbody><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR78">78</xref>]</p></td><td align="left"><p>Stool sample</p></td><td align="left"><p>10 Coeliac patients, 11 controls</p></td><td align="left"><p>PCR</p></td><td align="left"><p><sup>$</sup><italic>Lactobacillus</italic> diversity</p><p><sup>$</sup><italic>Lactobacillus sakei</italic></p><p><sup>$</sup><italic>Bifidobacterium</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR84">84</xref>]</p></td><td align="left"><p>Duodenal biopsy*</p></td><td align="left"><p>10 Treated Coeliac patients with persistent symptoms, 10 treated Coeliac patientsâ symptoms free</p></td><td align="left"><p>16 S rRNA sequencing</p></td><td align="left"><p><sup>#</sup>Proteobacteria</p><p><sup>$</sup>Bacteroidetes</p><p><sup>$</sup>Firmicutes</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR85">85</xref>]</p></td><td align="left"><p>Duodenal biopsy</p></td><td align="left"><p>6 Coeliac patients, 11 controls</p></td><td align="left"><p>16 S rRNA sequencing</p></td><td align="left"><p><sup>$</sup>Bacteroidetes</p><p><sup>$</sup>Fusobacteria</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR82">82</xref>]</p></td><td align="left"><p>Stool sample and Duodenal biopsy</p></td><td align="left"><p>23 Coeliac patients, 24 controls</p></td><td align="left"><p>16S rRNA gene sequencing</p></td><td align="left"><p>Stool sample:</p><p><sup>$</sup>Akkermanisia</p><p><sup>$</sup>Dorea</p><p>Duodenal biopsy:</p><p><sup>#</sup>Helicobacter</p><p><sup>#</sup>Megasphaera</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR78">78</xref>]</p></td><td align="left"><p>Duodenal biopsy</p></td><td align="left"><p>5 Coeliac Disease, 5 controls</p></td><td align="left"><p>16S rRNA gene sequencing</p></td><td align="left"><p><sup>#</sup><italic>Mycobacterium spp</italic></p><p><sup>#</sup><italic>Methylobacterium spp</italic></p></td></tr></tbody></table><table-wrap-foot><p>This table only includes the comparison of the microbial profiles in patients with active or untreated Coeliac disease and healthy controls. However, since very few studies are available in adults, we included one study<sup><bold>a</bold></sup> that allowed us to compare the treated coeliac patients (with persistent symptoms) with symptoms free treated Coeliac patients</p><p><sup>#</sup>Increase in relative abundance</p><p><sup>$</sup>Decrease in relative abundance</p></table-wrap-foot></table-wrap></p><p id="Par20">One of the initial studies aimed at identifying specific bacterial groups responsible for the gut microbiota alterations in children with the active coeliac disease found that rod-shaped bacteria were frequently found in small bowel biopsies of children with active and inactive coeliac disease, compared to controls [<xref ref-type="bibr" rid="CR87">87</xref>]. Using culture-based methods, Collado et al. concluded that the fecal samples collected from children with coeliac disease had significantly higher levels of genera <italic>Bacteroides</italic>, <italic>Clostridium</italic>, and <italic>Staphylococcus</italic> when compared to healthy subjects [<xref ref-type="bibr" rid="CR75">75</xref>]. Collado et al. followed up their results with PCRâbased analysis, using both fecal samples and duodenal biopsies collected from pediatric patients with active and non-active coeliac disease and healthy controls [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. They showed that the intestinal microbiota in untreated children with coeliac disease is unbalanced and was partially restored after long-term adherence to GFD [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. This imbalance was observed in both feces and intestinal biopsies in terms of reduction in the abundance of totalÂ <italic>Bifidobacterium</italic>Â count and species-specific <italic>Bifidobacterium longum</italic> [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. A Swedish study further explored the coeliac disease-related dysbiosis and found higher numbers of rod-shaped bacteria (<italic>Clostridium </italic>spp., <italic>Prevotella </italic>spp., and <italic>Actinomyces </italic>spp.) in the small bowel mucosa of coeliac disease patients [<xref ref-type="bibr" rid="CR88">88</xref>]. Other studies have reported a higher abundance of the <italic>Proteobacteria</italic> phylum (family <italic>Enterobacteriaceae</italic>), genera <italic>Bacteroides</italic> and <italic>Staphylococcus</italic> in the untreated coeliac disease when compared to healthy subjects [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. Many studies used fecal samples in addition to the duodenal samples, often showing an imbalance between gram-negativeÂ bacteria and gram-positiveÂ bacteria (G-/Gâ+)Â ratio marked by an increase in <italic>Bacteroides</italic> and <italic>Proteobacteria</italic>, and a decrease in <italic>Lactobacillus</italic> and <italic>Bifidobacteria</italic> in feces of patients with coeliac disease compared with controls [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR90">90</xref>â<xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par21">The genus of <italic>Bacteroides</italic> is a major component of the human intestinal microbiota and is generally considered symbiont, although some species have been involved in disrupting the integrity of the intestinal epithelial barrier and thus exhibiting pro-inflammatory effects [<xref ref-type="bibr" rid="CR94">94</xref>â<xref ref-type="bibr" rid="CR96">96</xref>]. Multiple studies in children and adults have reported an increase in the relative amount of gram-negative <italic>Bacteroides</italic>, <italic>Prevotella</italic><italic>species</italic>, <italic>Escherichia. coli</italic> [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] and low levels of the protective anti-inflammatory bacteria such as <italic>Bifidobacteria</italic>Â andÂ <italic>Lactobacilli</italic> [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. This suggests that gut microbiota could affect the pathogenesis and coeliac disease progression by activating the innate immune system, modulating the function of the epithelial barrier, and driving mucosal inflammation as discussed in more detail in the next section. Although the above studies have provided us with a general makeup of coeliac disease microbiota signatures and suggested a coeliac disease-driven dysbiosis, there is still a long way to go in answering specific questions such as whether these microbial changes precede the disease, are associated with the onset of gluten-driven disease or are the result of inflammation or other related immune cell phenotypes.</p><p id="Par22">Caminero et al. using mice populated with the human intestinal bacteria showed that the microbe-gluten-host interaction may modulate the autoimmune risk in genetically susceptible subjects and that the microbiome of coeliac disease patients processes gluten differently compared to the microbiome of healthy subjects [<xref ref-type="bibr" rid="CR98">98</xref>]. Associations have also been established between the HLA-DQ2/DQ8 genotype and the gut microbiota composition, by profiling the gut microbiota of genetically at-risk children [<xref ref-type="bibr" rid="CR99">99</xref>]. It has been shown that high-risk children carry specific microbiota compared with children at low genetic risk for coeliac disease [<xref ref-type="bibr" rid="CR100">100</xref>], suggesting that the microbiota may also serve as a predisposing factor for coeliac disease. Several studies have highlighted the central role of gluten intolerance and microbial dysbiosis in patients with coeliac disease [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. Changes in the abundance of various <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic> have been reported in patients with active coeliac disease. Also, the proportion of gluten-proteolytic bacteria such as <italic>Bifidobacterium, Lactobacillus, Rothia</italic><italic> spp</italic> is decreased [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>], while the abundance of Gram-negative <italic>Proteobacteria</italic> (<italic>E. coli</italic> and <italic>Enterobacteriaceae</italic>) is increased [<xref ref-type="bibr" rid="CR18">18</xref>]. This results in altered exposure of intestinal epithelial to bacterial lipopolysaccharides (LPS) and metabolites such as SCFAs [<xref ref-type="bibr" rid="CR18">18</xref>]. The dysbiotic microbiota may result in increased amounts of bacterial LPS in the intestine resulting in the dysregulated immune response that is evident through the activation of various intraepithelial lymphocytes (IELs) subsets and epithelial cells that act as a trigger for increased production of anti-microbial peptides (AMPs) and mucin [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. Furthermore, altered microbial metabolites can induce T<sub>Reg</sub> cells and dendritic cells [<xref ref-type="bibr" rid="CR105">105</xref>â<xref ref-type="bibr" rid="CR108">108</xref>] which in turn produce IL-10 and retinoic acid which activates various cellular functions within the lamina propria (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par23">The above data suggest a multifactorial etiology of coeliac disease in which the gut microbiota appears to be a critical player, with the overall consensus suggesting a coeliac disease association with over-representation of pathobionts and a decrease in protective symbionts and/or commensals numbers. However, further complicating this scenario is the complexity of the microbiota and its dependence on environmental and individual genetic factors. It is difficult to conclude, based on current evidence, whether changes in the composition and function of the microbial community in patients with coeliac disease are the cause or effect of the disease. Most studies of gut microbiota profiling use fecal samples as a proxy because of the noninvasiveness and the convenience of stool sampling, and the same seems to be the case with many studies of coeliac disease. However, it is important to remember that fecal samples are unlikely to represent the actual microbial composition which resides in the duodenum or along the surface of the duodenal mucosa. Therefore, it is advisable to analyze tissueÂ biopsiesÂ in addition to fecal samples to build aÂ comprehensive pictureÂ of the microbial diversity in coeliac disease research. Furthermore, prospective, multicenter, longitudinal studies mixing basic and applied research using âomicsâ approaches are required to explain the role of the gut microbiota as an additional factor involved in the onset of autoimmune diseases such as coeliac disease.</p></sec><sec id="Sec8"><title>Virome in coeliac disease</title><p id="Par24">The involvement of bacterial dysbiosis in modulating the intestinal homeostasis has been well described in various human diseases, however, the role of the virome, which is also an integral part of the human microbiota, is often overlooked. The human virome comprises a diverse collection of endogenous retroviruses, eukaryotic viruses, and bacteriophages [<xref ref-type="bibr" rid="CR109">109</xref>] and is progressively recognized as orchestrater of the intestinal barrier integrity and gut homeostasis. Changes in the enteric virome composition and their role in modulating the intestinal microbial diversity and functionality have been emphasized in several recent studies including in coeliac disease [<xref ref-type="bibr" rid="CR110">110</xref>â<xref ref-type="bibr" rid="CR114">114</xref>]. Many common viral infections play a role in disrupting the intestinal functions of the host and thereby causing various human diseases. Yet their role in causing coeliac disease is still debatable. The potential role of early viral infections, in particular adenovirus, enterovirus, rotavirus, and reovirus, in coeliac disease pathogenesis has been suggested primarily based on cross-sectional or epidemiological studies [<xref ref-type="bibr" rid="CR115">115</xref>â<xref ref-type="bibr" rid="CR118">118</xref>]. However, the evidence remains inconclusive due to the retrospective nature of the study, reverse casuality, and in some cases inconsistensy of later studies [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]. Bouziat et al. observed a trend in higher levels of anti-reovirus antibodies in patients with coeliac disease, suggesting a link between reovirus infection and pathogenesis of coeliac disease [<xref ref-type="bibr" rid="CR121">121</xref>]. In this study, reovirus-infected mice developed a protective immunity to reovirus post-infection, though they suffered a loss of tolerance to dietary gluten [<xref ref-type="bibr" rid="CR121">121</xref>]. Two prospective longitudinal birth cohort studies have recently pointed in the same direction; the first concluded that a higher prevalence of enterovirus, but not adenovirus, was associated with a later onset of coeliac disease during early childhood [<xref ref-type="bibr" rid="CR122">122</xref>]. A nested caseâcontrol cohort from the TEDDY study showed that the cumulative number of enteroviral stool exposures between 1 and 2Â years of age along with a higher gluten intake was associated with coeliac disease autoimmunity [<xref ref-type="bibr" rid="CR123">123</xref>]. These results indicate that in genetically predisposed children, enteroviral exposure increased by a higher intake of gluten could act as triggers of coeliac disease. Collectively, these results proposed a mechanism by which viral infections early in life, when the gut microbiota evolves, may probably lead to an altered microbial state, affecting the intestinal immune responses. These in turn disrupt the mucosal barrier resulting in increased translocation of gluten peptides into the mucosa leading to the loss of immune tolerance. Experimental studies are required to confirm the validity of enterovirus as a trigger factor and also the option of vaccination in reducing the risk of development of coeliac disease.</p></sec><sec id="Sec9"><title>Oral and blood microbiome in Coeliac disease</title><p id="Par25">Despite the role of oral microbes in gluten degradation [<xref ref-type="bibr" rid="CR124">124</xref>], coeliac microbiome research has focused mostly on the intestinal microbiota. TheÂ gastrointestinal systemÂ begins with the oral cavity and leads to the esophagus and extends to the anus via the stomach, small and large intestines. The oral cavity is one of the most diverse body sites harboring more than 700 different bacterial species that are quite distinct from the gut microbiota [<xref ref-type="bibr" rid="CR125">125</xref>], daily salivary secretions and subsequent swallowing carry 8âÃâ10<sup>10</sup>Â bacteria (that shed from the oral mucosal surfaces per day) to the GI tract [<xref ref-type="bibr" rid="CR126">126</xref>]. Thus, the salivary, duodenal, and fecal microbial analysis could capture comprehensive disease-specific microbial changes along the entire gastrointestinal tract that could be highly useful for understanding food-sensitiveÂ enteropathy diseases such as coeliac disease.</p><p id="Par26">Gluten, consisting of glutenins and gliadins, contains structurally relatively high concentrations ofÂ glutamineÂ andÂ prolineÂ residues [<xref ref-type="bibr" rid="CR127">127</xref>], rendering it highly resistant to degradation by human gastrointestinalÂ proteases. Examples of these protease-resistant peptides of particular concern are a 33-mer derived from Î±-gliadins and a 26-mer derived from Î³-gliadins [<xref ref-type="bibr" rid="CR128">128</xref>] that apart from being resistant to proteolysis, contain multiple copies of the highly immunogenic epitopes which stimulate CD4<sup>+</sup>Â T cells in theÂ lamina propriaÂ of HLA-DQ2-positive patients with coeliac disease [<xref ref-type="bibr" rid="CR129">129</xref>]. A mixture of naturally occurring bacteria in the human dental plaque may, however, cleave gliadins, including the immunogenic 33-mer and 26-mer domains [<xref ref-type="bibr" rid="CR130">130</xref>]. Few studies that have analyzed coeliac disease-related oral microbiome, reported that the salivary microbiota and metabolome are associated with coeliac disease [<xref ref-type="bibr" rid="CR131">131</xref>]. Oral microbiota showed an increased number of salivaryÂ <italic>Lactobacillus</italic> sp. in patients with active and refractory coeliac disease compared with healthy controls. This suggests its possible role in increased salivary gluten-degrading activity in patients with coeliac disease [<xref ref-type="bibr" rid="CR132">132</xref>]. Comparison of oropharyngeal samples from coeliac disease patients and control subjects showed a higher abundance of phyla <italic>Proteobacteria</italic> at the cost of <italic>Bacteroidetes</italic> in coeliac disease patients than in control subjects [<xref ref-type="bibr" rid="CR133">133</xref>]. The above studies pointed towards a possible relationship between gluten and the coeliac disease-associated dysbiosis, in the oral cavity with a continuum to the intestinal mucosa, but this needs to be clarified with further investigation.</p><p id="Par27">Though debatable, the concept of a blood microbiome emerges with cumulative evidence [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>]. Blood has long been considered a sterile environment with no proliferative microbes [<xref ref-type="bibr" rid="CR136">136</xref>], but it has now been shown to harbor numerous species of dormant bacteria that are not readily culturableÂ and that may constitute a healthy human blood microbiome (HBM) [<xref ref-type="bibr" rid="CR137">137</xref>]. It has been suggested that aberrant blood microbiota plays a role in various diseases such as type II diabetes and cardiovascular disease [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]. The concept of âAtopobiosisâ was put forward to describe the migration of the gut or oral microbes to the bloodstreamÂ which can lead to the dynamics of many inflammatory diseases [<xref ref-type="bibr" rid="CR135">135</xref>]. In a recent study, the alteration in blood microbiome composition and taxonomic diversity was observed in adult coeliac disease patients compared with healthy subjects [<xref ref-type="bibr" rid="CR140">140</xref>]. Damaged, inflamed intestines with increased permeability are typical of patients with coeliac disease, so is the likelihood of developing a unique blood microbiome that could indicateÂ intestinal damage and influence the response to gluten. The above hypothesis remains speculative and further studies involving larger cohorts are required to better define the role of the blood microbiome as a biomarker for patient classification, diagnosis and for therapeuticÂ stratifications.</p></sec></sec><sec id="Sec10"><title>Environmental factors in coeliac disease</title><sec id="Sec11"><title>Birth mode</title><p id="Par28">The human GIT is continuously exposed to numerous external stimuli, including food antigens, pathogenic, and commensal microbes, providing the largest interfaces in the human body for hostâpathogen interactions. According to the widely accepted hypothesis, the incoherent nature of external factors, including eating habit, diet, exposure to broad-spectrum antibiotics or other toxic chemicals can lead to a breakdown in the intestinal homeostasis by influencing the composition of the gut microbiota as well as the epithelial immune and barrier functions [<xref ref-type="bibr" rid="CR141">141</xref>â<xref ref-type="bibr" rid="CR143">143</xref>]. The birth mode is considered the critical determinant of early colonization of the neonatal gut microbiome [<xref ref-type="bibr" rid="CR144">144</xref>]. The Cesarean section commonly thought to have a permanent impact on the intestinal microbiota of infants, due to the lack of exposure to theÂ maternal vaginal and gut microbiota [<xref ref-type="bibr" rid="CR145">145</xref>]. Studies have indicated that there is an association between cesarean section and an increased risk of coeliac disease [<xref ref-type="bibr" rid="CR146">146</xref>â<xref ref-type="bibr" rid="CR148">148</xref>]. Differences in elective cesarean section where babies are not exposed to the maternal microbiota have been observed [<xref ref-type="bibr" rid="CR149">149</xref>]. In the case of an emergency Cesarean section, the risk of amniotic sac rupture exists, which exposes the baby to the vaginal microbes, such alterations in the intestinal microbiota during the first year of life can result in immune dysregulation and increase the risk of coeliac disease. However, other studies have found inconsistent conclusions and limited or no evidence to support any association between the birth mode and coeliac disease [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR150">150</xref>]. We have summarized the finding of the major studies in Table <xref rid="Tab3" ref-type="table">3</xref>.<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Overview of studies included in this review that have linked birth mode with the development of coeliac disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Study</p></th><th align="left"><p>Type of study</p></th><th align="left"><p>Subjects</p></th><th align="left"><p>Main findings</p></th></tr></thead><tbody><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR146">146</xref>]</p></td><td align="left"><p>Case control from Germany</p></td><td align="left"><p>157 coeliac disease cases, 862 controls</p></td><td align="left"><p>Children with coeliac disease had significantly high likelihood of being born by cesarean delivery compared with control subjects (odds ratio: 1.8 [95% confidence interval 1.13â2.88]; <italic>P</italic>â=â0.014)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR147">147</xref>]</p></td><td align="left"><p>Prospective birth cohort study from Norway</p></td><td align="left"><p>650 children with coeliac disease and 107,828 controls</p></td><td align="left"><p>Coeliac disease was not associated with mode of delivery (cesarean section, model 1: OR, 0.84; 95% confidence interval [CI] 0.65â1.09, and model 2: OR, 0.83; 95% CI 0.63â1.09)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR148">148</xref>]</p></td><td align="left"><p>Birth Registry-based study from Sweden</p></td><td align="left"><p>6596 children of who developed coeliac disease before 15Â years of age</p></td><td align="left"><p>Among boys, elective caesarean delivery increased the risk of coeliac disease (OR 1.2; 95% CI 1.0â1.4)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR149">149</xref>]</p></td><td align="left"><p>Population-based birth cohort study from Sweden</p></td><td align="left"><p>11,749 coeliac disease and 53,887 age- and sex-matched controls</p></td><td align="left"><p>Positive association between elective cesarean delivery and later coeliac disease (adjusted odds ratio [OR], 1.15; 95% confidence interval [CI] 1.04â1.26)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR194">194</xref>]</p></td><td align="left"><p>Birth Registry-based study from UK</p></td><td align="left"><p>90 children with coeliac disease and 24,8431 children for whom there was no record of admission for coeliac disease</p></td><td align="left"><p>No significant association between coeliac disease and cesarean birth (odds ratioâ=â0.29; 95% CI 0.07â1.17) (<italic>P</italic>â=â0.064)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR195">195</xref>]</p></td><td align="left"><p>Birth Registry-based study from Denmark</p></td><td align="left"><p>1944 children with coeliac disease</p></td><td align="left"><p>No significant association between coeliac disease and cesarean birth (PARF 0.99 (0.87â1.14); (<italic>P</italic>â=â.89)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR196">196</xref>]</p></td><td align="left"><p>Birth Registry-based study from Sweden</p></td><td align="left"><p>3817 children with coeliac disease 191 with had both coeliac disease and T1DM</p></td><td align="left"><p>The increased risk of having a double diagnosis of type 1 diabetes and coeliac disease was associated with being born by Caesarean sections (odds ratio 1.60 (1.07â2.39)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR150">150</xref>]</p></td><td align="left"><p>population-based birth cohortÂ from Italy</p></td><td align="left"><p>1,227 children with coeliac disease, 220230 controls</p></td><td align="left"><p>No significant association between coeliac disease and planned or un-planned cesarean birth</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR197">197</xref>]</p></td><td align="left"><p>Multinational birth cohort:The TEDDYÂ study</p></td><td align="left"><p>979 with CDA and 343 with coeliac disease</p></td><td align="left"><p>C-section is not associated with increased risk coeliac disease (HRâ=â0.85; 95% CI 0.65, 1.11; <italic>P</italic>â=â0.24) and coeliac disease autoimmunity (CDA) (HRâ=â0.91; 95% CI 0.78, 1.06; <italic>P</italic>â=â0.20)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR198">198</xref>]</p></td><td align="left"><p>Registry-based study</p><p>from Denmark and Norway</p></td><td align="left"><p>Denmark: (nâ=â1,049,633)</p><p>Cesarean sections</p><p>(<italic>n</italic>â=â196,512) coeliac disease (<italic>n</italic>â=â1,395) children</p><p>Norway: (nâ=â537,457)</p><p>Cesarean section (<italic>n</italic>â=â90,128) coeliac disease (<italic>n</italic>â=â1,919)</p></td><td align="left"><p>Mode of delivery was not associated with an increased risk of diagnosed coeliac disease. Odds ratio1.11 (95% CI 0.96â1.29) in the Danish cohort and 0.96 (95% CI 0.84â1.09) in the Norwegian cohort</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec12"><title>Use of antibiotic</title><p id="Par29">Several studies have shown that exposure to antibiotics can have a significant impact on the composition and functionality of the human gut microbiota [<xref ref-type="bibr" rid="CR151">151</xref>]. Antibiotics can modulate the gut microbial composition and influence the development of chronic diseases [<xref ref-type="bibr" rid="CR152">152</xref>]. Children exposed to antibiotics displayed a delayed maturation of microbiota compared with those not exposed to antibiotics [<xref ref-type="bibr" rid="CR153">153</xref>].</p><p id="Par30">Such alterations in the developing gut microbiota influence the immune maturation process and predispose to coeliac disease [<xref ref-type="bibr" rid="CR15">15</xref>]. Several studies have pointed towards a link between early intestinal infection and antibiotic usage with intestinal dysbiosis, alteration in the population of sub-lymphocytes [<xref ref-type="bibr" rid="CR154">154</xref>], and coeliac disease onset [<xref ref-type="bibr" rid="CR150">150</xref>]. Recent observational studies that found that subjects treated with antibiotics are more likely to develop coeliac disease later in life, further support this theory. In a nationwide registry-based cohort study, Sander and colleagues collected data on more than 1.7 million children born in Denmark and Norway including 3346 diagnosed with coeliac disease. They found that exposure to antibiotics in the first year of life was positively associated with a later diagnosis of coeliac disease [<xref ref-type="bibr" rid="CR155">155</xref>]. Interestingly, a dose-dependent association was also found between the increasing number of antibiotics used and the risk of coeliac disease [<xref ref-type="bibr" rid="CR155">155</xref>]. Antibiotic use has also been shown to be significantly associated with the development of coeliac disease in Swedish [<xref ref-type="bibr" rid="CR156">156</xref>] Italian [<xref ref-type="bibr" rid="CR150">150</xref>], and North American children [<xref ref-type="bibr" rid="CR157">157</xref>]. The dysbiosis induced by antibiotics was characterized by a decrease in the <italic>Bifidobacteria longum</italic> counts and an increase in the counts of <italic>Bacteroides fragilis</italic> [<xref ref-type="bibr" rid="CR154">154</xref>]. Several previous studies have identified the decrease in <italic>Bifidobacterium</italic> as a characteristic of dysbiosis in patients with coeliac disease [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. Collectively, these data suggest that dysbiosis resulting from antibiotics use can influence the development of coeliac disease. An overview of the studies that have linked the use of the antibiotics with the development of coeliac disease is shown in (Table <xref rid="Tab4" ref-type="table">4</xref>.)<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Overview of studies included in this review that have linked antibiotic use with the development of coeliac disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Study</p></th><th align="left"><p>Type of study</p></th><th align="left"><p>Subjects</p></th><th align="left"><p>Main findings</p></th></tr></thead><tbody><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR157">157</xref>]</p></td><td align="left"><p>Case control from USA</p></td><td align="left"><p>332 cases, 241 controls</p></td><td align="left"><p>Early life exposure to antibiotics associated with coeliac disease (adjusted or 1.133, 95% CI 1.032â1.244; <italic>P</italic>â=â0.007)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR155">155</xref>]</p></td><td align="left"><p>Register-based cohort study from Denmark and Norway</p></td><td align="left"><p>1.7 million</p></td><td align="left"><p>Exposure to systemic antibiotics in the first year of life was associated with coeliac disease (pooled OR 1.26, 95% confidence interval 1.16â1.36)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR156">156</xref>]</p></td><td align="left"><p>Nationwide caseâcontrol study from Sweden</p></td><td align="left"><p>2933 cases, 14,571 controls</p></td><td align="left"><p>Antibiotic use was associated with coeliac disease (ORâ=â1.40; 95% CI [1.27â1.53),</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR150">150</xref>]</p></td><td align="left"><p>Population-based birth cohort study from Italy</p></td><td align="left"><p>203,000 babies</p></td><td align="left"><p>Antibiotic use was significantly associated with coeliac disease onset (incidence rate ratio IRRâ=â1.24, 95% CI 1.07, 1.43)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR117">117</xref>]</p></td><td align="left"><p>Population-based incident case-referent study</p></td><td align="left"><p>(<italic>n</italic>â=â97) treated with antibiotic during the first 6Â months of life. (<italic>n</italic>â=â134) untreated</p></td><td align="left"><p>No significantly increased risk for coeliac disease was seen regarding antibiotic treatment (OR 1.2; 95% CI 0.87â1.6; <italic>P</italic>â=â0.27)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR118">118</xref>]</p></td><td align="left"><p>Multinational prospective birth cohort</p></td><td align="left"><p>8495 children</p></td><td align="left"><p>Cumulative use of any antibiotic during the first 4Â years of life was not associated with the appearance of any coeliac disease autoantibody (hazard ratio [HR], 0.98; 95% CI 0.95â1.01) or the transglutaminase autoantibody (HR, 1.00; 95% CI 0.98â1.02)</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec13"><title>Diet</title><p id="Par31">âLet food be thy medicineâ is the concept that was first proposed by Hippocrates in 400 BC, to emphasize the importance of dietary nutrients in preventing or curing diseases. Therapeutic utility of diet, dietary modulation experiments have become a method of choice for both understanding disease etiology [<xref ref-type="bibr" rid="CR158">158</xref>] and devising personalized treatment strategies [<xref ref-type="bibr" rid="CR159">159</xref>â<xref ref-type="bibr" rid="CR161">161</xref>]. Studies have highlighted the importance of dietary interventions in modulating the gut microbiota and eliciting specific effects [<xref ref-type="bibr" rid="CR162">162</xref>]. As discussed in the previous sections, the intestinal microbiota is exposed to a highly dynamic environment that can be influenced by different co-variants [<xref ref-type="bibr" rid="CR141">141</xref>â<xref ref-type="bibr" rid="CR143">143</xref>]. For example, the microbiota is routinely challenged by a complex mix of millions of dietary compounds and common medicinal products [<xref ref-type="bibr" rid="CR163">163</xref>]. Antibiotics and even non-antibiotic medicines such as metformin are widely recognized to have a side effect on the microbiota composition [<xref ref-type="bibr" rid="CR164">164</xref>â<xref ref-type="bibr" rid="CR166">166</xref>]. Similarly, several dietary components, such as vitamins, hormones, and other micronutrients, have been reported to impact the gut microbiota, which may influence the intestinal homeostasis and host health [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR167">167</xref>]. Of the multiple exogenous and endogenous host co-variant factors, diet and its contents appear to be the most dominant factors in affecting the microbial composition. Sudden and abrupt dietary changes, such as switching to animal-based or plant-based diets, have been shown to modify the microbial composition in just 24Â h of experimental initiation, but the discontinuation of such diet resulted in the reversion to baseline within 48Â h [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR168">168</xref>]. Among the common bacteria that are affected by diet, are <italic>Bifidobacterium</italic><italic>spp</italic>., <italic>Lactobacillus</italic><italic>spp</italic>.<italic>, BacteroidesÂ </italic><italic>spp</italic>., <italic>ClostridiumÂ </italic><italic>spp</italic>., <italic>EubacteriumÂ </italic><italic>spp</italic>., <italic>Enterococcus</italic><italic>spp</italic>., <italic>Escherichia coli, and Streptococcus</italic><italic>spp</italic>. [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR169">169</xref>]. Many of these microbes are associated with coeliac disease pathology as discussed. Considering the profound contribution of diet in the regulation of microbiota and its crucial role in the orchestration of human health, different health organizations across the world have set guidelines for a âhealthy dietâ that specifies the defined intake of micro and macronutrients and addresses common diseases such as IBD, IBS, and coeliac disease, although such recommendations are often conflicting [<xref ref-type="bibr" rid="CR170">170</xref>]. GFD, the key therapy for coeliac disease, has been shown to only partially restore the unbalanced gut microbiota of coeliac disease patients even after long-term treatment [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. This may be because a GFD is not always completely gluten-free. There is a debate over what a GFD should be, but a diet of up to 20 parts per million gluten is usually taken into account [<xref ref-type="bibr" rid="CR171">171</xref>]. Strict adherence to the GFD in coeliac patients has been reported to heal the damaged intestine rapidly and improve the symptoms of the disease [<xref ref-type="bibr" rid="CR172">172</xref>]. However, patient compliance with the therapy is highly variable, as many patients face difficulties following GFD, and eating gluten again may trigger disease relapse [<xref ref-type="bibr" rid="CR173">173</xref>] and in some patients, GFD was found to worsen the overall microbiota diversity [<xref ref-type="bibr" rid="CR70">70</xref>]. De Palma et al. studied the effects of a GFD on the composition of the gut microbiota in ten healthy subjects where they found that GFD was associated with a reduction of beneficial gut bacteria [<xref ref-type="bibr" rid="CR174">174</xref>]. The possible reason for this may be the fact that gluten exerts a prebiotic action [<xref ref-type="bibr" rid="CR175">175</xref>]. Therefore, the development of novel therapeutic approaches such as supplementation of GFD with pre- or probiotics is a promising approach to improve the clinical management of coeliac disease patients under GFD.</p></sec></sec><sec id="Sec14"><title>Microbiota as a potential therapeutic target for coeliac disease</title><p id="Par32">The aim of therapeutic modulation of the gut microbiota composition is to establish and maintain eubiosis. There are various methods which can be usually used. Those include dietary regulation, prebiotics, probiotics, and faecal microbial transplantation [<xref ref-type="bibr" rid="CR163">163</xref>, <xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>].</p><sec id="Sec15"><title>Probiotics and prebiotics as strategies to modulate microbiota in coeliac disease</title><p id="Par33">Recent studies have suggested that a diet with a low content of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) could be beneficial for patients with coeliac disease. In a small randomized controlled trial, Roncoroni et al. showed that a low FODMAP GFD improves the psychological health and gastrointestinal symptoms of adults with coeliac disease after 21Â days compared to standard GFD [<xref ref-type="bibr" rid="CR178">178</xref>]. Whilst the long-term effect of such a diet in coeliac disease is not clear, low FODMAP diets have recently been reported to be associated with alterations in the gut microbiota [<xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR180">180</xref>].</p><p id="Par34">The fact that microbial imbalances persist despite of a GFD has led to the consideration of other therapeutic approaches, such as the introduction of probiotics to the GFD. Probiotics are live microorganisms that when consumed in sufficient quantities confer health benefits. There are several reasons why probiotics might be useful in coeliac disease. Certain probiotic strains can safely activate an immune response, without inducing inflammation [<xref ref-type="bibr" rid="CR181">181</xref>]. <italic>Lactobacilli-</italic>made Bacteriocins result in the formation of pores in the plasma membrane of the pathogenic bacteria and promoting cell lysis [<xref ref-type="bibr" rid="CR181">181</xref>]. Probiotics also mediate increased expression of occlusion zone proteins, allowing the proper functioning of the tight junctions [<xref ref-type="bibr" rid="CR181">181</xref>]. In an animal model of coeliac disease, the administration of <italic>Bifidobacteria</italic> led to the downregulation of mRNA expression of pro-inflammatory markers and reduced production of NF-kB, TNF-alpha, and IL-1beta [<xref ref-type="bibr" rid="CR182">182</xref>]. Lindfors et al. studied the effects of two probiotic strains (<italic>Lactobacillus fermentum</italic> and <italic>Bifidobacterium lactis</italic>) on gliadin toxicity in intestinal epithelial cells [<xref ref-type="bibr" rid="CR183">183</xref>]. They found that <italic>B. lactis</italic> reduces intestinal permeability induced by gliadin, while <italic>L. fermentum</italic> did not affect this parameter. The authors emphasized the usefulness of this probiotic in coeliac disease patients who do not respond to the GFD [<xref ref-type="bibr" rid="CR183">183</xref>].</p><p id="Par35">Nonetheless, there have been contradictory reports from clinical studies examining the efficacy of probiotics in patients with coeliac disease. Data from a small randomized trial showed that a strain of <italic>Bifidobacterium infantis</italic> improved gastrointestinal symptoms in adults with the untreated coeliac disease such as indigestion, bowel constipation, and reflux but did not improve intestinal permeability [<xref ref-type="bibr" rid="CR184">184</xref>]. In another trial, Olivares et al. showed that a strain of <italic>Bifidobacterium longum</italic> improved the height percentile of children with coeliac disease but did not improve the gastrointestinal symptoms [<xref ref-type="bibr" rid="CR185">185</xref>]. We have summarized the human studies that have examined the role of probiotics in coeliac patients in (Table <xref rid="Tab5" ref-type="table">5</xref>). The inconsistencies in the findings of these studies may be due to the differences in the cohort selection and size of the sample, study length, type, and dosage of probiotics used. In addition to the direct administration of probiotics to patients with coeliac disease, some researchers have also examined the use of microorganisms as components of the food products. Di Cagno et al. reported that patients with coeliac disease who consumed Sourdough wheat bread containing probiotic strains <italic>L. alimentarius</italic>, <italic>L. brevis</italic>, <italic>L. sanfranciscensis</italic>, and <italic>L. hilgardii</italic>, showed reduced symptoms with improved gluten tolerance [<xref ref-type="bibr" rid="CR186">186</xref>]. Similar studies done with the pretreatment of wheat flour with probiotic bacterial strains have shown promising results [<xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR188">188</xref>].<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>Overview of studies that have investigated diet-based Probiotic and or Prebiotic interventions in the treatment of coeliac disease in Humans</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Study</p></th><th align="left"><p>Type of study</p></th><th align="left"><p>Subjects</p></th><th align="left"><p>Main findings</p></th></tr></thead><tbody><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR199">199</xref>]</p></td><td align="left"><p>Prospective, double- blind, randomized placebo-controlled parallel group study from Italy</p></td><td align="left"><p>109 coeliac disease adult patients with IBS-type symptoms on strict Gluten free diet. (<italic>n</italic>â=â54) received the probiotic blend of five strains and (<italic>n</italic>â=â55) in the placebo group</p></td><td align="left"><p>A 6-week probiotic treatment is effective inproved severity of IBS-type symptoms, in coeliac disease patients on strict GFD, also resulted in the modification of gut microbiota, specifically increase of B<italic>ifidobacteria</italic></p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR200">200</xref>]</p></td><td align="left"><p>Cohort based study from Brazil</p></td><td align="left"><p>14 coeliac patients and 17 healthy subjects with both groups on daily intake of 100gms of probiotic-containing yogurt for 30-day period</p></td><td align="left"><p>Probiotic yogurt intake lead to a significant increased the Bifidobacteria number in coeliac disease patients, but not in healthy participants</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR201">201</xref>]</p></td><td align="left"><p>Cohort based study from Argentina</p></td><td align="left"><p>41 adult participants (<italic>n</italic>â=â24), coeliac disease active, no treatment;</p><p>(<italic>n</italic>â=â12), coeliac disease active with <italic>Bifidobacterium infantis</italic>Â Natren Life Start super strain (NLS-SS) for 6Â weeks</p><p>(<italic>n</italic>â=â5), coeliac disease 1Â year on GFD</p></td><td align="left"><p><italic>B. infantis</italic>Â treatment decreased the innate immune markers, macrophage counts, Paneth cell counts and Î±-defensin-5 in coeliac disease patients. However, GFD was more effective than <italic>B. infantis</italic> in decreasing the duodenal macrophage counts in coeliac disease patients</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR184">184</xref>]</p></td><td align="left"><p>Â Placebo controlled, double blind study from Argentina</p></td><td align="left"><p>22 adults with untreated coeliac disease; (<italic>n</italic>â=â12) received the probiotic capsule <italic>Bifido bacterium</italic>Â natren life start (NLS), (<italic>n</italic>â=â10) placebo for 3Â weeks</p></td><td align="left"><p><italic>B. infantis</italic> is safe to use and may alleviate some symptoms in untreated coeliac disease. Overall probiotic treatment resulted in some immunologic changes but did not modify abnormal intestinal permeability</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR202">202</xref>]</p></td><td align="left"><p>Randomized control trail from Australia</p></td><td align="left"><p>45 adult patients with coeliac disease, Participants took 5Â g of VSL#â¢ probiotic formulation (<italic>n</italic>â=â23) or 5Â g placebo (<italic>n</italic>â=â22) orally twice daily for 12Â weeks</p></td><td align="left"><p>The probiotic formula when taken orally over the 12-week period did not significantly alter the microbiota measured in this population</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR187">187</xref>]</p></td><td align="left"><p>Randomized trail from Italy</p></td><td align="left"><p>13 patients with coeliac disease (<italic>n</italic>â=â6) assigned to natural flour baked goods (NFBG),(<italic>n</italic>â=â7) assigned to hydrolyzed flour baked goodsÂ with sourdough lactobacilli for 60Â days</p></td><td align="left"><p>Hydrolyzed wheat flour, manufactured with sourdough lactobacilli and fungal proteases, was safe for consumption and was not toxic to patients with coeliac disease</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR203">203</xref>]</p></td><td align="left"><p>A prospective cohort study with from USA, Finland, Germany and Sweden</p></td><td align="left"><p>6520 genetically susceptible children with 1460 reporting the probiotic use in the first year of life</p></td><td align="left"><p>Overall exposure of probiotics during the first year of life was not associated with CDA or coeliac disease. However, intake of probiotics via dietary supplements was associated with increased risk of coeliac disease Autoimmunity (CDA)</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR189">189</xref>]</p></td><td align="left"><p>Randomized, Placebo-Controlled Trial from Poland</p></td><td align="left"><p>34 paediatric coeliac disease patients on GFD. (<italic>n</italic>â=â18) receving prebiotic (Synergy 1) or placebo (maltodextrin) daily for 3Â months</p></td><td align="left"><p><italic>Bifidobacterium</italic>Â count increased significantly (<italic>P</italic>â&lt;â0.05) in the Synergy 1 group. Along with an increase in faecal acetate and butyrate levels was observed in the prebiotic group</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR204">204</xref>]</p></td><td align="left"><p>A double-blind placebo-controlled study from Slovenia</p></td><td align="left"><p>40 coeliac disease children and 16 healthy children. Group of 20 each coeliac disease children received probiotic formulation (a mixture of 2 strains, <italic>B.Â breve</italic> BR03 (DSM 16,604) and <italic>B.Â breve</italic> B632 (DSM 24,706) in ratio 1:1)and the other placebo for 3Â months</p></td><td align="left"><p>Probiotic administration had a negative correlation between <italic>Verrucomicrobia</italic>, some unknown phyla of Bacteria, Synergistetes, Euryarchaeota and some SCFAs, identifying them as potential target in microbiome restoration process</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR205">205</xref>]</p></td><td align="left"><p>Double-blinded, placebo-controlled study from Slovenia</p></td><td align="left"><p>40 coeliac disease children on GFD before and after probiotic (<italic>Bifidbacterium breve strains B632 and BRO3)</italic> or placebo administration and 16 healthy children (Control group) for 3Â months</p></td><td align="left"><p>Probiotic resulted in an increase ofÂ <italic>Actinobacteria along with the Firmicutes/Bacteroidetes</italic>Â ratio. Concluding that 3-month administration ofÂ <italic>B. breve</italic>Â strains helps in restoring the healthy percentage of major microbial components</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR206">206</xref>]</p></td><td align="left"><p>Double blind placebo-controlled trial from Slovenia</p></td><td align="left"><p>49 coeliac disease children on gluten-free diet (GFD) and 18 healthy control. (<italic>n</italic>â=â24 children with coeliac disease) daily received <italic>B. breve</italic> BR03 and B632) and the second group (<italic>n</italic>â=â25 children with coeliac disease) received placebo for 3Â months</p></td><td align="left"><p>Probiotic intervention with <italic>B. breve</italic> strain resulted in a decrease the production of pro-inflammatory cytokine TNF-Î± in children with coeliac disease on GFD</p></td></tr><tr><td align="left"><p>[<xref ref-type="bibr" rid="CR185">185</xref>]</p></td><td align="left"><p>Double blind, randomized, placebo-controlled trial from Spain</p></td><td align="left"><p>33 coeliac disease children on GFD received a capsule containing either <italic>B. longum</italic> CECT 7347 (10<sup>9</sup> colony-forming units) or placebo (excipients) daily for 3Â months</p></td><td align="left"><p>Probiotic treatment showed greater height percentile, decreased peripheral CD3<sup>+</sup>Â T lymphocytes, and slightly reduced TNF-Î± concentration. The number ofÂ <italic>Bacteroides fragilis</italic>Â and content of secretory IgA in the stool was also reduced by the probiotic treatment. The small sample size is a limitation of the study</p></td></tr></tbody></table></table-wrap></p><p id="Par36">To promote the growth of âbeneficialâ bacteria, specific prebiotics have been added to the GFD and were evaluated in clinical trials. A recent study found that when added to the GFD, oligofructose-enriched inulin (Synergy 1), a prebiotic, increased <italic>Bifidobacterium</italic> counts, and the levels of acetate and butyrate in the gut, with no side effects [<xref ref-type="bibr" rid="CR189">189</xref>]. Finally, the above studies have demonstrated the safety of using pre and probiotic in coeliac disease patients, additional studies are required to confirm the efficacy of probiotics and/or prebiotics as a potential adjunct in the treatment coeliac disease.</p></sec><sec id="Sec16"><title>Fecal microbiota transplantation for coeliac disease</title><p id="Par37">Another approach that has been considered is the use of fecal microbiota transplantation (FMT). FMT is a mechanism by which feces from a healthy donor are infused into a recipientâs GI tract to treat a particluar disease associated with gut microbiota alteration [<xref ref-type="bibr" rid="CR190">190</xref>]. FMT is an effective treatment for <italic>Clostridium difficle</italic> infections [<xref ref-type="bibr" rid="CR191">191</xref>]. Formal studies on the use of FMT in coeliac disease are lacking, but Beurden et al. recently reported a 68-year-old with refractory coeliac disease who received FMT as a treatment for Clostridium difficile infection [<xref ref-type="bibr" rid="CR192">192</xref>]. Interestingly, the patientâs symptoms also resolved following FMT and duodenal biopsies obtained 6Â months after FMT showed complete recovery of villous atrophy.</p></sec></sec><sec id="Sec17" sec-type="conclusions"><title>Conclusions</title><p id="Par38">Although genetic factors such as the presence of HLA-DQ2 or HLA DQ-8, and dietary gluten exposure are necessary for coeliac disease development, they are not sufficient. Several studies have demonstrated that alterations in the gut microbial composition, such as reduced <italic>Bifidobacteria</italic> and <italic>Lactobacilli</italic> levels and increased levels of <italic>Proteobacteria</italic> can contribute towards the pathogenesis of the disease. However, these studies were unable to determine the cause vs consequence of the altered microbiome in Coeliac disease, as well as the mechanistic analysis on how different bacterial strains may influence the intestinal health. Multi-omics data from ongoing longitudinal cohort studies such as CDGEMM (Coeliac Disease, Genomic, Environmental, Microbiome, and Metabolomic Study) are expected to clarify some of the above questions. The role of fungi and viruses in coeliac disease pathogenesis has received little attention and warrants further investigations. The dynamic interplay between genetic, microbial, and environmental factors such as infant feeding practices, diet, antibiotics, and infections, that contribute to the development of coeliac disease will be a major focus of future research. To develop precise epidemiological modeling and clinical path, prospective studies on prevalence, risk group screening, disease classification, intervention time point analysis are needed. GFD, the key treatment for coeliac disease has been shown to only partially restore the unbalanced gut microbiota in coeliac patients even after long-term treatment while GFD itself may contribute to dysbiosis. The efficacy of potential gut microbiota modulators such as probiotics, prebiotics, and FMT as adjunctive therapies in coeliac disease is largely unproven and requires further investigation.</p></sec></body><back><sec><title>Funding</title><p>Open access funding provided by Qatar National Library.</p></sec><ack><title>Acknowledgements</title><p>The publication of this article was funded by the Qatar National Library.</p></ack><sec sec-type="author-contribution"><title>Author contributions</title><p>Guarantor of the article: SAK. Specific author contributions: AKA conceivedÂ theÂ idea for the review. PS, MK, SAK, and AKA wrote the first draft of the review. SAK and AKA critically revised the paper for important intellectual content. All authors approved the final version.</p></sec><sec sec-type="ethics-statement"><title>Compliance with ethical standards</title><sec id="FPar1" sec-type="COI-statement"><title>Conflict of interest</title><p id="Par39">The authors declared that they have no conflict of interest.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Magris</surname><given-names>R</given-names></name><name><surname>Cannizzaro</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">New insights into the pathogenesis of celiac disease</article-title><source>Front Med (Lausanne)</source><year>2017</year><volume>4</volume><fpage>137</fpage><pub-id pub-id-type="doi">10.3389/fmed.2017.00137</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Arora</surname><given-names>A</given-names></name><name><surname>Strand</surname><given-names>TA</given-names></name><name><surname>Leffler</surname><given-names>DA</given-names></name><name><surname>Catassi</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>Kelly</surname><given-names>CP</given-names></name><name><surname>Ahuja</surname><given-names>V</given-names></name><name><surname>Makharia</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">Global prevalence of celiac disease: systematic review and meta-analysis</article-title><source>Clin Gastroenterol Hepatol</source><year>2018</year><volume>16</volume><issue>6</issue><fpage>823</fpage><lpage>836</lpage><pub-id pub-id-type="pid">29551598</pub-id><pub-id pub-id-type="doi">10.1016/j.cgh.2017.06.037</pub-id><comment>(e822)</comment></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebwohl</surname><given-names>B</given-names></name><name><surname>Sanders</surname><given-names>DS</given-names></name><name><surname>Green</surname><given-names>PHR</given-names></name></person-group><article-title xml:lang="en">Coeliac disease</article-title><source>Lancet</source><year>2018</year><volume>391</volume><issue>10115</issue><fpage>70</fpage><lpage>81</lpage><pub-id pub-id-type="pid">28760445</pub-id><pub-id pub-id-type="doi">10.1016/s0140-6736(17)31796-8</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>Meisel</surname><given-names>M</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name></person-group><article-title xml:lang="en">Mechanisms by which gut microorganisms influence food sensitivities</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2019</year><volume>16</volume><issue>1</issue><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhslWgs7bO</pub-id><pub-id pub-id-type="pid">30214038</pub-id><pub-id pub-id-type="pmcid">6767923</pub-id><pub-id pub-id-type="doi">10.1038/s41575-018-0064-z</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludvigsson</surname><given-names>JF</given-names></name><name><surname>Leffler</surname><given-names>DA</given-names></name><name><surname>Bai</surname><given-names>JC</given-names></name><name><surname>Biagi</surname><given-names>F</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>Hadjivassiliou</surname><given-names>M</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>CP</given-names></name><name><surname>Leonard</surname><given-names>JN</given-names></name><name><surname>Lundin</surname><given-names>KE</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name><name><surname>Sanders</surname><given-names>DS</given-names></name><name><surname>Walker</surname><given-names>MM</given-names></name><name><surname>Zingone</surname><given-names>F</given-names></name><name><surname>Ciacci</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">The Oslo definitions for coeliac disease and related terms</article-title><source>Gut</source><year>2013</year><volume>62</volume><issue>1</issue><fpage>43</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2011-301346</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>PC</given-names></name><name><surname>van Heel</surname><given-names>DA</given-names></name></person-group><article-title xml:lang="en">Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease</article-title><source>Clin Exp Immunol</source><year>2008</year><volume>153</volume><issue>2</issue><fpage>162</fpage><lpage>173</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtVOnu7%2FO</pub-id><pub-id pub-id-type="pid">18713140</pub-id><pub-id pub-id-type="pmcid">2492906</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03704.x</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marasco</surname><given-names>G</given-names></name><name><surname>Di Biase</surname><given-names>AR</given-names></name><name><surname>Schiumerini</surname><given-names>R</given-names></name><name><surname>Eusebi</surname><given-names>LH</given-names></name><name><surname>Iughetti</surname><given-names>L</given-names></name><name><surname>Ravaioli</surname><given-names>F</given-names></name><name><surname>Scaioli</surname><given-names>E</given-names></name><name><surname>Colecchia</surname><given-names>A</given-names></name><name><surname>Festi</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Gut microbiota and celiac disease</article-title><source>Dig Dis Sci</source><year>2016</year><volume>61</volume><issue>6</issue><fpage>1461</fpage><lpage>1472</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XksFGguw%3D%3D</pub-id><pub-id pub-id-type="pid">26725064</pub-id><pub-id pub-id-type="doi">10.1007/s10620-015-4020-2</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scher</surname><given-names>JU</given-names></name></person-group><article-title xml:lang="en">The microbiome in celiac disease: beyond diet-genetic interactions</article-title><source>Cleve Clin J Med</source><year>2016</year><volume>83</volume><issue>3</issue><fpage>228</fpage><lpage>230</lpage><pub-id pub-id-type="pid">26974994</pub-id><pub-id pub-id-type="doi">10.3949/ccjm.83a.15123</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionetti</surname><given-names>E</given-names></name><name><surname>Castellaneta</surname><given-names>S</given-names></name><name><surname>Francavilla</surname><given-names>R</given-names></name><name><surname>Pulvirenti</surname><given-names>A</given-names></name><name><surname>Tonutti</surname><given-names>E</given-names></name><name><surname>Amarri</surname><given-names>S</given-names></name><name><surname>Barbato</surname><given-names>M</given-names></name><name><surname>Barbera</surname><given-names>C</given-names></name><name><surname>Barera</surname><given-names>G</given-names></name><name><surname>Bellantoni</surname><given-names>A</given-names></name><name><surname>Castellano</surname><given-names>E</given-names></name><name><surname>Guariso</surname><given-names>G</given-names></name><name><surname>Limongelli</surname><given-names>MG</given-names></name><name><surname>Pellegrino</surname><given-names>S</given-names></name><name><surname>Polloni</surname><given-names>C</given-names></name><name><surname>Ughi</surname><given-names>C</given-names></name><name><surname>Zuin</surname><given-names>G</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Catassi</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Introduction of gluten, HLA status, and the risk of Celiac disease in children</article-title><source>N Engl J Med</source><year>2014</year><volume>371</volume><issue>14</issue><fpage>1295</fpage><lpage>1303</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhslamurbL</pub-id><pub-id pub-id-type="pid">25271602</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa1400697</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Walter</surname><given-names>J</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group><article-title xml:lang="en">Role of the gut microbiota in nutrition and health</article-title><source>BMJ</source><year>2018</year><volume>361</volume><fpage>k2179</fpage><pub-id pub-id-type="pid">29899036</pub-id><pub-id pub-id-type="pmcid">6000740</pub-id><pub-id pub-id-type="doi">10.1136/bmj.k2179</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>HJ</given-names></name><name><surname>Scott</surname><given-names>KP</given-names></name><name><surname>Louis</surname><given-names>P</given-names></name><name><surname>Duncan</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">The role of the gut microbiota in nutrition and health</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2012</year><volume>9</volume><issue>10</issue><fpage>577</fpage><lpage>589</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhsVKmurrF</pub-id><pub-id pub-id-type="pid">22945443</pub-id><pub-id pub-id-type="doi">10.1038/nrgastro.2012.156</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thursby</surname><given-names>E</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Introduction to the human gut microbiota</article-title><source>Biochem J</source><year>2017</year><volume>474</volume><issue>11</issue><fpage>1823</fpage><lpage>1836</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXptFenurY%3D</pub-id><pub-id pub-id-type="pid">28512250</pub-id><pub-id pub-id-type="pmcid">5433529</pub-id><pub-id pub-id-type="doi">10.1042/bcj20160510</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzosa</surname><given-names>EA</given-names></name><name><surname>Sirota-Madi</surname><given-names>A</given-names></name><name><surname>Avila-Pacheco</surname><given-names>J</given-names></name><name><surname>Fornelos</surname><given-names>N</given-names></name><name><surname>Haiser</surname><given-names>HJ</given-names></name><name><surname>Reinker</surname><given-names>S</given-names></name><name><surname>Vatanen</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>AB</given-names></name><name><surname>Mallick</surname><given-names>H</given-names></name><name><surname>McIver</surname><given-names>LJ</given-names></name><name><surname>Sauk</surname><given-names>JS</given-names></name><name><surname>Wilson</surname><given-names>RG</given-names></name><name><surname>Stevens</surname><given-names>BW</given-names></name><name><surname>Scott</surname><given-names>JM</given-names></name><name><surname>Pierce</surname><given-names>K</given-names></name><name><surname>Deik</surname><given-names>AA</given-names></name><name><surname>Bullock</surname><given-names>K</given-names></name><name><surname>Imhann</surname><given-names>F</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Weersma</surname><given-names>RK</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Vlamakis</surname><given-names>H</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name></person-group><article-title xml:lang="en">Gut microbiome structure and metabolic activity in inflammatory bowel disease</article-title><source>Nat Microbiol</source><year>2019</year><volume>4</volume><issue>2</issue><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXisVyhtbnM</pub-id><pub-id pub-id-type="pid">30531976</pub-id><pub-id pub-id-type="doi">10.1038/s41564-018-0306-4</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Gut microbiota and type 1 diabetes</article-title><source>Int J Mol Sci</source><year>2018</year><pub-id pub-id-type="pid">30586944</pub-id><pub-id pub-id-type="pmcid">6337707</pub-id><pub-id pub-id-type="doi">10.3390/ijms19040995</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Capilla</surname><given-names>A</given-names></name><name><surname>Benitez-Paez</surname><given-names>A</given-names></name><name><surname>Palau</surname><given-names>F</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Gut microbiota trajectory in early life may predict development of celiac disease</article-title><source>Microbiome</source><year>2018</year><volume>6</volume><issue>1</issue><fpage>36</fpage><pub-id pub-id-type="pid">29458413</pub-id><pub-id pub-id-type="pmcid">5819212</pub-id><pub-id pub-id-type="doi">10.1186/s40168-018-0415-6</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chibbar</surname><given-names>R</given-names></name><name><surname>Dieleman</surname><given-names>LA</given-names></name></person-group><article-title xml:lang="en">The gut microbiota in celiac disease and probiotics</article-title><source>Nutrients</source><year>2019</year><pub-id pub-id-type="pid">31590358</pub-id><pub-id pub-id-type="pmcid">6836185</pub-id><pub-id pub-id-type="doi">10.3390/nu11102375</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnareddy</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">The microbiome in celiac disease</article-title><source>Gastroenterol Clin North Am</source><year>2019</year><volume>48</volume><issue>1</issue><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="pid">30711204</pub-id><pub-id pub-id-type="doi">10.1016/j.gtc.2018.09.008</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Benitez-Paez</surname><given-names>A</given-names></name><name><surname>de Palma</surname><given-names>G</given-names></name><name><surname>Capilla</surname><given-names>A</given-names></name><name><surname>Nova</surname><given-names>E</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Varea</surname><given-names>V</given-names></name><name><surname>Marcos</surname><given-names>A</given-names></name><name><surname>Garrote</surname><given-names>JA</given-names></name><name><surname>Polanco</surname><given-names>I</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calvo</surname><given-names>C</given-names></name><name><surname>Ortigosa</surname><given-names>L</given-names></name><name><surname>Palau</surname><given-names>F</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study</article-title><source>Gut Microbes</source><year>2018</year><volume>9</volume><issue>6</issue><fpage>551</fpage><lpage>558</lpage><pub-id pub-id-type="pid">29672211</pub-id><pub-id pub-id-type="pmcid">6287676</pub-id><pub-id pub-id-type="doi">10.1080/19490976.2018.1451276</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollid</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Molecular basis of celiac disease</article-title><source>Annu Rev Immunol</source><year>2000</year><volume>18</volume><fpage>53</fpage><lpage>81</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXjs1GmsLs%3D</pub-id><pub-id pub-id-type="pid">10837052</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.53</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagnoff</surname><given-names>MF</given-names></name></person-group><article-title xml:lang="en">Celiac disease: pathogenesis of a model immunogenetic disease</article-title><source>J Clin Invest</source><year>2007</year><volume>117</volume><issue>1</issue><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmvV2rsQ%3D%3D</pub-id><pub-id pub-id-type="pid">17200705</pub-id><pub-id pub-id-type="pmcid">1716218</pub-id><pub-id pub-id-type="doi">10.1172/JCI30253</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabri</surname><given-names>B</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">T cells in celiac disease</article-title><source>J Immunol</source><year>2017</year><volume>198</volume><issue>8</issue><fpage>3005</fpage><lpage>3014</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXlsVWgsb8%3D</pub-id><pub-id pub-id-type="pid">28373482</pub-id><pub-id pub-id-type="pmcid">5426360</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1601693</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>C</given-names></name><name><surname>Rudloff</surname><given-names>S</given-names></name><name><surname>Lochnit</surname><given-names>G</given-names></name><name><surname>Arampatzi</surname><given-names>S</given-names></name><name><surname>Maison</surname><given-names>W</given-names></name><name><surname>Zimmer</surname><given-names>KP</given-names></name></person-group><article-title xml:lang="en">Epithelial transport of immunogenic and toxic gliadin peptides in vitro</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>11</issue><fpage>e113932</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXisFCmsr0%3D</pub-id><pub-id pub-id-type="pid">25415429</pub-id><pub-id pub-id-type="pmcid">4240668</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0113932</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Molberg</surname><given-names>O</given-names></name><name><surname>Parrot</surname><given-names>I</given-names></name><name><surname>Hausch</surname><given-names>F</given-names></name><name><surname>Filiz</surname><given-names>F</given-names></name><name><surname>Gray</surname><given-names>GM</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Structural basis for gluten intolerance in celiac sprue</article-title><source>Science</source><year>2002</year><volume>297</volume><issue>5590</issue><fpage>2275</fpage><lpage>2279</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XntlWlt70%3D</pub-id><pub-id pub-id-type="pid">12351792</pub-id><pub-id pub-id-type="doi">10.1126/science.1074129</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer</article-title><source>Physiol Rev</source><year>2011</year><volume>91</volume><issue>1</issue><fpage>151</fpage><lpage>175</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXisVCht78%3D</pub-id><pub-id pub-id-type="pid">21248165</pub-id><pub-id pub-id-type="doi">10.1152/physrev.00003.2008</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>S</given-names></name><name><surname>El Asmar</surname><given-names>R</given-names></name><name><surname>Di Pierro</surname><given-names>M</given-names></name><name><surname>Grazia Clemente</surname><given-names>M</given-names></name><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Sapone</surname><given-names>A</given-names></name><name><surname>Thakar</surname><given-names>M</given-names></name><name><surname>Iacono</surname><given-names>G</given-names></name><name><surname>Carroccio</surname><given-names>A</given-names></name><name><surname>D'Agate</surname><given-names>C</given-names></name><name><surname>Not</surname><given-names>T</given-names></name><name><surname>Zampini</surname><given-names>L</given-names></name><name><surname>Catassi</surname><given-names>C</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines</article-title><source>Scand J Gastroenterol</source><year>2006</year><volume>41</volume><issue>4</issue><fpage>408</fpage><lpage>419</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XjvVaktb4%3D</pub-id><pub-id pub-id-type="pid">16635908</pub-id><pub-id pub-id-type="doi">10.1080/00365520500235334</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Lammers</surname><given-names>KM</given-names></name><name><surname>Goldblum</surname><given-names>S</given-names></name><name><surname>Shea-Donohue</surname><given-names>T</given-names></name><name><surname>Netzel-Arnett</surname><given-names>S</given-names></name><name><surname>Buzza</surname><given-names>MS</given-names></name><name><surname>Antalis</surname><given-names>TM</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name><name><surname>Zhao</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Arrietta</surname><given-names>M-C</given-names></name><name><surname>Meddings</surname><given-names>JB</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><issue>39</issue><fpage>16799</fpage><lpage>16804</lpage><pub-id pub-id-type="pid">19805376</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0906773106</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molberg</surname><given-names>O</given-names></name><name><surname>McAdam</surname><given-names>SN</given-names></name><name><surname>Korner</surname><given-names>R</given-names></name><name><surname>Quarsten</surname><given-names>H</given-names></name><name><surname>Kristiansen</surname><given-names>C</given-names></name><name><surname>Madsen</surname><given-names>L</given-names></name><name><surname>Fugger</surname><given-names>L</given-names></name><name><surname>Scott</surname><given-names>H</given-names></name><name><surname>Noren</surname><given-names>O</given-names></name><name><surname>Roepstorff</surname><given-names>P</given-names></name><name><surname>Lundin</surname><given-names>KE</given-names></name><name><surname>Sjostrom</surname><given-names>H</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease</article-title><source>Nat Med</source><year>1998</year><volume>4</volume><issue>6</issue><fpage>713</fpage><lpage>717</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXjsFymurs%3D</pub-id><pub-id pub-id-type="pid">9623982</pub-id><pub-id pub-id-type="doi">10.1038/nm0698-713</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Markussen</surname><given-names>G</given-names></name><name><surname>Ek</surname><given-names>J</given-names></name><name><surname>Gjerde</surname><given-names>H</given-names></name><name><surname>Vartdal</surname><given-names>F</given-names></name><name><surname>Thorsby</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer</article-title><source>J Exp Med</source><year>1989</year><volume>169</volume><issue>1</issue><fpage>345</fpage><lpage>350</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL1MXntlKqtQ%3D%3D</pub-id><pub-id pub-id-type="pid">2909659</pub-id><pub-id pub-id-type="doi">10.1084/jem.169.1.345</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karell</surname><given-names>K</given-names></name><name><surname>Louka</surname><given-names>AS</given-names></name><name><surname>Moodie</surname><given-names>SJ</given-names></name><name><surname>Ascher</surname><given-names>H</given-names></name><name><surname>Clot</surname><given-names>F</given-names></name><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Ciclitira</surname><given-names>PJ</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><collab>European Genetics Cluster on Celiac D</collab></person-group><article-title xml:lang="en">HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease</article-title><source>Hum Immunol</source><year>2003</year><volume>64</volume><issue>4</issue><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXitV2hsr4%3D</pub-id><pub-id pub-id-type="pid">12651074</pub-id><pub-id pub-id-type="pmcid">12651074</pub-id><pub-id pub-id-type="doi">10.1016/S0198-8859(03)00027-2</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meresse</surname><given-names>B</given-names></name><name><surname>Malamut</surname><given-names>G</given-names></name><name><surname>Cerf-Bensussan</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Celiac disease: an immunological jigsaw</article-title><source>Immunity</source><year>2012</year><volume>36</volume><issue>6</issue><fpage>907</fpage><lpage>919</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XpsVWisbw%3D</pub-id><pub-id pub-id-type="pid">22749351</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2012.06.006</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>XB</given-names></name><name><surname>Uhde</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>Alaedini</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Autoantibodies in the extraintestinal manifestations of celiac disease</article-title><source>Nutrients</source><year>2018</year><pub-id pub-id-type="pid">30586919</pub-id><pub-id pub-id-type="pmcid">6357144</pub-id><pub-id pub-id-type="doi">10.3390/nu10081123</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Sabatino</surname><given-names>A</given-names></name><name><surname>Corazza</surname><given-names>GR</given-names></name></person-group><article-title xml:lang="en">Coeliac disease</article-title><source>Lancet</source><year>2009</year><volume>373</volume><issue>9673</issue><fpage>1480</fpage><lpage>1493</lpage><pub-id pub-id-type="pid">19394538</pub-id><pub-id pub-id-type="doi">10.1016/s0140-6736(09)60254-3</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname><given-names>MA</given-names></name><name><surname>Lindenbergh-Kortleve</surname><given-names>DJ</given-names></name><name><surname>Raatgeep</surname><given-names>HC</given-names></name><name><surname>de Ruiter</surname><given-names>LF</given-names></name><name><surname>de Krijger</surname><given-names>RR</given-names></name><name><surname>Groeneweg</surname><given-names>M</given-names></name><name><surname>Escher</surname><given-names>JC</given-names></name><name><surname>Samsom</surname><given-names>JN</given-names></name></person-group><article-title xml:lang="en">Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease</article-title><source>Mucosal Immunol</source><year>2013</year><volume>6</volume><issue>6</issue><fpage>1202</fpage><lpage>1213</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXls1Sns7k%3D</pub-id><pub-id pub-id-type="pid">23571506</pub-id><pub-id pub-id-type="doi">10.1038/mi.2013.19</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abadie</surname><given-names>V</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">IL-15: a central regulator of celiac disease immunopathology</article-title><source>Immunol Rev</source><year>2014</year><volume>260</volume><issue>1</issue><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtVahtrvK</pub-id><pub-id pub-id-type="pid">24942692</pub-id><pub-id pub-id-type="pmcid">4066219</pub-id><pub-id pub-id-type="doi">10.1111/imr.12191</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhrberg</surname><given-names>M</given-names></name><name><surname>Valiante</surname><given-names>NM</given-names></name><name><surname>Young</surname><given-names>NT</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Phillips</surname><given-names>JH</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns</article-title><source>J Immunol</source><year>2001</year><volume>166</volume><issue>6</issue><fpage>3923</fpage><lpage>3932</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXitVGmsr0%3D</pub-id><pub-id pub-id-type="pid">11238637</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.166.6.3923</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabri</surname><given-names>B</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Tissue-mediated control of immunopathology in coeliac disease</article-title><source>Nat Rev Immunol</source><year>2009</year><volume>9</volume><issue>12</issue><fpage>858</fpage><lpage>870</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsVOhur3O</pub-id><pub-id pub-id-type="pid">19935805</pub-id><pub-id pub-id-type="doi">10.1038/nri2670</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thome</surname><given-names>JJ</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">Emerging concepts in tissue-resident T cells: lessons from humans</article-title><source>Trends Immunol</source><year>2015</year><volume>36</volume><issue>7</issue><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXpt1Oitbs%3D</pub-id><pub-id pub-id-type="pid">26072286</pub-id><pub-id pub-id-type="pmcid">4491028</pub-id><pub-id pub-id-type="doi">10.1016/j.it.2015.05.003</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarra</surname><given-names>M</given-names></name><name><surname>Cupi</surname><given-names>ML</given-names></name><name><surname>Monteleone</surname><given-names>I</given-names></name><name><surname>Franze</surname><given-names>E</given-names></name><name><surname>Ronchetti</surname><given-names>G</given-names></name><name><surname>Di Sabatino</surname><given-names>A</given-names></name><name><surname>Gentileschi</surname><given-names>P</given-names></name><name><surname>Franceschilli</surname><given-names>L</given-names></name><name><surname>Sileri</surname><given-names>P</given-names></name><name><surname>Sica</surname><given-names>G</given-names></name><name><surname>Del Vecchio</surname><given-names>BG</given-names></name><name><surname>Cretella</surname><given-names>M</given-names></name><name><surname>Paoluzi</surname><given-names>OA</given-names></name><name><surname>Corazza</surname><given-names>GR</given-names></name><name><surname>Pallone</surname><given-names>F</given-names></name><name><surname>Monteleone</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">IL-15 positively regulates IL-21 production in celiac disease mucosa</article-title><source>Mucosal Immunol</source><year>2013</year><volume>6</volume><issue>2</issue><fpage>244</fpage><lpage>255</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtVSgtbfE</pub-id><pub-id pub-id-type="pid">22785229</pub-id><pub-id pub-id-type="doi">10.1038/mi.2012.65</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciccocioppo</surname><given-names>R</given-names></name><name><surname>Di Sabatino</surname><given-names>A</given-names></name><name><surname>Corazza</surname><given-names>GR</given-names></name></person-group><article-title xml:lang="en">The immune recognition of gluten in coeliac disease</article-title><source>Clin Exp Immunol</source><year>2005</year><volume>140</volume><issue>3</issue><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXlvFOis7k%3D</pub-id><pub-id pub-id-type="pid">15932501</pub-id><pub-id pub-id-type="pmcid">1809391</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02783.x</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Foundation Cd future therapies for celiac disease. <ext-link ext-link-type="uri" xlink:href="https://celiac.org/about-celiac-disease/future-therapies-for-celiac-disease/">https://celiac.org/about-celiac-disease/future-therapies-for-celiac-disease/</ext-link></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Withoff</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jonkers</surname><given-names>I</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Understanding celiac disease by genomics</article-title><source>Trends Genet</source><year>2016</year><volume>32</volume><issue>5</issue><fpage>295</fpage><lpage>308</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xjtleqs7Y%3D</pub-id><pub-id pub-id-type="pid">26972670</pub-id><pub-id pub-id-type="doi">10.1016/j.tig.2016.02.003</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catassi</surname><given-names>C</given-names></name><name><surname>Kryszak</surname><given-names>D</given-names></name><name><surname>Bhatti</surname><given-names>B</given-names></name><name><surname>Sturgeon</surname><given-names>C</given-names></name><name><surname>Helzlsouer</surname><given-names>K</given-names></name><name><surname>Clipp</surname><given-names>SL</given-names></name><name><surname>Gelfond</surname><given-names>D</given-names></name><name><surname>Puppa</surname><given-names>E</given-names></name><name><surname>Sferruzza</surname><given-names>A</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Natural history of celiac disease autoimmunity in a USA cohort followed since 1974</article-title><source>Ann Med</source><year>2010</year><volume>42</volume><issue>7</issue><fpage>530</fpage><lpage>538</lpage><pub-id pub-id-type="pid">20868314</pub-id><pub-id pub-id-type="doi">10.3109/07853890.2010.514285</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vriezinga</surname><given-names>SL</given-names></name><name><surname>Auricchio</surname><given-names>R</given-names></name><name><surname>Bravi</surname><given-names>E</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Chmielewska</surname><given-names>A</given-names></name><name><surname>Crespo Escobar</surname><given-names>P</given-names></name><name><surname>KolaÄek</surname><given-names>S</given-names></name><name><surname>Koletzko</surname><given-names>S</given-names></name><name><surname>Korponay-Szabo</surname><given-names>IR</given-names></name><name><surname>Mummert</surname><given-names>E</given-names></name><name><surname>Polanco</surname><given-names>I</given-names></name><name><surname>Putter</surname><given-names>H</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Shamir</surname><given-names>R</given-names></name><name><surname>Szajewska</surname><given-names>H</given-names></name><name><surname>Werkstetter</surname><given-names>K</given-names></name><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Gyimesi</surname><given-names>J</given-names></name><name><surname>Hartman</surname><given-names>C</given-names></name><name><surname>Hogen Esch</surname><given-names>C</given-names></name><name><surname>Hopman</surname><given-names>E</given-names></name><name><surname>Ivarsson</surname><given-names>A</given-names></name><name><surname>Koltai</surname><given-names>T</given-names></name><name><surname>Koning</surname><given-names>F</given-names></name><name><surname>Martinez-Ojinaga</surname><given-names>E</given-names></name><name><surname>te Marvelde</surname><given-names>C</given-names></name><name><surname>Pavic</surname><given-names>A</given-names></name><name><surname>Romanos</surname><given-names>J</given-names></name><name><surname>Stoopman</surname><given-names>E</given-names></name><name><surname>Villanacci</surname><given-names>V</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Troncone</surname><given-names>R</given-names></name><name><surname>Mearin</surname><given-names>ML</given-names></name></person-group><article-title xml:lang="en">Randomized feeding intervention in infants at high risk for celiac disease</article-title><source>N Engl J Med</source><year>2014</year><volume>371</volume><issue>14</issue><fpage>1304</fpage><lpage>1315</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhslamurfF</pub-id><pub-id pub-id-type="pid">25271603</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa1404172</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>RJ</given-names></name><name><surname>Kelly</surname><given-names>CP</given-names></name></person-group><article-title xml:lang="en">Celiac sprue</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>3</issue><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XksVCltA%3D%3D</pub-id><pub-id pub-id-type="pid">11796853</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra010852</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammers</surname><given-names>KM</given-names></name><name><surname>Herrera</surname><given-names>MG</given-names></name><name><surname>Dodero</surname><given-names>VI</given-names></name></person-group><article-title xml:lang="en">Translational chemistry meets gluten-related disorders</article-title><source>Chemist Open</source><year>2018</year><volume>7</volume><issue>3</issue><fpage>217</fpage><lpage>232</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXjtlaksLY%3D</pub-id><pub-id pub-id-type="doi">10.1002/open.201700197</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>GD</given-names></name><name><surname>Albenberg</surname><given-names>L</given-names></name><name><surname>Tomov</surname><given-names>VT</given-names></name></person-group><article-title xml:lang="en">Gut microbiota and IBD: causation or correlation?</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2017</year><volume>14</volume><issue>10</issue><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="pid">28743984</pub-id><pub-id pub-id-type="pmcid">5880536</pub-id><pub-id pub-id-type="doi">10.1038/nrgastro.2017.88</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruvada</surname><given-names>P</given-names></name><name><surname>Leone</surname><given-names>V</given-names></name><name><surname>Kaplan</surname><given-names>LM</given-names></name><name><surname>Chang</surname><given-names>EB</given-names></name></person-group><article-title xml:lang="en">The human microbiome and obesity: moving beyond associations</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><issue>5</issue><fpage>589</fpage><lpage>599</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhslyktr3I</pub-id><pub-id pub-id-type="pid">29120742</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2017.10.005</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Mahowald</surname><given-names>MA</given-names></name><name><surname>Magrini</surname><given-names>V</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">An obesity-associated gut microbiome with increased capacity for energy harvest</article-title><source>Nature</source><year>2006</year><volume>444</volume><issue>7122</issue><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="pid">17183312</pub-id><pub-id pub-id-type="doi">10.1038/nature05414</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jandhyala</surname><given-names>SM</given-names></name><name><surname>Talukdar</surname><given-names>R</given-names></name><name><surname>Subramanyam</surname><given-names>C</given-names></name><name><surname>Vuyyuru</surname><given-names>H</given-names></name><name><surname>Sasikala</surname><given-names>M</given-names></name><name><surname>Nageshwar Reddy</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Role of the normal gut microbiota</article-title><source>World J Gastroenterol</source><year>2015</year><volume>21</volume><issue>29</issue><fpage>8787</fpage><lpage>8803</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XosVSlsw%3D%3D</pub-id><pub-id pub-id-type="pid">26269668</pub-id><pub-id pub-id-type="pmcid">4528021</pub-id><pub-id pub-id-type="doi">10.3748/wjg.v21.i29.8787</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backhed</surname><given-names>F</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">Host-bacterial mutualism in the human intestine</article-title><source>Science</source><year>2005</year><volume>307</volume><issue>5717</issue><fpage>1915</fpage><lpage>1920</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXisVyiu78%3D</pub-id><pub-id pub-id-type="pid">15790844</pub-id><pub-id pub-id-type="doi">10.1126/science.1104816</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>DC</given-names></name></person-group><article-title xml:lang="en">Microbial ecology of the gastrointestinal tract</article-title><source>Annu Rev Microbiol</source><year>1977</year><volume>31</volume><fpage>107</fpage><lpage>133</lpage><pub-id pub-id-type="coi">1:STN:280:DyaE1c%2FhvVGksw%3D%3D</pub-id><pub-id pub-id-type="pid">334036</pub-id><pub-id pub-id-type="doi">10.1146/annurev.mi.31.100177.000543</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Al Khodor</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Vitamin D deficiency in the gulf cooperation council: exploring the triad of genetic predisposition, the gut microbiome and the immune system</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>1042</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXhvVSntLfK</pub-id><pub-id pub-id-type="pid">31134092</pub-id><pub-id pub-id-type="pmcid">6524467</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01042</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Gut microbiotas and host evolution: scaling up symbiosis</article-title><source>Trends Ecol Evol</source><year>2016</year><volume>31</volume><issue>7</issue><fpage>539</fpage><lpage>549</lpage><pub-id pub-id-type="pid">27039196</pub-id><pub-id pub-id-type="doi">10.1016/j.tree.2016.03.006</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>JM</given-names></name><name><surname>Murphy</surname><given-names>K</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Kober</surname><given-names>OI</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name><name><surname>Avershina</surname><given-names>E</given-names></name><name><surname>Rudi</surname><given-names>K</given-names></name><name><surname>Narbad</surname><given-names>A</given-names></name><name><surname>Jenmalm</surname><given-names>MC</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name></person-group><article-title xml:lang="en">The composition of the gut microbiota throughout life, with an emphasis on early life</article-title><source>Microb Ecol Health Dis</source><year>2015</year><volume>26</volume><fpage>26050</fpage><pub-id pub-id-type="pid">25651996</pub-id><pub-id pub-id-type="doi">10.3402/mehd.v26.26050</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funkhouser</surname><given-names>LJ</given-names></name><name><surname>Bordenstein</surname><given-names>SR</given-names></name></person-group><article-title xml:lang="en">Mom knows best: the universality of maternal microbial transmission</article-title><source>PLoS Biol</source><year>2013</year><volume>11</volume><issue>8</issue><fpage>e1001631</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhsVWhtrbK</pub-id><pub-id pub-id-type="pid">23976878</pub-id><pub-id pub-id-type="pmcid">3747981</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001631</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouhy</surname><given-names>F</given-names></name><name><surname>Watkins</surname><given-names>C</given-names></name><name><surname>Hill</surname><given-names>CJ</given-names></name><name><surname>OâShea</surname><given-names>CA</given-names></name><name><surname>Nagle</surname><given-names>B</given-names></name><name><surname>Dempsey</surname><given-names>EM</given-names></name><name><surname>O'Toole</surname><given-names>PW</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Ryan</surname><given-names>CA</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Perinatal factors affect the gut microbiota up to four years after birth</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><issue>1</issue><fpage>1517</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXoslGku7k%3D</pub-id><pub-id pub-id-type="pid">6447568</pub-id><pub-id pub-id-type="pmcid">6447568</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-09252-4</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>EMM</given-names></name></person-group><article-title xml:lang="en">Gut bacteria in health and disease</article-title><source>Gastroenterolo Hepatol</source><year>2013</year><volume>9</volume><issue>9</issue><fpage>560</fpage><lpage>569</lpage></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group><article-title xml:lang="en">Minireview: gut microbiota: the neglected endocrine organ</article-title><source>Mol Endocrinol</source><year>2014</year><volume>28</volume><issue>8</issue><fpage>1221</fpage><lpage>1238</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhs1ektr%2FN</pub-id><pub-id pub-id-type="pid">24892638</pub-id><pub-id pub-id-type="pmcid">5414803</pub-id><pub-id pub-id-type="doi">10.1210/me.2014-1108</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchison</surname><given-names>CA</given-names><suffix>3rd</suffix></name></person-group><article-title xml:lang="en">DNA sequencing: bench to bedside and beyond</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><issue>18</issue><fpage>6227</fpage><lpage>6237</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXht1ejsLzF</pub-id><pub-id pub-id-type="pid">17855400</pub-id><pub-id pub-id-type="pmcid">2094077</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkm688</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawat</surname><given-names>A</given-names></name><name><surname>Engelthaler</surname><given-names>DM</given-names></name><name><surname>Driebe</surname><given-names>EM</given-names></name><name><surname>Keim</surname><given-names>P</given-names></name><name><surname>Foster</surname><given-names>JT</given-names></name></person-group><article-title xml:lang="en">MetaGeniE: characterizing human clinical samples using deep metagenomic sequencing</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>11</issue><fpage>e110915</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhvFyhtbbP</pub-id><pub-id pub-id-type="pid">25365329</pub-id><pub-id pub-id-type="pmcid">4218713</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0110915</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheuch</surname><given-names>M</given-names></name><name><surname>HÃ¶per</surname><given-names>D</given-names></name><name><surname>Beer</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">RIEMS: a software pipeline for sensitive and comprehensive taxonomic classification of reads from metagenomics datasets</article-title><source>BMC Bioinform</source><year>2015</year><volume>16</volume><issue>1</issue><fpage>69</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXmsVGjtrw%3D</pub-id><pub-id pub-id-type="doi">10.1186/s12859-015-0503-6</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Human Microbiome Project C</collab></person-group><article-title xml:lang="en">Structure, function and diversity of the healthy human microbiome</article-title><source>Nature</source><year>2012</year><volume>486</volume><issue>7402</issue><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xos1ejurs%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature11234</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rautava</surname><given-names>S</given-names></name><name><surname>Luoto</surname><given-names>R</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Microbial contact during pregnancy, intestinal colonization and human disease</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2012</year><volume>9</volume><issue>10</issue><fpage>565</fpage><lpage>576</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhsVKmurvO</pub-id><pub-id pub-id-type="pid">22890113</pub-id><pub-id pub-id-type="doi">10.1038/nrgastro.2012.144</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Kalliomaki</surname><given-names>M</given-names></name><name><surname>Heilig</surname><given-names>HG</given-names></name><name><surname>Palva</surname><given-names>A</given-names></name><name><surname>Lahteenoja</surname><given-names>H</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Salojarvi</surname><given-names>J</given-names></name><name><surname>Satokari</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease</article-title><source>BMC Gastroenterol</source><year>2013</year><volume>13</volume><fpage>113</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXht1Cmt7jO</pub-id><pub-id pub-id-type="pid">23844808</pub-id><pub-id pub-id-type="pmcid">3716955</pub-id><pub-id pub-id-type="doi">10.1186/1471-230X-13-113</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wacklin</surname><given-names>P</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name><name><surname>Tuovinen</surname><given-names>E</given-names></name><name><surname>Collin</surname><given-names>P</given-names></name><name><surname>Lindfors</surname><given-names>K</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Maki</surname><given-names>M</given-names></name><name><surname>Matto</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease</article-title><source>Inflamm Bowel Dis</source><year>2013</year><volume>19</volume><issue>5</issue><fpage>934</fpage><lpage>941</lpage><pub-id pub-id-type="pid">23478804</pub-id><pub-id pub-id-type="doi">10.1097/MIB.0b013e31828029a9</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hara</surname><given-names>AM</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">The gut flora as a forgotten organ</article-title><source>EMBO Rep</source><year>2006</year><volume>7</volume><issue>7</issue><fpage>688</fpage><lpage>693</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XmsVanurg%3D</pub-id><pub-id pub-id-type="pid">16819463</pub-id><pub-id pub-id-type="pmcid">1500832</pub-id><pub-id pub-id-type="doi">10.1038/sj.embor.7400731</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ensari</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Gluten-sensitive enteropathy (celiac disease): controversies in diagnosis and classification</article-title><source>Arch Pathol Lab Med</source><year>2010</year><volume>134</volume><issue>6</issue><fpage>826</fpage><lpage>836</lpage><pub-id pub-id-type="pid">20524861</pub-id><pub-id pub-id-type="doi">10.1043/1543-2165-134.6.826</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rondonotti</surname><given-names>E</given-names></name><name><surname>Spada</surname><given-names>C</given-names></name><name><surname>Cave</surname><given-names>D</given-names></name><name><surname>Pennazio</surname><given-names>M</given-names></name><name><surname>Riccioni</surname><given-names>ME</given-names></name><name><surname>De Vitis</surname><given-names>I</given-names></name><name><surname>Schneider</surname><given-names>D</given-names></name><name><surname>Sprujevnik</surname><given-names>T</given-names></name><name><surname>Villa</surname><given-names>F</given-names></name><name><surname>Langelier</surname><given-names>J</given-names></name><name><surname>Arrigoni</surname><given-names>A</given-names></name><name><surname>Costamagna</surname><given-names>G</given-names></name><name><surname>de Franchis</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study</article-title><source>Am J Gastroenterol</source><year>2007</year><volume>102</volume><issue>8</issue><fpage>1624</fpage><lpage>1631</lpage><pub-id pub-id-type="pid">17459022</pub-id><pub-id pub-id-type="doi">10.1111/j.1572-0241.2007.01238.x</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurminen</surname><given-names>S</given-names></name><name><surname>KivelÃ¤</surname><given-names>L</given-names></name><name><surname>Huhtala</surname><given-names>H</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name><name><surname>Kurppa</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Extraintestinal manifestations were common in children with coeliac disease and were more prevalent in patients with more severe clinical and histological presentation</article-title><source>Acta Paediatr</source><year>2019</year><volume>108</volume><issue>4</issue><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="pid">29569302</pub-id><pub-id pub-id-type="doi">10.1111/apa.14324</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G</given-names></name><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects</article-title><source>Br J Nutr</source><year>2009</year><volume>102</volume><issue>8</issue><fpage>1154</fpage><lpage>1160</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtl2itr7N</pub-id><pub-id pub-id-type="pid">19445821</pub-id><pub-id pub-id-type="doi">10.1017/S0007114509371767</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G</given-names></name><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>63</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXisl2ksrw%3D</pub-id><pub-id pub-id-type="pid">20181275</pub-id><pub-id pub-id-type="pmcid">2843610</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-63</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G</given-names></name><name><surname>Capilla</surname><given-names>A</given-names></name><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Nova</surname><given-names>E</given-names></name><name><surname>Pozo</surname><given-names>T</given-names></name><name><surname>Varea</surname><given-names>V</given-names></name><name><surname>Polanco</surname><given-names>I</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Lopez</surname><given-names>A</given-names></name><name><surname>Garrote</surname><given-names>JA</given-names></name><name><surname>Calvo</surname><given-names>C</given-names></name><name><surname>Garcia-Novo</surname><given-names>MD</given-names></name><name><surname>Cilleruelo</surname><given-names>ML</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Palau</surname><given-names>F</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine</article-title><source>Curr Issues Mol Biol</source><year>2010</year><volume>12</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pid">19478349</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Santacruz</surname><given-names>A</given-names></name><name><surname>Marcos</surname><given-names>A</given-names></name><name><surname>Warnberg</surname><given-names>J</given-names></name><name><surname>Garagorri</surname><given-names>JM</given-names></name><name><surname>Moreno</surname><given-names>LA</given-names></name><name><surname>Martin-Matillas</surname><given-names>M</given-names></name><name><surname>Campoy</surname><given-names>C</given-names></name><name><surname>Marti</surname><given-names>A</given-names></name><name><surname>Moleres</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Veiga</surname><given-names>OL</given-names></name><name><surname>Garcia-Fuentes</surname><given-names>M</given-names></name><name><surname>Redondo</surname><given-names>CG</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents</article-title><source>Int J Obes (Lond)</source><year>2009</year><volume>33</volume><issue>7</issue><fpage>758</fpage><lpage>767</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD1MvnvV2ksg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/ijo.2008.260</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>De Pasquale</surname><given-names>I</given-names></name><name><surname>Ndagijimana</surname><given-names>M</given-names></name><name><surname>Vernocchi</surname><given-names>P</given-names></name><name><surname>Ricciuti</surname><given-names>P</given-names></name><name><surname>Gagliardi</surname><given-names>F</given-names></name><name><surname>Laghi</surname><given-names>L</given-names></name><name><surname>Crecchio</surname><given-names>C</given-names></name><name><surname>Guerzoni</surname><given-names>ME</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>Francavilla</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization</article-title><source>BMC Microbiol</source><year>2011</year><volume>11</volume><fpage>219</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhsVSgs7nL</pub-id><pub-id pub-id-type="pid">21970810</pub-id><pub-id pub-id-type="pmcid">3206437</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-11-219</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Differences between the fecal microbiota of coeliac infants and healthy controls</article-title><source>Curr Issues Intest Microbiol</source><year>2007</year><volume>8</volume><issue>1</issue><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXltlOhtrg%3D</pub-id><pub-id pub-id-type="pid">17489434</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease</article-title><source>BMC Microbiol</source><year>2008</year><volume>8</volume><fpage>232</fpage><pub-id pub-id-type="pid">19102766</pub-id><pub-id pub-id-type="pmcid">2635381</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-8-232</pub-id></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease</article-title><source>J Clin Pathol</source><year>2009</year><volume>62</volume><issue>3</issue><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD1M7nt1Wrtw%3D%3D</pub-id><pub-id pub-id-type="pid">18996905</pub-id><pub-id pub-id-type="doi">10.1136/jcp.2008.061366</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nistal</surname><given-names>E</given-names></name><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>Herran</surname><given-names>AR</given-names></name><name><surname>Arias</surname><given-names>L</given-names></name><name><surname>Vivas</surname><given-names>S</given-names></name><name><surname>de Morales</surname><given-names>JM</given-names></name><name><surname>Calleja</surname><given-names>S</given-names></name><name><surname>de Miera</surname><given-names>LE</given-names></name><name><surname>Arroyo</surname><given-names>P</given-names></name><name><surname>Casqueiro</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease</article-title><source>Inflamm Bowel Dis</source><year>2012</year><volume>18</volume><issue>4</issue><fpage>649</fpage><lpage>656</lpage><pub-id pub-id-type="pid">21826768</pub-id><pub-id pub-id-type="doi">10.1002/ibd.21830</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippa</surname><given-names>S</given-names></name><name><surname>Iebba</surname><given-names>V</given-names></name><name><surname>Barbato</surname><given-names>M</given-names></name><name><surname>Di Nardo</surname><given-names>G</given-names></name><name><surname>Totino</surname><given-names>V</given-names></name><name><surname>Checchi</surname><given-names>MP</given-names></name><name><surname>Longhi</surname><given-names>C</given-names></name><name><surname>Maiella</surname><given-names>G</given-names></name><name><surname>Cucchiara</surname><given-names>S</given-names></name><name><surname>Conte</surname><given-names>MP</given-names></name></person-group><article-title xml:lang="en">A distinctive âmicrobial signatureâ in celiac pediatric patients</article-title><source>BMC Microbiol</source><year>2010</year><volume>10</volume><fpage>175</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXotV2lur0%3D</pub-id><pub-id pub-id-type="pid">20565734</pub-id><pub-id pub-id-type="pmcid">2906462</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-175</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Intestinal bacteroides species associated with coeliac disease</article-title><source>J Clin Pathol</source><year>2010</year><volume>63</volume><issue>12</issue><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXltlWnsw%3D%3D</pub-id><pub-id pub-id-type="pid">20972239</pub-id><pub-id pub-id-type="doi">10.1136/jcp.2010.076950</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SÃ¡nchez</surname><given-names>E</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>FernÃ¡ndez-Murga</surname><given-names>ML</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Duodenal-mucosal bacteria associated with celiac disease in children</article-title><source>Appl Environ Microbiol</source><year>2013</year><volume>79</volume><issue>18</issue><fpage>5472</fpage><lpage>5479</lpage><pub-id pub-id-type="pid">23835180</pub-id><pub-id pub-id-type="pmcid">3754165</pub-id><pub-id pub-id-type="doi">10.1128/AEM.00869-13</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodkhe</surname><given-names>R</given-names></name><name><surname>Shetty</surname><given-names>SA</given-names></name><name><surname>Dhotre</surname><given-names>DP</given-names></name><name><surname>Verma</surname><given-names>AK</given-names></name><name><surname>Bhatia</surname><given-names>K</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Pande</surname><given-names>P</given-names></name><name><surname>Bangarusamy</surname><given-names>DK</given-names></name><name><surname>Santosh</surname><given-names>BP</given-names></name><name><surname>Perumal</surname><given-names>RC</given-names></name><name><surname>Ahuja</surname><given-names>V</given-names></name><name><surname>Shouche</surname><given-names>YS</given-names></name><name><surname>Makharia</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">Comparison of small gut and whole gut microbiota of first-degree relatives with adult celiac disease patients and controls</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>164</fpage><pub-id pub-id-type="pid">30800106</pub-id><pub-id pub-id-type="pmcid">6376745</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.00164</pub-id></mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golfetto</surname><given-names>L</given-names></name><name><surname>de Senna</surname><given-names>FD</given-names></name><name><surname>Hermes</surname><given-names>J</given-names></name><name><surname>Beserra</surname><given-names>BT</given-names></name><name><surname>Franca Fda</surname><given-names>S</given-names></name><name><surname>Martinello</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet</article-title><source>Arq Gastroenterol</source><year>2014</year><volume>51</volume><issue>2</issue><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="pid">25003267</pub-id><pub-id pub-id-type="doi">10.1590/s0004-28032014000200013</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wacklin</surname><given-names>P</given-names></name><name><surname>Laurikka</surname><given-names>P</given-names></name><name><surname>Lindfors</surname><given-names>K</given-names></name><name><surname>Collin</surname><given-names>P</given-names></name><name><surname>Salmi</surname><given-names>T</given-names></name><name><surname>Lahdeaho</surname><given-names>ML</given-names></name><name><surname>Saavalainen</surname><given-names>P</given-names></name><name><surname>Maki</surname><given-names>M</given-names></name><name><surname>Matto</surname><given-names>J</given-names></name><name><surname>Kurppa</surname><given-names>K</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet</article-title><source>Am J Gastroenterol</source><year>2014</year><volume>109</volume><issue>12</issue><fpage>1933</fpage><lpage>1941</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitVCitrvE</pub-id><pub-id pub-id-type="pid">25403367</pub-id><pub-id pub-id-type="doi">10.1038/ajg.2014.355</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Mazcorro</surname><given-names>JF</given-names></name><name><surname>Rivera-Gutierrez</surname><given-names>X</given-names></name><name><surname>Cobos-Quevedo</surname><given-names>OJ</given-names></name><name><surname>Grube-Pagola</surname><given-names>P</given-names></name><name><surname>Meixueiro-Daza</surname><given-names>A</given-names></name><name><surname>Hernandez-Flores</surname><given-names>K</given-names></name><name><surname>Cabrera-Jorge</surname><given-names>FJ</given-names></name><name><surname>Vivanco-Cid</surname><given-names>H</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name><name><surname>Remes-Troche</surname><given-names>JM</given-names></name></person-group><article-title xml:lang="en">First insights into the gut microbiota of mexican patients with celiac disease and non-celiac gluten sensitivity</article-title><source>Nutrients</source><year>2018</year><pub-id pub-id-type="pid">30400238</pub-id><pub-id pub-id-type="pmcid">6266755</pub-id><pub-id pub-id-type="doi">10.3390/nu10111641</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Galipeau</surname><given-names>HJ</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Novel players in coeliac disease pathogenesis: role of the gut microbiota</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2015</year><volume>12</volume><issue>9</issue><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhtFKktbrO</pub-id><pub-id pub-id-type="pid">26055247</pub-id><pub-id pub-id-type="pmcid">5102016</pub-id><pub-id pub-id-type="doi">10.1038/nrgastro.2015.90</pub-id></mixed-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsberg</surname><given-names>G</given-names></name><name><surname>Fahlgren</surname><given-names>A</given-names></name><name><surname>HÃ¶rstedt</surname><given-names>P</given-names></name><name><surname>HammarstrÃ¶m</surname><given-names>S</given-names></name><name><surname>Hernell</surname><given-names>O</given-names></name><name><surname>HammarstrÃ¶m</surname><given-names>M-L</given-names></name></person-group><article-title xml:lang="en">Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease</article-title><source>Am J Gastroenterol</source><year>2004</year><volume>99</volume><issue>5</issue><fpage>894</fpage><lpage>904</lpage><pub-id pub-id-type="pid">15128357</pub-id><pub-id pub-id-type="doi">10.1111/j.1572-0241.2004.04157.x</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>G</given-names></name><name><surname>Hedberg</surname><given-names>M</given-names></name><name><surname>HÃ¶rstedt</surname><given-names>P</given-names></name><name><surname>Baranov</surname><given-names>V</given-names></name><name><surname>Forsberg</surname><given-names>G</given-names></name><name><surname>Drobni</surname><given-names>M</given-names></name><name><surname>SandstrÃ¶m</surname><given-names>O</given-names></name><name><surname>Wai</surname><given-names>SN</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>HammarstrÃ¶m</surname><given-names>M-L</given-names></name><name><surname>Hernell</surname><given-names>O</given-names></name><name><surname>HammarstrÃ¶m</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease</article-title><source>Am J Gastroenterol</source><year>2009</year><volume>104</volume><issue>12</issue><fpage>3058</fpage><lpage>3067</lpage><pub-id pub-id-type="pid">19755974</pub-id><pub-id pub-id-type="doi">10.1038/ajg.2009.524</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Fernandez-Murga</surname><given-names>ML</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Duodenal-mucosal bacteria associated with celiac disease in children</article-title><source>Appl Environ Microbiol</source><year>2013</year><volume>79</volume><issue>18</issue><fpage>5472</fpage><lpage>5479</lpage><pub-id pub-id-type="pid">23835180</pub-id><pub-id pub-id-type="pmcid">3754165</pub-id><pub-id pub-id-type="doi">10.1128/AEM.00869-13</pub-id></mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>Y</given-names></name><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Marzotto</surname><given-names>M</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Torriani</surname><given-names>S</given-names></name><name><surname>Dellaglio</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis</article-title><source>FEMS Immunol Med Microbiol</source><year>2007</year><volume>51</volume><issue>3</issue><fpage>562</fpage><lpage>568</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhsVeit7rK</pub-id><pub-id pub-id-type="pid">17919298</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00337.x</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>Rizzello</surname><given-names>CG</given-names></name><name><surname>Gagliardi</surname><given-names>F</given-names></name><name><surname>Ricciuti</surname><given-names>P</given-names></name><name><surname>Ndagijimana</surname><given-names>M</given-names></name><name><surname>Francavilla</surname><given-names>R</given-names></name><name><surname>Guerzoni</surname><given-names>ME</given-names></name><name><surname>Crecchio</surname><given-names>C</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease</article-title><source>Appl Environ Microbiol</source><year>2009</year><volume>75</volume><issue>12</issue><fpage>3963</fpage><lpage>3971</lpage><pub-id pub-id-type="pid">19376912</pub-id><pub-id pub-id-type="pmcid">2698361</pub-id><pub-id pub-id-type="doi">10.1128/aem.02793-08</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G</given-names></name><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><name><surname>Donat</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children</article-title><source>BMC Microbiol</source><year>2010</year><pub-id pub-id-type="pid">20181275</pub-id><pub-id pub-id-type="pmcid">2843610</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-63</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Capilla</surname><given-names>A</given-names></name><name><surname>BenÃ­tez-PÃ¡ez</surname><given-names>A</given-names></name><name><surname>Palau</surname><given-names>F</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Gut microbiota trajectory in early life may predict development of celiac disease</article-title><source>Microbiome</source><year>2018</year><pub-id pub-id-type="pid">29458413</pub-id><pub-id pub-id-type="pmcid">5819212</pub-id><pub-id pub-id-type="doi">10.1186/s40168-018-0415-6</pub-id></mixed-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiba</surname><given-names>T</given-names></name><name><surname>Aiba</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Ushiyama</surname><given-names>A</given-names></name><name><surname>Takagi</surname><given-names>A</given-names></name><name><surname>Mine</surname><given-names>T</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease</article-title><source>Microbiol Immunol</source><year>2003</year><volume>47</volume><issue>6</issue><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXlslCqsLc%3D</pub-id><pub-id pub-id-type="pid">12906096</pub-id><pub-id pub-id-type="doi">10.1111/j.1348-0421.2003.tb03368.x</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydora</surname><given-names>BC</given-names></name><name><surname>Macfarlane</surname><given-names>SM</given-names></name><name><surname>Walker</surname><given-names>JW</given-names></name><name><surname>Dmytrash</surname><given-names>AL</given-names></name><name><surname>Churchill</surname><given-names>TA</given-names></name><name><surname>Doyle</surname><given-names>J</given-names></name><name><surname>Fedorak</surname><given-names>RN</given-names></name></person-group><article-title xml:lang="en">Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse</article-title><source>Inflamm Bowel Dis</source><year>2007</year><volume>13</volume><issue>8</issue><fpage>947</fpage><lpage>954</lpage><pub-id pub-id-type="pid">17427241</pub-id><pub-id pub-id-type="doi">10.1002/ibd.20155</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setoyama</surname><given-names>H</given-names></name><name><surname>Imaoka</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Umesaki</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Prevention of gut inflammation by <italic>Bifidobacterium</italic> in dextran sulfate-treated gnotobiotic mice associated with <italic>Bacteroides</italic> strains isolated from ulcerative colitis patients</article-title><source>Microbes Infect</source><year>2003</year><volume>5</volume><issue>2</issue><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="pid">12650769</pub-id><pub-id pub-id-type="doi">10.1016/s1286-4579(02)00080-1</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nistal</surname><given-names>E</given-names></name><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>Vivas</surname><given-names>S</given-names></name><name><surname>Ruiz de Morales</surname><given-names>JM</given-names></name><name><surname>Saenz de Miera</surname><given-names>LE</given-names></name><name><surname>Rodriguez-Aparicio</surname><given-names>LB</given-names></name><name><surname>Casqueiro</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients</article-title><source>Biochimie</source><year>2012</year><volume>94</volume><issue>8</issue><fpage>1724</fpage><lpage>1729</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xms12ktL0%3D</pub-id><pub-id pub-id-type="pid">22542995</pub-id><pub-id pub-id-type="doi">10.1016/j.biochi.2012.03.025</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>Galipeau</surname><given-names>HJ</given-names></name><name><surname>McCarville</surname><given-names>JL</given-names></name><name><surname>Johnston</surname><given-names>CW</given-names></name><name><surname>Bernier</surname><given-names>SP</given-names></name><name><surname>Russell</surname><given-names>AK</given-names></name><name><surname>Jury</surname><given-names>J</given-names></name><name><surname>Herran</surname><given-names>AR</given-names></name><name><surname>Casqueiro</surname><given-names>J</given-names></name><name><surname>Tye-Din</surname><given-names>JA</given-names></name><name><surname>Surette</surname><given-names>MG</given-names></name><name><surname>Magarvey</surname><given-names>NA</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name></person-group><article-title xml:lang="en">Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity</article-title><source>Gastroenterology</source><year>2016</year><volume>151</volume><issue>4</issue><fpage>670</fpage><lpage>683</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsVeltr7P</pub-id><pub-id pub-id-type="pid">27373514</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2016.06.041</pub-id></mixed-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Neef</surname><given-names>A</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Palma</surname><given-names>GD</given-names></name><name><surname>Varea</surname><given-names>V</given-names></name><name><surname>Capilla</surname><given-names>A</given-names></name><name><surname>Palau</surname><given-names>F</given-names></name><name><surname>Nova</surname><given-names>E</given-names></name><name><surname>Marcos</surname><given-names>A</given-names></name><name><surname>Polanco</surname><given-names>I</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Ortigosa</surname><given-names>L</given-names></name><name><surname>Izquierdo</surname><given-names>L</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease</article-title><source>Gut</source><year>2015</year><volume>64</volume><issue>3</issue><fpage>406</fpage><lpage>417</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXntFemtL8%3D</pub-id><pub-id pub-id-type="pid">24939571</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2014-306931</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellitto</surname><given-names>M</given-names></name><name><surname>Bai</surname><given-names>G</given-names></name><name><surname>Serena</surname><given-names>G</given-names></name><name><surname>Fricke</surname><given-names>WF</given-names></name><name><surname>Sturgeon</surname><given-names>C</given-names></name><name><surname>Gajer</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>JR</given-names></name><name><surname>Koenig</surname><given-names>SS</given-names></name><name><surname>Sakamoto</surname><given-names>J</given-names></name><name><surname>Boothe</surname><given-names>D</given-names></name><name><surname>Gicquelais</surname><given-names>R</given-names></name><name><surname>Kryszak</surname><given-names>D</given-names></name><name><surname>Puppa</surname><given-names>E</given-names></name><name><surname>Catassi</surname><given-names>C</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><issue>3</issue><fpage>e33387</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xks1Kitrg%3D</pub-id><pub-id pub-id-type="pid">22432018</pub-id><pub-id pub-id-type="pmcid">3303818</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033387</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Lavermicocca</surname><given-names>P</given-names></name><name><surname>De Vincenzi</surname><given-names>M</given-names></name><name><surname>Giovannini</surname><given-names>C</given-names></name><name><surname>Faccia</surname><given-names>M</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance</article-title><source>Appl Environ Microbiol</source><year>2002</year><volume>68</volume><issue>2</issue><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="pid">11823200</pub-id><pub-id pub-id-type="pmcid">126681</pub-id><pub-id pub-id-type="doi">10.1128/aem.68.2.623-633.2002</pub-id></mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamakhchari</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Dewhirst</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Oppenheim</surname><given-names>FG</given-names></name><name><surname>Helmerhorst</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><issue>9</issue><fpage>e24455</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXht12nsL7J</pub-id><pub-id pub-id-type="pid">21957450</pub-id><pub-id pub-id-type="pmcid">3177827</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0024455</pub-id></mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>VL</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">Interactions between the intestinal microbiota and innate lymphoid cells</article-title><source>Gut Microbes</source><year>2014</year><volume>5</volume><issue>1</issue><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="pid">24418741</pub-id><pub-id pub-id-type="doi">10.4161/gmic.27289</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>K</given-names></name><name><surname>Koyasu</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Innate lymphoid cells, possible interaction with microbiota</article-title><source>Semin Immunopathol</source><year>2015</year><volume>37</volume><issue>1</issue><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitFOgurrN</pub-id><pub-id pub-id-type="pid">25502370</pub-id><pub-id pub-id-type="doi">10.1007/s00281-014-0470-4</pub-id></mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrncir</surname><given-names>T</given-names></name><name><surname>Stepankova</surname><given-names>R</given-names></name><name><surname>Kozakova</surname><given-names>H</given-names></name><name><surname>Hudcovic</surname><given-names>T</given-names></name><name><surname>Tlaskalova-Hogenova</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice</article-title><source>BMC Immunol</source><year>2008</year><volume>9</volume><fpage>65</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhsVKksb%2FE</pub-id><pub-id pub-id-type="pid">18990206</pub-id><pub-id pub-id-type="pmcid">2588440</pub-id><pub-id pub-id-type="doi">10.1186/1471-2172-9-65</pub-id></mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arpaia</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Dikiy</surname><given-names>S</given-names></name><name><surname>van der Veeken</surname><given-names>J</given-names></name><name><surname>deRoos</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Cross</surname><given-names>JR</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Coffer</surname><given-names>PJ</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group><article-title xml:lang="en">Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation</article-title><source>Nature</source><year>2013</year><volume>504</volume><issue>7480</issue><fpage>451</fpage><lpage>455</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvFOmtrrJ</pub-id><pub-id pub-id-type="pid">24226773</pub-id><pub-id pub-id-type="pmcid">3869884</pub-id><pub-id pub-id-type="doi">10.1038/nature12726</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furusawa</surname><given-names>Y</given-names></name><name><surname>Obata</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Endo</surname><given-names>TA</given-names></name><name><surname>Nakato</surname><given-names>G</given-names></name><name><surname>Takahashi</surname><given-names>D</given-names></name><name><surname>Nakanishi</surname><given-names>Y</given-names></name><name><surname>Uetake</surname><given-names>C</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Fukuda</surname><given-names>NN</given-names></name><name><surname>Murakami</surname><given-names>S</given-names></name><name><surname>Miyauchi</surname><given-names>E</given-names></name><name><surname>Hino</surname><given-names>S</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Onawa</surname><given-names>S</given-names></name><name><surname>Fujimura</surname><given-names>Y</given-names></name><name><surname>Lockett</surname><given-names>T</given-names></name><name><surname>Clarke</surname><given-names>JM</given-names></name><name><surname>Topping</surname><given-names>DL</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Ohara</surname><given-names>O</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Kikuchi</surname><given-names>J</given-names></name><name><surname>Honda</surname><given-names>K</given-names></name><name><surname>Hase</surname><given-names>K</given-names></name><name><surname>Ohno</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title><source>Nature</source><year>2013</year><volume>504</volume><issue>7480</issue><fpage>446</fpage><lpage>450</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvFOltr3F</pub-id><pub-id pub-id-type="pid">24226770</pub-id><pub-id pub-id-type="doi">10.1038/nature12721</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PM</given-names></name><name><surname>Howitt</surname><given-names>MR</given-names></name><name><surname>Panikov</surname><given-names>N</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Gallini</surname><given-names>CA</given-names></name><name><surname>Bohlooly</surname><given-names>YM</given-names></name><name><surname>Glickman</surname><given-names>JN</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name></person-group><article-title xml:lang="en">The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title><source>Science</source><year>2013</year><volume>341</volume><issue>6145</issue><fpage>569</fpage><lpage>573</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtFyjsr3P</pub-id><pub-id pub-id-type="pid">23828891</pub-id><pub-id pub-id-type="pmcid">23828891</pub-id><pub-id pub-id-type="doi">10.1126/science.1241165</pub-id></mixed-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>KM</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">Emerging view of the human virome</article-title><source>Transl Res</source><year>2012</year><volume>160</volume><issue>4</issue><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtlOju77K</pub-id><pub-id pub-id-type="pid">22683423</pub-id><pub-id pub-id-type="pmcid">3701101</pub-id><pub-id pub-id-type="doi">10.1016/j.trsl.2012.03.006</pub-id></mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A</given-names></name><name><surname>Matthias</surname><given-names>T</given-names></name><name><surname>Aminov</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Potential effects of horizontal gene exchange in the human gut</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>1630</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitFemsLvO</pub-id><pub-id pub-id-type="pid">29230215</pub-id><pub-id pub-id-type="pmcid">5711824</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01630</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>S</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Coffey</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name></person-group><article-title xml:lang="en">Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota</article-title><source>Gut Microbes</source><year>2013</year><volume>4</volume><issue>1</issue><fpage>4</fpage><lpage>16</lpage><pub-id pub-id-type="pid">23022738</pub-id><pub-id pub-id-type="pmcid">3555884</pub-id><pub-id pub-id-type="doi">10.4161/gmic.22371</pub-id></mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>F</given-names></name><name><surname>Muniesa</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Phages in the Human Body</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>566</fpage><pub-id pub-id-type="pid">28421059</pub-id><pub-id pub-id-type="pmcid">5378999</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.00566</pub-id></mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manrique</surname><given-names>P</given-names></name><name><surname>Dills</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">The human gut phage community and its implications for health and disease</article-title><source>Viruses</source><year>2017</year><pub-id pub-id-type="pid">28594392</pub-id><pub-id pub-id-type="pmcid">5490818</pub-id><pub-id pub-id-type="doi">10.3390/v9060141</pub-id></mixed-citation></ref><ref id="CR114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopin</surname><given-names>MC</given-names></name><name><surname>Chopin</surname><given-names>A</given-names></name><name><surname>Bidnenko</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Phage abortive infection in lactococci: variations on a theme</article-title><source>Curr Opin Microbiol</source><year>2005</year><volume>8</volume><issue>4</issue><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXmvVCmsLg%3D</pub-id><pub-id pub-id-type="pid">15979388</pub-id><pub-id pub-id-type="doi">10.1016/j.mib.2005.06.006</pub-id></mixed-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagnoff</surname><given-names>MF</given-names></name><name><surname>Paterson</surname><given-names>YJ</given-names></name><name><surname>Kumar</surname><given-names>PJ</given-names></name><name><surname>Kasarda</surname><given-names>DD</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Unsworth</surname><given-names>DJ</given-names></name><name><surname>Austin</surname><given-names>RK</given-names></name></person-group><article-title xml:lang="en">Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease</article-title><source>Gut</source><year>1987</year><volume>28</volume><issue>8</issue><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL1c%2FjtVymtA%3D%3D</pub-id><pub-id pub-id-type="pid">2822550</pub-id><pub-id pub-id-type="pmcid">1433141</pub-id><pub-id pub-id-type="doi">10.1136/gut.28.8.995</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stene</surname><given-names>LC</given-names></name><name><surname>Honeyman</surname><given-names>MC</given-names></name><name><surname>Hoffenberg</surname><given-names>EJ</given-names></name><name><surname>Haas</surname><given-names>JE</given-names></name><name><surname>Sokol</surname><given-names>RJ</given-names></name><name><surname>Emery</surname><given-names>L</given-names></name><name><surname>Taki</surname><given-names>I</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Erlich</surname><given-names>HA</given-names></name><name><surname>Eisenbarth</surname><given-names>GS</given-names></name><name><surname>Rewers</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study</article-title><source>Am J Gastroenterol</source><year>2006</year><volume>101</volume><issue>10</issue><fpage>2333</fpage><lpage>2340</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xht1SqsbbM</pub-id><pub-id pub-id-type="pid">17032199</pub-id><pub-id pub-id-type="doi">10.1111/j.1572-0241.2006.00741.x</pub-id></mixed-citation></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MylÃ©us</surname><given-names>A</given-names></name><name><surname>Hernell</surname><given-names>O</given-names></name><name><surname>Gothefors</surname><given-names>L</given-names></name><name><surname>HammarstrÃ¶m</surname><given-names>M-L</given-names></name><name><surname>Persson</surname><given-names>L-Ã</given-names></name><name><surname>Stenlund</surname><given-names>H</given-names></name><name><surname>Ivarsson</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Early infections are associated with increased risk for celiac disease: an incident case-referent study</article-title><source>BMC Pediat</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/1471-2431-12-194</pub-id></mixed-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemppainen</surname><given-names>KM</given-names></name><name><surname>Lynch</surname><given-names>KF</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Lonnrot</surname><given-names>M</given-names></name><name><surname>Simell</surname><given-names>V</given-names></name><name><surname>Briese</surname><given-names>T</given-names></name><name><surname>Koletzko</surname><given-names>S</given-names></name><name><surname>Hagopian</surname><given-names>W</given-names></name><name><surname>Rewers</surname><given-names>M</given-names></name><name><surname>She</surname><given-names>JX</given-names></name><name><surname>Simell</surname><given-names>O</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name><name><surname>Akolkar</surname><given-names>B</given-names></name><name><surname>Krischer</surname><given-names>JP</given-names></name><name><surname>Lernmark</surname><given-names>A</given-names></name><name><surname>Hyoty</surname><given-names>H</given-names></name><name><surname>Triplett</surname><given-names>EW</given-names></name><name><surname>Agardh</surname><given-names>D</given-names></name><collab>Group TS</collab></person-group><article-title xml:lang="en">Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life</article-title><source>Clin Gastroenterol Hepatol</source><year>2017</year><volume>15</volume><issue>5</issue><fpage>694</fpage><lpage>702</lpage><pub-id pub-id-type="pid">27840181</pub-id><pub-id pub-id-type="doi">10.1016/j.cgh.2016.10.033</pub-id><comment>(e695)</comment></mixed-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziberna</surname><given-names>F</given-names></name><name><surname>De Lorenzo</surname><given-names>G</given-names></name><name><surname>Schiavon</surname><given-names>V</given-names></name><name><surname>Arnoldi</surname><given-names>F</given-names></name><name><surname>Quaglia</surname><given-names>S</given-names></name><name><surname>De Leo</surname><given-names>L</given-names></name><name><surname>Vatta</surname><given-names>S</given-names></name><name><surname>Martelossi</surname><given-names>S</given-names></name><name><surname>Burrone</surname><given-names>OR</given-names></name><name><surname>Ventura</surname><given-names>A</given-names></name><name><surname>Not</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease</article-title><source>Clin Exp Immunol</source><year>2016</year><volume>186</volume><issue>3</issue><fpage>356</fpage><lpage>363</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvVWmsr7I</pub-id><pub-id pub-id-type="pid">27548641</pub-id><pub-id pub-id-type="pmcid">5108075</pub-id><pub-id pub-id-type="doi">10.1111/cei.12855</pub-id></mixed-citation></ref><ref id="CR120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plot</surname><given-names>L</given-names></name><name><surname>Amital</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Infectious associations of Celiac disease</article-title><source>Autoimmun Rev</source><year>2009</year><volume>8</volume><issue>4</issue><fpage>316</fpage><lpage>319</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmtVyqsrk%3D</pub-id><pub-id pub-id-type="pid">18973831</pub-id><pub-id pub-id-type="doi">10.1016/j.autrev.2008.10.001</pub-id></mixed-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouziat</surname><given-names>R</given-names></name><name><surname>Hinterleitner</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>JJ</given-names></name><name><surname>Stencel-Baerenwald</surname><given-names>JE</given-names></name><name><surname>Ikizler</surname><given-names>M</given-names></name><name><surname>Mayassi</surname><given-names>T</given-names></name><name><surname>Meisel</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Discepolo</surname><given-names>V</given-names></name><name><surname>Pruijssers</surname><given-names>AJ</given-names></name><name><surname>Ernest</surname><given-names>JD</given-names></name><name><surname>Iskarpatyoti</surname><given-names>JA</given-names></name><name><surname>Costes</surname><given-names>LM</given-names></name><name><surname>Lawrence</surname><given-names>I</given-names></name><name><surname>Palanski</surname><given-names>BA</given-names></name><name><surname>Varma</surname><given-names>M</given-names></name><name><surname>Zurenski</surname><given-names>MA</given-names></name><name><surname>Khomandiak</surname><given-names>S</given-names></name><name><surname>McAllister</surname><given-names>N</given-names></name><name><surname>Aravamudhan</surname><given-names>P</given-names></name><name><surname>Boehme</surname><given-names>KW</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Samsom</surname><given-names>JN</given-names></name><name><surname>Reinecker</surname><given-names>HC</given-names></name><name><surname>Kupfer</surname><given-names>SS</given-names></name><name><surname>Guandalini</surname><given-names>S</given-names></name><name><surname>Semrad</surname><given-names>CE</given-names></name><name><surname>Abadie</surname><given-names>V</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease</article-title><source>Science</source><year>2017</year><volume>356</volume><issue>6333</issue><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXlsVymsbs%3D</pub-id><pub-id pub-id-type="pid">28386004</pub-id><pub-id pub-id-type="pmcid">5506690</pub-id><pub-id pub-id-type="doi">10.1126/science.aah5298</pub-id></mixed-citation></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahrs</surname><given-names>CR</given-names></name><name><surname>Chuda</surname><given-names>K</given-names></name><name><surname>Tapia</surname><given-names>G</given-names></name><name><surname>Stene</surname><given-names>LC</given-names></name><name><surname>MÃ¥rild</surname><given-names>K</given-names></name><name><surname>Rasmussen</surname><given-names>T</given-names></name><name><surname>RÃ¸nningen</surname><given-names>KS</given-names></name><name><surname>Lundin</surname><given-names>KEA</given-names></name><name><surname>Kramna</surname><given-names>L</given-names></name><name><surname>Cinek</surname><given-names>O</given-names></name><name><surname>StÃ¸rdal</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort</article-title><source>BMJ</source><year>2019</year><volume>364</volume><fpage>l231</fpage><pub-id pub-id-type="pid">30760441</pub-id><pub-id pub-id-type="pmcid">6372922</pub-id><pub-id pub-id-type="doi">10.1136/bmj.l231</pub-id></mixed-citation></ref><ref id="CR123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindfors</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>H-S</given-names></name><name><surname>HyÃ¶ty</surname><given-names>H</given-names></name><name><surname>Nykter</surname><given-names>M</given-names></name><name><surname>Kurppa</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Koletzko</surname><given-names>S</given-names></name><name><surname>Rewers</surname><given-names>M</given-names></name><name><surname>Hagopian</surname><given-names>W</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Ziegler</surname><given-names>A-G</given-names></name><name><surname>Akolkar</surname><given-names>B</given-names></name><name><surname>Krischer</surname><given-names>JP</given-names></name><name><surname>Petrosino</surname><given-names>JF</given-names></name><name><surname>Lloyd</surname><given-names>RE</given-names></name><name><surname>Agardh</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study</article-title><source>Gut</source><year>2019</year><pub-id pub-id-type="pid">31744911</pub-id><pub-id pub-id-type="pmcid">7234892</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2019-319809</pub-id><comment>(gutjnl-2019-319809)</comment></mixed-citation></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>HerrÃ¡n</surname><given-names>AR</given-names></name><name><surname>Nistal</surname><given-names>E</given-names></name><name><surname>PÃ©rez-AndrÃ©s</surname><given-names>J</given-names></name><name><surname>Vaquero</surname><given-names>L</given-names></name><name><surname>Vivas</surname><given-names>S</given-names></name><name><surname>Ruiz de Morales</surname><given-names>JMG</given-names></name><name><surname>Albillos</surname><given-names>SM</given-names></name><name><surname>Casqueiro</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease</article-title><source>FEMS Microbiol Ecol</source><year>2014</year><volume>88</volume><issue>2</issue><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXnsVSksrs%3D</pub-id><pub-id pub-id-type="pid">24499426</pub-id><pub-id pub-id-type="doi">10.1111/1574-6941.12295</pub-id></mixed-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Lauber</surname><given-names>CL</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Bacterial community variation in human body habitats across space and time</article-title><source>Science (New York, NY)</source><year>2009</year><volume>326</volume><issue>5960</issue><fpage>1694</fpage><lpage>1697</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsFGmsL7K</pub-id><pub-id pub-id-type="doi">10.1126/science.1177486</pub-id></mixed-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>MA</given-names></name><name><surname>Zenobia</surname><given-names>C</given-names></name><name><surname>Darveau</surname><given-names>RP</given-names></name></person-group><article-title xml:lang="en">The relationship of the oral microbiotia to periodontal health and disease</article-title><source>Cell Host Microbe</source><year>2011</year><volume>10</volume><issue>4</issue><fpage>302</fpage><lpage>306</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlKisbfJ</pub-id><pub-id pub-id-type="pid">22018230</pub-id><pub-id pub-id-type="pmcid">3216488</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2011.09.008</pub-id></mixed-citation></ref><ref id="CR127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">1 The precipitating factor in coeliac disease</article-title><source>Bailliereâs Clin Gastroenterol</source><year>1995</year><volume>9</volume><issue>2</issue><fpage>191</fpage><lpage>207</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK28%2FitlOguw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/0950-3528(95)90027-6</pub-id></mixed-citation></ref><ref id="CR128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Molberg</surname><given-names>Ã</given-names></name><name><surname>Parrot</surname><given-names>I</given-names></name><name><surname>Hausch</surname><given-names>F</given-names></name><name><surname>Filiz</surname><given-names>F</given-names></name><name><surname>Gray</surname><given-names>GM</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Khosla</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Structural basis for gluten intolerance in celiac sprue</article-title><source>Science (New York, NY)</source><year>2002</year><volume>297</volume><issue>5590</issue><fpage>2275</fpage><lpage>2279</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XntlWlt70%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1074129</pub-id></mixed-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vader</surname><given-names>LW</given-names></name><name><surname>de Ru</surname><given-names>A</given-names></name><name><surname>van der Wal</surname><given-names>Y</given-names></name><name><surname>Kooy</surname><given-names>YM</given-names></name><name><surname>Benckhuijsen</surname><given-names>W</given-names></name><name><surname>Mearin</surname><given-names>ML</given-names></name><name><surname>Drijfhout</surname><given-names>JW</given-names></name><name><surname>van Veelen</surname><given-names>P</given-names></name><name><surname>Koning</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Specificity of tissue transglutaminase explains cereal toxicity in celiac disease</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><issue>5</issue><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XitV2nu7g%3D</pub-id><pub-id pub-id-type="pid">11877487</pub-id><pub-id pub-id-type="pmcid">2193762</pub-id><pub-id pub-id-type="doi">10.1084/jem.20012028</pub-id></mixed-citation></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmerhorst</surname><given-names>EJ</given-names></name><name><surname>Zamakhchari</surname><given-names>M</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Oppenheim</surname><given-names>FG</given-names></name></person-group><article-title xml:lang="en">Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><issue>10</issue><fpage>e13264</fpage><lpage>e13264</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtlSlt73L</pub-id><pub-id pub-id-type="pid">20948997</pub-id><pub-id pub-id-type="pmcid">2952584</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0013264</pub-id></mixed-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francavilla</surname><given-names>R</given-names></name><name><surname>Ercolini</surname><given-names>D</given-names></name><name><surname>Piccolo</surname><given-names>M</given-names></name><name><surname>Vannini</surname><given-names>L</given-names></name><name><surname>Siragusa</surname><given-names>S</given-names></name><name><surname>De Filippis</surname><given-names>F</given-names></name><name><surname>De Pasquale</surname><given-names>I</given-names></name><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>Di Toma</surname><given-names>M</given-names></name><name><surname>Gozzi</surname><given-names>G</given-names></name><name><surname>Serrazanetti</surname><given-names>DI</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Salivary microbiota and metabolome associated with celiac disease</article-title><source>Appl Environ Microbiol</source><year>2014</year><volume>80</volume><issue>11</issue><fpage>3416</fpage><lpage>3425</lpage><pub-id pub-id-type="pid">24657864</pub-id><pub-id pub-id-type="pmcid">4018861</pub-id><pub-id pub-id-type="doi">10.1128/aem.00362-14</pub-id></mixed-citation></ref><ref id="CR132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>N</given-names></name><name><surname>Faller</surname><given-names>L</given-names></name><name><surname>Leffler</surname><given-names>DA</given-names></name><name><surname>Kelly</surname><given-names>CP</given-names></name><name><surname>Hansen</surname><given-names>J</given-names></name><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Paster</surname><given-names>BJ</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Helmerhorst</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Salivary gluten degradation and oral microbial profiles in healthy individuals and celiac disease patients</article-title><source>Appl Environ Microbiol</source><year>2017</year><volume>83</volume><issue>6</issue><fpage>e03330</fpage><lpage>e13316</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtFCntL%2FM</pub-id><pub-id pub-id-type="pid">28087531</pub-id><pub-id pub-id-type="pmcid">5335528</pub-id><pub-id pub-id-type="doi">10.1128/AEM.03330-16</pub-id></mixed-citation></ref><ref id="CR133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iaffaldano</surname><given-names>L</given-names></name><name><surname>Granata</surname><given-names>I</given-names></name><name><surname>Pagliuca</surname><given-names>C</given-names></name><name><surname>Esposito</surname><given-names>MV</given-names></name><name><surname>Casaburi</surname><given-names>G</given-names></name><name><surname>Salerno</surname><given-names>G</given-names></name><name><surname>Colicchio</surname><given-names>R</given-names></name><name><surname>Piccirillo</surname><given-names>M</given-names></name><name><surname>Ciacci</surname><given-names>C</given-names></name><name><surname>Del Vecchio</surname><given-names>BG</given-names></name><name><surname>Guarracino</surname><given-names>MR</given-names></name><name><surname>Salvatore</surname><given-names>P</given-names></name><name><surname>Salvatore</surname><given-names>F</given-names></name><name><surname>DâArgenio</surname><given-names>V</given-names></name><name><surname>Sacchetti</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Oropharyngeal microbiome evaluation highlights Neisseria abundance in active celiac patients</article-title><source>Scientific Reports</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>11047</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitVejsbnJ</pub-id><pub-id pub-id-type="pid">30038321</pub-id><pub-id pub-id-type="pmcid">6056421</pub-id><pub-id pub-id-type="doi">10.1038/s41598-018-29443-1</pub-id></mixed-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>PaÃ¯ssÃ©</surname><given-names>S</given-names></name><name><surname>Valle</surname><given-names>C</given-names></name><name><surname>Servant</surname><given-names>F</given-names></name><name><surname>Courtney</surname><given-names>M</given-names></name><name><surname>Burcelin</surname><given-names>R</given-names></name><name><surname>Amar</surname><given-names>J</given-names></name><name><surname>Lelouvier</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Comprehensive description of blood microbiome from healthy donors assessed by 16 S targeted metagenomic sequencing</article-title><source>Transfusion</source><year>2016</year><volume>56</volume><issue>5</issue><fpage>1138</fpage><lpage>1147</lpage><pub-id pub-id-type="pid">26865079</pub-id><pub-id pub-id-type="doi">10.1111/trf.13477</pub-id></mixed-citation></ref><ref id="CR135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potgieter</surname><given-names>M</given-names></name><name><surname>Bester</surname><given-names>J</given-names></name><name><surname>Kell</surname><given-names>DB</given-names></name><name><surname>Pretorius</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">The dormant blood microbiome in chronic, inflammatory diseases</article-title><source>FEMS Microbiol Rev</source><year>2015</year><volume>39</volume><issue>4</issue><fpage>567</fpage><lpage>591</lpage><pub-id pub-id-type="pid">25940667</pub-id><pub-id pub-id-type="pmcid">4487407</pub-id><pub-id pub-id-type="doi">10.1093/femsre/fuv013</pub-id></mixed-citation></ref><ref id="CR136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proal</surname><given-names>AD</given-names></name><name><surname>Albert</surname><given-names>PJ</given-names></name><name><surname>Marshall</surname><given-names>TG</given-names></name></person-group><article-title xml:lang="en">Inflammatory disease and the human microbiome</article-title><source>Discov Med</source><year>2014</year><volume>17</volume><issue>95</issue><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pid">24882717</pub-id></mixed-citation></ref><ref id="CR137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>DJ</given-names></name><name><surname>Rifkin</surname><given-names>RF</given-names></name><name><surname>Cowan</surname><given-names>DA</given-names></name><name><surname>Potgieter</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The Healthy Human Blood Microbiome: Fact or Fiction?</article-title><source>Front Cell Infect Microbiol</source><year>2019</year><volume>9</volume><fpage>148</fpage><lpage>148</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BB3cXhslCksrk%3D</pub-id><pub-id pub-id-type="pid">31139578</pub-id><pub-id pub-id-type="pmcid">6519389</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00148</pub-id></mixed-citation></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="other">Amar J, Lange C, Payros G, Garret C, Chabo C, Lantieri O, Courtney M, Marre M, Charles MA, Balkau B (2013) Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the DESIR study. PLoS One 8(1). 10.1371/journal.pone.0054461</mixed-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>J</given-names></name><name><surname>Kanazawa</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Yoshihara</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Komiya</surname><given-names>K</given-names></name><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Ogihara</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Gut dysbiosis and detection of âlive gut bacteriaâ in blood of Japanese patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2014</year><volume>37</volume><issue>8</issue><fpage>2343</fpage><lpage>2350</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhsFert77J</pub-id><pub-id pub-id-type="pid">24824547</pub-id><pub-id pub-id-type="doi">10.2337/dc13-2817</pub-id></mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serena</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>C</given-names></name><name><surname>Cetinbas</surname><given-names>M</given-names></name><name><surname>Sadreyev</surname><given-names>RI</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Analysis of blood and fecal microbiome profile in patients with celiac disease</article-title><source>Human Microb J</source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.humic.2018.12.001</pub-id></mixed-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galipeau</surname><given-names>HJ</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name></person-group><article-title xml:lang="en">Gut microbes and adverse food reactions: focus on gluten related disorders</article-title><source>Gut Microbes</source><year>2014</year><volume>5</volume><issue>5</issue><fpage>594</fpage><lpage>605</lpage><pub-id pub-id-type="pid">25483329</pub-id><pub-id pub-id-type="pmcid">5154254</pub-id><pub-id pub-id-type="doi">10.4161/19490976.2014.969635</pub-id></mixed-citation></ref><ref id="CR142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebwohl</surname><given-names>B</given-names></name><name><surname>Ludvigsson</surname><given-names>JF</given-names></name><name><surname>Green</surname><given-names>PH</given-names></name></person-group><article-title xml:lang="en">Celiac disease and non-celiac gluten sensitivity</article-title><source>BMJ</source><year>2015</year><volume>351</volume><fpage>h4347</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XmtFGqsrY%3D</pub-id><pub-id pub-id-type="pid">26438584</pub-id><pub-id pub-id-type="pmcid">4596973</pub-id><pub-id pub-id-type="doi">10.1136/bmj.h4347</pub-id></mixed-citation></ref><ref id="CR143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>KB</given-names></name></person-group><article-title xml:lang="en">Editorial: celiac disease and intestinal bacteria: not only gluten?</article-title><source>J Leukoc Biol</source><year>2010</year><volume>87</volume><issue>5</issue><fpage>749</fpage><lpage>751</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXmvVChtrk%3D</pub-id><pub-id pub-id-type="pid">20430780</pub-id><pub-id pub-id-type="doi">10.1189/jlb.1209784</pub-id></mixed-citation></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Contreras</surname><given-names>M</given-names></name><name><surname>Magris</surname><given-names>M</given-names></name><name><surname>Hidalgo</surname><given-names>G</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title><source>Proc Natl Acad Sci</source><year>2010</year><volume>107</volume><issue>26</issue><fpage>11971</fpage><lpage>11975</lpage><pub-id pub-id-type="pid">20566857</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1002601107</pub-id></mixed-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salminen</surname><given-names>S</given-names></name><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>McCartney</surname><given-names>AL</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Influence of mode of delivery on gut microbiota composition in seven year old children</article-title><source>Gut</source><year>2004</year><volume>53</volume><issue>9</issue><fpage>1388</fpage><lpage>1389</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD2cvgt1CrtQ%3D%3D</pub-id><pub-id pub-id-type="pid">15306608</pub-id><pub-id pub-id-type="pmcid">1774211</pub-id><pub-id pub-id-type="doi">10.1136/gut.2004.041640</pub-id></mixed-citation></ref><ref id="CR146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>E</given-names></name><name><surname>Engelmann</surname><given-names>G</given-names></name><name><surname>Findeisen</surname><given-names>A</given-names></name><name><surname>Gerner</surname><given-names>P</given-names></name><name><surname>Laass</surname><given-names>M</given-names></name><name><surname>Ney</surname><given-names>D</given-names></name><name><surname>Posovszky</surname><given-names>C</given-names></name><name><surname>Hoy</surname><given-names>L</given-names></name><name><surname>Hornef</surname><given-names>MW</given-names></name></person-group><article-title xml:lang="en">Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children</article-title><source>Pediatrics</source><year>2010</year><volume>125</volume><issue>6</issue><fpage>e1433</fpage><lpage>1440</lpage><pub-id pub-id-type="pid">20478942</pub-id><pub-id pub-id-type="doi">10.1542/peds.2009-2260</pub-id></mixed-citation></ref><ref id="CR147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emilsson</surname><given-names>L</given-names></name><name><surname>Magnus</surname><given-names>MC</given-names></name><name><surname>Stordal</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Perinatal risk factors for development of celiac disease in children, based on the prospective norwegian mother and child cohort study</article-title><source>Clin Gastroenterol Hepatol</source><year>2015</year><volume>13</volume><issue>5</issue><fpage>921</fpage><lpage>927</lpage><pub-id pub-id-type="pid">25459557</pub-id><pub-id pub-id-type="doi">10.1016/j.cgh.2014.10.012</pub-id></mixed-citation></ref><ref id="CR148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namatovu</surname><given-names>F</given-names></name><name><surname>Olsson</surname><given-names>C</given-names></name><name><surname>Lindkvist</surname><given-names>M</given-names></name><name><surname>MylÃ©us</surname><given-names>A</given-names></name><name><surname>HÃ¶gberg</surname><given-names>U</given-names></name><name><surname>Ivarsson</surname><given-names>A</given-names></name><name><surname>SandstrÃ¶m</surname><given-names>O</given-names></name></person-group><article-title xml:lang="en">Maternal and perinatal conditions and the risk of developing celiac disease during childhood</article-title><source>BMC Pediat</source><year>2016</year><volume>16</volume><fpage>77</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1186/s12887-016-0613-y</pub-id></mixed-citation></ref><ref id="CR149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MÃ¥rild</surname><given-names>K</given-names></name><name><surname>Stephansson</surname><given-names>O</given-names></name><name><surname>Montgomery</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name><name><surname>Ludvigsson</surname><given-names>JF</given-names></name></person-group><article-title xml:lang="en">Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study</article-title><source>Gastroenterology</source><year>2012</year><volume>142</volume><issue>1</issue><fpage>39</fpage><lpage>45.e33</lpage><pub-id pub-id-type="pid">21995948</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2011.09.047</pub-id></mixed-citation></ref><ref id="CR150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canova</surname><given-names>C</given-names></name><name><surname>Zabeo</surname><given-names>V</given-names></name><name><surname>Pitter</surname><given-names>G</given-names></name><name><surname>Romor</surname><given-names>P</given-names></name><name><surname>Baldovin</surname><given-names>T</given-names></name><name><surname>Zanotti</surname><given-names>R</given-names></name><name><surname>Simonato</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy</article-title><source>Am J Epidemiol</source><year>2014</year><volume>180</volume><issue>1</issue><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="pid">24853109</pub-id><pub-id pub-id-type="doi">10.1093/aje/kwu101</pub-id></mixed-citation></ref><ref id="CR151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becattini</surname><given-names>S</given-names></name><name><surname>Taur</surname><given-names>Y</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group><article-title xml:lang="en">Antibiotic-induced changes in the intestinal microbiota and disease</article-title><source>Trends Mol Med</source><year>2016</year><volume>22</volume><issue>6</issue><fpage>458</fpage><lpage>478</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xns1eiu70%3D</pub-id><pub-id pub-id-type="pid">27178527</pub-id><pub-id pub-id-type="pmcid">4885777</pub-id><pub-id pub-id-type="doi">10.1016/j.molmed.2016.04.003</pub-id></mixed-citation></ref><ref id="CR152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ianiro</surname><given-names>G</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Antibiotics as deep modulators of gut microbiota: between good and evil</article-title><source>Gut</source><year>2016</year><volume>65</volume><issue>11</issue><fpage>1906</fpage><lpage>1915</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsVSlurY%3D</pub-id><pub-id pub-id-type="pid">27531828</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2016-312297</pub-id></mixed-citation></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokulich</surname><given-names>NA</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Battaglia</surname><given-names>T</given-names></name><name><surname>Henderson</surname><given-names>N</given-names></name><name><surname>Jay</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>DL</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Perez-Perez</surname><given-names>GI</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Schweizer</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Contreras</surname><given-names>M</given-names></name><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">Antibiotics, birth mode, and diet shape microbiome maturation during early life</article-title><source>Sci Transl Med</source><year>2016</year><pub-id pub-id-type="pid">27306664</pub-id><pub-id pub-id-type="pmcid">5308924</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aad7121</pub-id><comment>(8 (343):343ra382)</comment></mixed-citation></ref><ref id="CR154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozo-Rubio</surname><given-names>T</given-names></name><name><surname>de Palma</surname><given-names>G</given-names></name><name><surname>Mujico</surname><given-names>JR</given-names></name><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Marcos</surname><given-names>A</given-names></name><name><surname>AcuÃ±a</surname><given-names>MD</given-names></name><name><surname>Polanco</surname><given-names>I</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name><name><surname>Nova</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study</article-title><source>Nutr Hosp</source><year>2013</year><volume>28</volume><issue>2</issue><fpage>464</fpage><lpage>473</lpage><pub-id pub-id-type="pid">23822699</pub-id><pub-id pub-id-type="doi">10.3305/nh.2013.28.2.6310</pub-id></mixed-citation></ref><ref id="CR155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dydensborg Sander</surname><given-names>S</given-names></name><name><surname>Nybo Andersen</surname><given-names>AM</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name><name><surname>Karlstad</surname><given-names>O</given-names></name><name><surname>Husby</surname><given-names>S</given-names></name><name><surname>Stordal</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Association Between Antibiotics in the First Year of Life and Celiac Disease</article-title><source>Gastroenterology</source><year>2019</year><volume>156</volume><issue>8</issue><fpage>2217</fpage><lpage>2229</lpage><pub-id pub-id-type="pid">30836095</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2019.02.039</pub-id></mixed-citation></ref><ref id="CR156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marild</surname><given-names>K</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Lebwohl</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Card</surname><given-names>T</given-names></name><name><surname>Ludvigsson</surname><given-names>JF</given-names></name></person-group><article-title xml:lang="en">Antibiotic exposure and the development of coeliac disease: a nationwide case-control study</article-title><source>BMC Gastroenterol</source><year>2013</year><volume>13</volume><fpage>109</fpage><pub-id pub-id-type="pid">23834758</pub-id><pub-id pub-id-type="pmcid">3720284</pub-id><pub-id pub-id-type="doi">10.1186/1471-230X-13-109</pub-id></mixed-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittker</surname><given-names>SS</given-names></name><name><surname>Bell</surname><given-names>KR</given-names></name></person-group><article-title xml:lang="en">Potential risk factors for celiac disease in childhood: a case-control epidemiological survey</article-title><source>Clin Exp Gastroenterol</source><year>2019</year><volume>12</volume><fpage>303</fpage><lpage>319</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BB3cXjsVGrsrg%3D</pub-id><pub-id pub-id-type="pid">31308721</pub-id><pub-id pub-id-type="pmcid">6615019</pub-id><pub-id pub-id-type="doi">10.2147/CEG.S210060</pub-id></mixed-citation></ref><ref id="CR158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Hall</surname><given-names>KD</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>McCartney</surname><given-names>AL</given-names></name><name><surname>Roberto</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Nutrition and the science of disease prevention: a systems approach to support metabolic health</article-title><source>Ann N Y Acad Sci</source><year>2015</year><volume>1352</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pid">26415028</pub-id><pub-id pub-id-type="pmcid">5298925</pub-id><pub-id pub-id-type="doi">10.1111/nyas.12945</pub-id></mixed-citation></ref><ref id="CR159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordovas</surname><given-names>JM</given-names></name><name><surname>Ferguson</surname><given-names>LR</given-names></name><name><surname>Tai</surname><given-names>ES</given-names></name><name><surname>Mathers</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Personalised nutrition and health</article-title><source>BMJ</source><year>2018</year><pub-id pub-id-type="pid">29898881</pub-id><pub-id pub-id-type="pmcid">6081996</pub-id><pub-id pub-id-type="doi">10.1136/bmj.k2173</pub-id><comment>(361:bmj k2173)</comment></mixed-citation></ref><ref id="CR160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loos</surname><given-names>RJF</given-names></name></person-group><article-title xml:lang="en">From nutrigenomics to personalizing diets: are we ready for precision medicine?</article-title><source>Am J Clin Nutr</source><year>2019</year><volume>109</volume><issue>1</issue><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="pid">30715122</pub-id><pub-id pub-id-type="pmcid">6358032</pub-id><pub-id pub-id-type="doi">10.1093/ajcn/nqy364</pub-id></mixed-citation></ref><ref id="CR161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macready</surname><given-names>AL</given-names></name><name><surname>Fallaize</surname><given-names>R</given-names></name><name><surname>Butler</surname><given-names>LT</given-names></name><name><surname>Ellis</surname><given-names>JA</given-names></name><name><surname>Kuznesof</surname><given-names>S</given-names></name><name><surname>Frewer</surname><given-names>LJ</given-names></name><name><surname>Celis-Morales</surname><given-names>C</given-names></name><name><surname>Livingstone</surname><given-names>KM</given-names></name><name><surname>Araujo-Soares</surname><given-names>V</given-names></name><name><surname>Fischer</surname><given-names>AR</given-names></name><name><surname>Stewart-Knox</surname><given-names>BJ</given-names></name><name><surname>Mathers</surname><given-names>JC</given-names></name><name><surname>Lovegrove</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Application of behavior change techniques in a personalized nutrition electronic health intervention study: protocol for the web-based food4me randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2018</year><volume>7</volume><issue>4</issue><fpage>e87</fpage><pub-id pub-id-type="pid">29631993</pub-id><pub-id pub-id-type="pmcid">5913568</pub-id><pub-id pub-id-type="doi">10.2196/resprot.8703</pub-id></mixed-citation></ref><ref id="CR162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Ucmak</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Abrouk</surname><given-names>M</given-names></name><name><surname>Farahnik</surname><given-names>B</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>TH</given-names></name><name><surname>Bhutani</surname><given-names>T</given-names></name><name><surname>Liao</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Influence of diet on the gut microbiome and implications for human health</article-title><source>J Transl Med</source><year>2017</year><volume>15</volume><issue>1</issue><fpage>73</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsVans7%2FO</pub-id><pub-id pub-id-type="pid">28388917</pub-id><pub-id pub-id-type="pmcid">5385025</pub-id><pub-id pub-id-type="doi">10.1186/s12967-017-1175-y</pub-id></mixed-citation></ref><ref id="CR163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>TSB</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">The human gut microbiome: from association to modulation</article-title><source>Cell</source><year>2018</year><volume>172</volume><issue>6</issue><fpage>1198</fpage><lpage>1215</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXktlSksbo%3D</pub-id><pub-id pub-id-type="pid">29522742</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.02.044</pub-id></mixed-citation></ref><ref id="CR164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Pruteanu</surname><given-names>M</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Zeller</surname><given-names>G</given-names></name><name><surname>Telzerow</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>EE</given-names></name><name><surname>Brochado</surname><given-names>AR</given-names></name><name><surname>Fernandez</surname><given-names>KC</given-names></name><name><surname>Dose</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Patil</surname><given-names>KR</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Typas</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Extensive impact of non-antibiotic drugs on human gut bacteria</article-title><source>Nature</source><year>2018</year><volume>555</volume><issue>7698</issue><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXltVyqsLY%3D</pub-id><pub-id pub-id-type="pid">29555994</pub-id><pub-id pub-id-type="pmcid">6108420</pub-id><pub-id pub-id-type="doi">10.1038/nature25979</pub-id></mixed-citation></ref><ref id="CR165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Mathur</surname><given-names>T</given-names></name><name><surname>Joshi</surname><given-names>V</given-names></name><name><surname>Upadhyay</surname><given-names>DJ</given-names></name><name><surname>Inoue</surname><given-names>SI</given-names></name><name><surname>Masuda</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Effect of DS-2969b, a novel GyrB inhibitor, on rat and monkey intestinal microbiota</article-title><source>Anaerobe</source><year>2018</year><volume>51</volume><fpage>120</fpage><lpage>123</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXpsFOltr8%3D</pub-id><pub-id pub-id-type="pid">29758524</pub-id><pub-id pub-id-type="doi">10.1016/j.anaerobe.2018.04.017</pub-id></mixed-citation></ref><ref id="CR166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudek-Wicher</surname><given-names>RK</given-names></name><name><surname>Junka</surname><given-names>A</given-names></name><name><surname>Bartoszewicz</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The influence of antibiotics and dietary components on gut microbiota</article-title><source>Prz Gastroenterol</source><year>2018</year><volume>13</volume><issue>2</issue><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXhs1KhtL3M</pub-id><pub-id pub-id-type="pid">30002765</pub-id><pub-id pub-id-type="pmcid">6040098</pub-id><pub-id pub-id-type="doi">10.5114/pg.2018.76005</pub-id></mixed-citation></ref><ref id="CR167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Statovci</surname><given-names>D</given-names></name><name><surname>Aguilera</surname><given-names>M</given-names></name><name><surname>MacSharry</surname><given-names>J</given-names></name><name><surname>Melgar</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">The impact of western diet and nutrients on the microbiota and immune response at mucosal interfaces</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>838</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitVWnsbfF</pub-id><pub-id pub-id-type="pid">28804483</pub-id><pub-id pub-id-type="pmcid">5532387</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00838</pub-id></mixed-citation></ref><ref id="CR168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>LA</given-names></name><name><surname>Maurice</surname><given-names>CF</given-names></name><name><surname>Carmody</surname><given-names>RN</given-names></name><name><surname>Gootenberg</surname><given-names>DB</given-names></name><name><surname>Button</surname><given-names>JE</given-names></name><name><surname>Wolfe</surname><given-names>BE</given-names></name><name><surname>Ling</surname><given-names>AV</given-names></name><name><surname>Devlin</surname><given-names>AS</given-names></name><name><surname>Varma</surname><given-names>Y</given-names></name><name><surname>Fischbach</surname><given-names>MA</given-names></name><name><surname>Biddinger</surname><given-names>SB</given-names></name><name><surname>Dutton</surname><given-names>RJ</given-names></name><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name></person-group><article-title xml:lang="en">Diet rapidly and reproducibly alters the human gut microbiome</article-title><source>Nature</source><year>2014</year><volume>505</volume><issue>7484</issue><fpage>559</fpage><lpage>563</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtFOls78%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature12820</pub-id></mixed-citation></ref><ref id="CR169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinzone</surname><given-names>MR</given-names></name><name><surname>Celesia</surname><given-names>BM</given-names></name><name><surname>Di Rosa</surname><given-names>M</given-names></name><name><surname>Cacopardo</surname><given-names>B</given-names></name><name><surname>Nunnari</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Microbial translocation in chronic liver diseases</article-title><source>Int J Microbiol</source><year>2012</year><volume>2012</volume><fpage>694629</fpage><pub-id pub-id-type="pid">22848224</pub-id><pub-id pub-id-type="pmcid">3405644</pub-id><pub-id pub-id-type="doi">10.1155/2012/694629</pub-id></mixed-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="other">World Health Organization (2003) Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation 916. <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/42665/WHO_TRS_916.pdf;jsessionid=4D311C3BE1D830F26EDDA65210DE5A22?sequence=1">https://apps.who.int/iris/bitstream/handle/10665/42665/WHO_TRS_916.pdf;jsessionid=4D311C3BE1D830F26EDDA65210DE5A22?sequence=1</ext-link></mixed-citation></ref><ref id="CR171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akobeng</surname><given-names>AK</given-names></name><name><surname>Thomas</surname><given-names>AG</given-names></name></person-group><article-title xml:lang="en">Systematic review: tolerable amount of gluten for people with coeliac disease</article-title><source>Aliment Pharmacol Ther</source><year>2008</year><volume>27</volume><issue>11</issue><fpage>1044</fpage><lpage>1052</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXotFamurY%3D</pub-id><pub-id pub-id-type="pid">18315587</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2036.2008.03669.x</pub-id></mixed-citation></ref><ref id="CR172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciacci</surname><given-names>C</given-names></name><name><surname>Ciclitira</surname><given-names>P</given-names></name><name><surname>Hadjivassiliou</surname><given-names>M</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name><name><surname>Ludvigsson</surname><given-names>JF</given-names></name><name><surname>McGough</surname><given-names>N</given-names></name><name><surname>Sanders</surname><given-names>DS</given-names></name><name><surname>Woodward</surname><given-names>J</given-names></name><name><surname>Leonard</surname><given-names>JN</given-names></name><name><surname>Swift</surname><given-names>GL</given-names></name></person-group><article-title xml:lang="en">The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis</article-title><source>United Eur Gastroenterol J</source><year>2015</year><volume>3</volume><issue>2</issue><fpage>121</fpage><lpage>135</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1ehu7fL</pub-id><pub-id pub-id-type="doi">10.1177/2050640614559263</pub-id></mixed-citation></ref><ref id="CR173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogberg</surname><given-names>L</given-names></name><name><surname>Grodzinsky</surname><given-names>E</given-names></name><name><surname>Stenhammar</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Better dietary compliance in patients with coeliac disease diagnosed in early childhood</article-title><source>Scand J Gastroenterol</source><year>2003</year><volume>38</volume><issue>7</issue><fpage>751</fpage><lpage>754</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3szls1OqsQ%3D%3D</pub-id><pub-id pub-id-type="pid">12889562</pub-id><pub-id pub-id-type="doi">10.1080/00365520310003318</pub-id></mixed-citation></ref><ref id="CR174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G</given-names></name><name><surname>Nadal</surname><given-names>I</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects</article-title><source>Br J Nutr</source><year>2009</year><volume>102</volume><issue>8</issue><fpage>1154</fpage><lpage>1160</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtl2itr7N</pub-id><pub-id pub-id-type="pid">19445821</pub-id><pub-id pub-id-type="doi">10.1017/S0007114509371767</pub-id></mixed-citation></ref><ref id="CR175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>FW</given-names></name></person-group><article-title xml:lang="en">Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects - comment by Jackson</article-title><source>Br J Nutr</source><year>2010</year><volume>104</volume><issue>5</issue><fpage>773</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtFCktbrL</pub-id><pub-id pub-id-type="pid">20465858</pub-id><pub-id pub-id-type="doi">10.1017/s0007114510001960</pub-id></mixed-citation></ref><ref id="CR176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarin</surname><given-names>SK</given-names></name><name><surname>Pande</surname><given-names>A</given-names></name><name><surname>Schnabl</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Microbiome as a therapeutic target in alcohol-related liver disease</article-title><source>J Hepatol</source><year>2019</year><volume>70</volume><issue>2</issue><fpage>260</fpage><lpage>272</lpage><pub-id pub-id-type="pid">30658727</pub-id><pub-id pub-id-type="doi">10.1016/j.jhep.2018.10.019</pub-id></mixed-citation></ref><ref id="CR177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoruts</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Targeting the microbiome: from probiotics to fecal microbiota transplantation</article-title><source>Gen Med</source><year>2018</year><volume>10</volume><issue>1</issue><fpage>80</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXpslKkt7Y%3D</pub-id><pub-id pub-id-type="doi">10.1186/s13073-018-0592-8</pub-id></mixed-citation></ref><ref id="CR178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncoroni</surname><given-names>L</given-names></name><name><surname>Bascunan</surname><given-names>KA</given-names></name><name><surname>Doneda</surname><given-names>L</given-names></name><name><surname>Scricciolo</surname><given-names>A</given-names></name><name><surname>Lombardo</surname><given-names>V</given-names></name><name><surname>Branchi</surname><given-names>F</given-names></name><name><surname>Ferretti</surname><given-names>F</given-names></name><name><surname>Dell'Osso</surname><given-names>B</given-names></name><name><surname>Montanari</surname><given-names>V</given-names></name><name><surname>Bardella</surname><given-names>MT</given-names></name><name><surname>Elli</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">A low fodmap gluten-free diet improves functional gastrointestinal disorders and overall mental health of celiac disease patients: a randomized controlled trial</article-title><source>Nutrients</source><year>2018</year><pub-id pub-id-type="pid">30445688</pub-id><pub-id pub-id-type="pmcid">6265860</pub-id><pub-id pub-id-type="doi">10.3390/nu10081023</pub-id></mixed-citation></ref><ref id="CR179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddel</surname><given-names>S</given-names></name><name><surname>Putignani</surname><given-names>L</given-names></name><name><surname>Del Chierico</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">The impact of low-FODMAPs, gluten-free, and ketogenic diets on gut microbiota modulation in pathological conditions</article-title><source>Nutrients</source><year>2019</year><pub-id pub-id-type="pid">31887978</pub-id><pub-id pub-id-type="pmcid">7019826</pub-id><pub-id pub-id-type="doi">10.3390/nu11020373</pub-id></mixed-citation></ref><ref id="CR180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieterich</surname><given-names>W</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Schink</surname><given-names>M</given-names></name><name><surname>Schwappacher</surname><given-names>R</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name><name><surname>Agaimy</surname><given-names>A</given-names></name><name><surname>Neurath</surname><given-names>MF</given-names></name><name><surname>Zopf</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity</article-title><source>Clin Nutr</source><year>2019</year><volume>38</volume><issue>2</issue><fpage>697</fpage><lpage>707</lpage><pub-id pub-id-type="pid">29653862</pub-id><pub-id pub-id-type="doi">10.1016/j.clnu.2018.03.017</pub-id></mixed-citation></ref><ref id="CR181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderpool</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Polk</surname><given-names>DB</given-names></name></person-group><article-title xml:lang="en">Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases</article-title><source>Inflamm Bowel Dis</source><year>2008</year><volume>14</volume><issue>11</issue><fpage>1585</fpage><lpage>1596</lpage><pub-id pub-id-type="pid">18623173</pub-id><pub-id pub-id-type="doi">10.1002/ibd.20525</pub-id></mixed-citation></ref><ref id="CR182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laparra</surname><given-names>JM</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion</article-title><source>J Cell Biochem</source><year>2010</year><volume>109</volume><issue>4</issue><fpage>801</fpage><lpage>807</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXisFGrsLw%3D</pub-id><pub-id pub-id-type="pid">20052669</pub-id><pub-id pub-id-type="doi">10.1002/jcb.22459</pub-id></mixed-citation></ref><ref id="CR183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindfors</surname><given-names>K</given-names></name><name><surname>Blomqvist</surname><given-names>T</given-names></name><name><surname>Juuti-Uusitalo</surname><given-names>K</given-names></name><name><surname>Stenman</surname><given-names>S</given-names></name><name><surname>Venalainen</surname><given-names>J</given-names></name><name><surname>Maki</surname><given-names>M</given-names></name><name><surname>Kaukinen</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture</article-title><source>Clin Exp Immunol</source><year>2008</year><volume>152</volume><issue>3</issue><fpage>552</fpage><lpage>558</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD1czgtVWlsQ%3D%3D</pub-id><pub-id pub-id-type="pid">18422736</pub-id><pub-id pub-id-type="pmcid">2453197</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03635.x</pub-id></mixed-citation></ref><ref id="CR184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smecuol</surname><given-names>E</given-names></name><name><surname>Hwang</surname><given-names>HJ</given-names></name><name><surname>Sugai</surname><given-names>E</given-names></name><name><surname>Corso</surname><given-names>L</given-names></name><name><surname>Chernavsky</surname><given-names>AC</given-names></name><name><surname>Bellavite</surname><given-names>FP</given-names></name><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Vodanovich</surname><given-names>F</given-names></name><name><surname>Moreno</surname><given-names>ML</given-names></name><name><surname>Vazquez</surname><given-names>H</given-names></name><name><surname>Lozano</surname><given-names>G</given-names></name><name><surname>Niveloni</surname><given-names>S</given-names></name><name><surname>Mazure</surname><given-names>R</given-names></name><name><surname>Meddings</surname><given-names>J</given-names></name><name><surname>Maurino</surname><given-names>E</given-names></name><name><surname>Bai</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease</article-title><source>J Clin Gastroenterol</source><year>2013</year><volume>47</volume><issue>2</issue><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pid">23314670</pub-id><pub-id pub-id-type="doi">10.1097/MCG.0b013e31827759ac</pub-id></mixed-citation></ref><ref id="CR185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Castillejo</surname><given-names>G</given-names></name><name><surname>Varea</surname><given-names>V</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease</article-title><source>Br J Nutr</source><year>2014</year><volume>112</volume><issue>1</issue><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXps1CjsL8%3D</pub-id><pub-id pub-id-type="pid">24774670</pub-id><pub-id pub-id-type="doi">10.1017/s0007114514000609</pub-id></mixed-citation></ref><ref id="CR186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Auricchio</surname><given-names>S</given-names></name><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>C</given-names></name><name><surname>De Vincenzi</surname><given-names>M</given-names></name><name><surname>Giovannini</surname><given-names>C</given-names></name><name><surname>D'Archivio</surname><given-names>M</given-names></name><name><surname>Landolfo</surname><given-names>F</given-names></name><name><surname>Parrilli</surname><given-names>G</given-names></name><name><surname>Minervini</surname><given-names>F</given-names></name><name><surname>Arendt</surname><given-names>E</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients</article-title><source>Appl Environ Microbiol</source><year>2004</year><volume>70</volume><issue>2</issue><fpage>1088</fpage><lpage>1096</lpage><pub-id pub-id-type="pid">14766592</pub-id><pub-id pub-id-type="pmcid">348803</pub-id><pub-id pub-id-type="doi">10.1128/aem.70.2.1088-1096.2004</pub-id></mixed-citation></ref><ref id="CR187"><label>187.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>Auricchio</surname><given-names>R</given-names></name><name><surname>Di Mase</surname><given-names>R</given-names></name><name><surname>Landolfo</surname><given-names>F</given-names></name><name><surname>Paparo</surname><given-names>F</given-names></name><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Rizzello</surname><given-names>CG</given-names></name><name><surname>Cassone</surname><given-names>A</given-names></name><name><surname>Terrone</surname><given-names>G</given-names></name><name><surname>Timpone</surname><given-names>L</given-names></name><name><surname>D'Aniello</surname><given-names>M</given-names></name><name><surname>Maglio</surname><given-names>M</given-names></name><name><surname>Troncone</surname><given-names>R</given-names></name><name><surname>Auricchio</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing</article-title><source>Clin Gastroenterol Hepatol</source><year>2011</year><volume>9</volume><issue>1</issue><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="pid">20951830</pub-id><pub-id pub-id-type="doi">10.1016/j.cgh.2010.09.025</pub-id></mixed-citation></ref><ref id="CR188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Rizzello</surname><given-names>CG</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Clemente</surname><given-names>MG</given-names></name><name><surname>De Simone</surname><given-names>C</given-names></name><name><surname>Silano</surname><given-names>M</given-names></name><name><surname>De Vincenzi</surname><given-names>M</given-names></name><name><surname>Losito</surname><given-names>I</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue</article-title><source>Biochim Biophys Acta</source><year>2006</year><volume>1762</volume><issue>1</issue><fpage>80</fpage><lpage>93</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXht1OntbnI</pub-id><pub-id pub-id-type="pid">16311022</pub-id><pub-id pub-id-type="doi">10.1016/j.bbadis.2005.09.008</pub-id></mixed-citation></ref><ref id="CR189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drabinska</surname><given-names>N</given-names></name><name><surname>Jarocka-Cyrta</surname><given-names>E</given-names></name><name><surname>Markiewicz</surname><given-names>LH</given-names></name><name><surname>Krupa-Kozak</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">The effect of oligofructose-enriched inulin on faecal bacterial counts and microbiota-associated characteristics in celiac disease children following a gluten-free diet: results of a randomized placebo-controlled trial</article-title><source>Nutrients</source><year>2018</year><pub-id pub-id-type="pid">30469412</pub-id><pub-id pub-id-type="pmcid">6266607</pub-id><pub-id pub-id-type="doi">10.3390/nu10020201</pub-id></mixed-citation></ref><ref id="CR190"><label>190.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cammarota</surname><given-names>G</given-names></name><name><surname>Ianiro</surname><given-names>G</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name><name><surname>Rajilic-Stojanovic</surname><given-names>M</given-names></name><name><surname>Kump</surname><given-names>P</given-names></name><name><surname>Satokari</surname><given-names>R</given-names></name><name><surname>Sokol</surname><given-names>H</given-names></name><name><surname>Arkkila</surname><given-names>P</given-names></name><name><surname>Pintus</surname><given-names>C</given-names></name><name><surname>Hart</surname><given-names>A</given-names></name><name><surname>Segal</surname><given-names>J</given-names></name><name><surname>Aloi</surname><given-names>M</given-names></name><name><surname>Masucci</surname><given-names>L</given-names></name><name><surname>Molinaro</surname><given-names>A</given-names></name><name><surname>Scaldaferri</surname><given-names>F</given-names></name><name><surname>Gasbarrini</surname><given-names>G</given-names></name><name><surname>Lopez-Sanroman</surname><given-names>A</given-names></name><name><surname>Link</surname><given-names>A</given-names></name><name><surname>de Groot</surname><given-names>P</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Hogenauer</surname><given-names>C</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Mattila</surname><given-names>E</given-names></name><name><surname>Milosavljevic</surname><given-names>T</given-names></name><name><surname>Nieuwdorp</surname><given-names>M</given-names></name><name><surname>Sanguinetti</surname><given-names>M</given-names></name><name><surname>Simren</surname><given-names>M</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name><name><surname>European</surname><given-names>FMTWG</given-names></name></person-group><article-title xml:lang="en">European consensus conference on faecal microbiota transplantation in clinical practice</article-title><source>Gut</source><year>2017</year><volume>66</volume><issue>4</issue><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="pid">28087657</pub-id><pub-id pub-id-type="pmcid">5529972</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2016-313017</pub-id></mixed-citation></ref><ref id="CR191"><label>191.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quraishi</surname><given-names>MN</given-names></name><name><surname>Widlak</surname><given-names>M</given-names></name><name><surname>Bhala</surname><given-names>N</given-names></name><name><surname>Moore</surname><given-names>D</given-names></name><name><surname>Price</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Iqbal</surname><given-names>TH</given-names></name></person-group><article-title xml:lang="en">Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory clostridium difficile infection</article-title><source>Aliment Pharmacol Ther</source><year>2017</year><volume>46</volume><issue>5</issue><fpage>479</fpage><lpage>493</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXht1yisLzK</pub-id><pub-id pub-id-type="pid">28707337</pub-id><pub-id pub-id-type="doi">10.1111/apt.14201</pub-id></mixed-citation></ref><ref id="CR192"><label>192.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beurden</surname><given-names>YH</given-names></name><name><surname>van Gils</surname><given-names>T</given-names></name><name><surname>van Gils</surname><given-names>NA</given-names></name><name><surname>Kassam</surname><given-names>Z</given-names></name><name><surname>Mulder</surname><given-names>CJ</given-names></name><name><surname>Aparicio-Pages</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Serendipity in refractory celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer</article-title><source>J Gastrointestin Liver Dis</source><year>2016</year><volume>25</volume><issue>3</issue><fpage>385</fpage><lpage>388</lpage><pub-id pub-id-type="pid">27689204</pub-id><pub-id pub-id-type="doi">10.15403/jgld.2014.1121.253.cel</pub-id></mixed-citation></ref><ref id="CR193"><label>193.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Ribes-Koninckx</surname><given-names>C</given-names></name><name><surname>Calabuig</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Intestinal <italic>Staphylococcus</italic> spp. and virulent features associated with coeliac disease</article-title><source>J Clin Pathol</source><year>2012</year><volume>65</volume><issue>9</issue><fpage>830</fpage><lpage>834</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1Wqtb3M</pub-id><pub-id pub-id-type="pid">22718843</pub-id><pub-id pub-id-type="doi">10.1136/jclinpath-2012-200759</pub-id></mixed-citation></ref><ref id="CR194"><label>194.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>SE</given-names></name><name><surname>Williams</surname><given-names>JG</given-names></name><name><surname>Meddings</surname><given-names>D</given-names></name><name><surname>Davidson</surname><given-names>R</given-names></name><name><surname>Goldacre</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">Perinatal risk factors and coeliac disease in children and young adults: a record linkage study</article-title><source>Aliment Pharmacol Ther</source><year>2009</year><volume>29</volume><issue>2</issue><fpage>222</fpage><lpage>231</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD1M%2Fls1KrsA%3D%3D</pub-id><pub-id pub-id-type="pid">18945253</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2036.2008.03871.x</pub-id></mixed-citation></ref><ref id="CR195"><label>195.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevelsted</surname><given-names>A</given-names></name><name><surname>Stokholm</surname><given-names>J</given-names></name><name><surname>BÃ¸nnelykke</surname><given-names>K</given-names></name><name><surname>Bisgaard</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Cesarean section and chronic immune disorders</article-title><source>Pediatrics</source><year>2014</year><pub-id pub-id-type="pid">25452656</pub-id><pub-id pub-id-type="doi">10.1542/peds.2014-0596</pub-id><comment>(peds.2014-0596)</comment></mixed-citation></ref><ref id="CR196"><label>196.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlercreutz</surname><given-names>EH</given-names></name><name><surname>Wingren</surname><given-names>CJ</given-names></name><name><surname>Vincente</surname><given-names>RP</given-names></name><name><surname>Merlo</surname><given-names>J</given-names></name><name><surname>Agardh</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease</article-title><source>Acta Paediatr</source><year>2015</year><volume>104</volume><issue>2</issue><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="pid">25346455</pub-id><pub-id pub-id-type="doi">10.1111/apa.12836</pub-id></mixed-citation></ref><ref id="CR197"><label>197.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koletzko</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Beyerlein</surname><given-names>A</given-names></name><name><surname>Aronsson</surname><given-names>CA</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Simell</surname><given-names>V</given-names></name><name><surname>Kurppa</surname><given-names>K</given-names></name><name><surname>Lernmark</surname><given-names>A</given-names></name><name><surname>Hagopian</surname><given-names>W</given-names></name><name><surname>Rewers</surname><given-names>M</given-names></name><name><surname>She</surname><given-names>JX</given-names></name><name><surname>Simell</surname><given-names>O</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name><name><surname>Krischer</surname><given-names>J</given-names></name><name><surname>Agardh</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">cesarean section on the risk of celiac disease in the offspring: the teddy study</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2018</year><volume>66</volume><issue>3</issue><fpage>417</fpage><lpage>424</lpage><pub-id pub-id-type="pid">28753178</pub-id><pub-id pub-id-type="pmcid">5787038</pub-id><pub-id pub-id-type="doi">10.1097/mpg.0000000000001682</pub-id></mixed-citation></ref><ref id="CR198"><label>198.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dydensborg Sander</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>AV</given-names></name><name><surname>Stordal</surname><given-names>K</given-names></name><name><surname>Andersen</surname><given-names>AN</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name><name><surname>Husby</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Mode of delivery is not associated with celiac disease</article-title><source>Clin Epidemiol</source><year>2018</year><volume>10</volume><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="pid">29593435</pub-id><pub-id pub-id-type="pmcid">5865582</pub-id><pub-id pub-id-type="doi">10.2147/clep.S152168</pub-id></mixed-citation></ref><ref id="CR199"><label>199.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francavilla</surname><given-names>R</given-names></name><name><surname>Piccolo</surname><given-names>M</given-names></name><name><surname>Francavilla</surname><given-names>A</given-names></name><name><surname>Polimeno</surname><given-names>L</given-names></name><name><surname>Semeraro</surname><given-names>F</given-names></name><name><surname>Cristofori</surname><given-names>F</given-names></name><name><surname>Castellaneta</surname><given-names>S</given-names></name><name><surname>Barone</surname><given-names>M</given-names></name><name><surname>Indrio</surname><given-names>F</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>De Angelis</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent ibs-type symptoms: a randomized, double-blind, placebo-controlled</article-title><source>Multicenter Trial J Clin Gastroenterol</source><year>2019</year><volume>53</volume><issue>3</issue><fpage>e117</fpage><lpage>e125</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXis1Ghsrc%3D</pub-id><pub-id pub-id-type="pid">29688915</pub-id><pub-id pub-id-type="doi">10.1097/mcg.0000000000001023</pub-id></mixed-citation></ref><ref id="CR200"><label>200.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinello</surname><given-names>F</given-names></name><name><surname>Roman</surname><given-names>CF</given-names></name><name><surname>Souza</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">EFFECTS OF PROBIOTIC INTAKE ON INTESTINAL BIFIDOBACTERIA OF CELIAC PATIENTS</article-title><source>Arq Gastroenterol</source><year>2017</year><volume>54</volume><issue>2</issue><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pid">28273274</pub-id><pub-id pub-id-type="doi">10.1590/s0004-2803.201700000-07</pub-id></mixed-citation></ref><ref id="CR201"><label>201.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Sanchez</surname><given-names>MI</given-names></name><name><surname>Smecuol</surname><given-names>EC</given-names></name><name><surname>Temprano</surname><given-names>MP</given-names></name><name><surname>Sugai</surname><given-names>E</given-names></name><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Moreno</surname><given-names>ML</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Bercik</surname><given-names>P</given-names></name><name><surname>Cabanne</surname><given-names>A</given-names></name><name><surname>Vazquez</surname><given-names>H</given-names></name><name><surname>Niveloni</surname><given-names>S</given-names></name><name><surname>Mazure</surname><given-names>R</given-names></name><name><surname>Maurino</surname><given-names>E</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Bai</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Bifidobacterium infantis NLS super strain reduces the expression of alpha-defensin-5, a marker of innate immunity, in the mucosa of active celiac disease patients</article-title><source>J Clin Gastroenterol</source><year>2017</year><volume>51</volume><issue>9</issue><fpage>814</fpage><lpage>817</lpage><pub-id pub-id-type="pid">27636409</pub-id><pub-id pub-id-type="doi">10.1097/mcg.0000000000000687</pub-id></mixed-citation></ref><ref id="CR202"><label>202.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harnett</surname><given-names>J</given-names></name><name><surname>Myers</surname><given-names>SP</given-names></name><name><surname>Rolfe</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Probiotics and the microbiome in celiac disease: a randomised controlled trial</article-title><source>Evid Based Compl Alternat Med</source><year>2016</year><volume>2016</volume><fpage>9048574</fpage><pub-id pub-id-type="doi">10.1155/2016/9048574</pub-id></mixed-citation></ref><ref id="CR203"><label>203.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uusitalo</surname><given-names>U</given-names></name><name><surname>Andren Aronsson</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kurppa</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Skidmore</surname><given-names>J</given-names></name><name><surname>Winkler</surname><given-names>C</given-names></name><name><surname>Rewers</surname><given-names>MJ</given-names></name><name><surname>Hagopian</surname><given-names>WA</given-names></name><name><surname>She</surname><given-names>JX</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name><name><surname>Akolkar</surname><given-names>B</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Virtanen</surname><given-names>SM</given-names></name><name><surname>Krischer</surname><given-names>JP</given-names></name><name><surname>Agardh</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Early probiotic supplementation and the risk of celiac disease in children at genetic risk</article-title><source>Nutrients</source><year>2019</year><pub-id pub-id-type="pid">31382440</pub-id><pub-id pub-id-type="pmcid">6722940</pub-id><pub-id pub-id-type="doi">10.3390/nu11081790</pub-id></mixed-citation></ref><ref id="CR204"><label>204.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Primec</surname><given-names>M</given-names></name><name><surname>Klemenak</surname><given-names>M</given-names></name><name><surname>Di Gioia</surname><given-names>D</given-names></name><name><surname>Aloisio</surname><given-names>I</given-names></name><name><surname>Bozzi Cionci</surname><given-names>N</given-names></name><name><surname>Quagliariello</surname><given-names>A</given-names></name><name><surname>Gorenjak</surname><given-names>M</given-names></name><name><surname>Micetic-Turk</surname><given-names>D</given-names></name><name><surname>Langerholc</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-alpha and short-chain fatty acids</article-title><source>Clin Nutr</source><year>2019</year><volume>38</volume><issue>3</issue><fpage>1373</fpage><lpage>1381</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhtF2jt7vO</pub-id><pub-id pub-id-type="pid">29960810</pub-id><pub-id pub-id-type="doi">10.1016/j.clnu.2018.06.931</pub-id></mixed-citation></ref><ref id="CR205"><label>205.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quagliariello</surname><given-names>A</given-names></name><name><surname>Aloisio</surname><given-names>I</given-names></name><name><surname>Bozzi Cionci</surname><given-names>N</given-names></name><name><surname>Luiselli</surname><given-names>D</given-names></name><name><surname>D'Auria</surname><given-names>G</given-names></name><name><surname>Martinez-Priego</surname><given-names>L</given-names></name><name><surname>Perez-Villarroya</surname><given-names>D</given-names></name><name><surname>Langerholc</surname><given-names>T</given-names></name><name><surname>Primec</surname><given-names>M</given-names></name><name><surname>Micetic-Turk</surname><given-names>D</given-names></name><name><surname>Di Gioia</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Effect of bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study</article-title><source>Nutrients</source><year>2016</year><pub-id pub-id-type="pid">27782071</pub-id><pub-id pub-id-type="pmcid">5084046</pub-id><pub-id pub-id-type="doi">10.3390/nu8100660</pub-id></mixed-citation></ref><ref id="CR206"><label>206.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klemenak</surname><given-names>M</given-names></name><name><surname>Dolinsek</surname><given-names>J</given-names></name><name><surname>Langerholc</surname><given-names>T</given-names></name><name><surname>Di Gioia</surname><given-names>D</given-names></name><name><surname>Micetic-Turk</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Administration of bifidobacterium breve decreases the production of tnf-alpha in children with celiac disease</article-title><source>Dig Dis Sci</source><year>2015</year><volume>60</volume><issue>11</issue><fpage>3386</fpage><lpage>3392</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhtFGlur3L</pub-id><pub-id pub-id-type="pid">26134988</pub-id><pub-id pub-id-type="doi">10.1007/s10620-015-3769-7</pub-id></mixed-citation></ref></ref-list></ref-list></back></article></records><facets><facet name="subject"><facet-value count="1">Chemistry</facet-value><facet-value count="1">Nutrition</facet-value></facet><facet name="keyword"><facet-value count="1">Coeliac disease</facet-value><facet-value count="1">Dysbiosis</facet-value><facet-value count="1">Metagenomics</facet-value><facet-value count="1">Microbiota</facet-value></facet><facet name="pub"><facet-value count="1">European Journal of Nutrition</facet-value></facet><facet name="year"><facet-value count="1">2020</facet-value></facet><facet name="country"><facet-value count="1">Qatar</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
